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ABSTRACT 
 
MOLECULAR ANALYSES OF CHANGES INDUCED IN THE MICROBIAL 
POPULATIONS OF MURINE COLON AFTER As (III) EXPOSURE 
 
 
 
By 
Rishu Dheer 
August, 2011 
 
Dissertation supervised by Dr. John F. Stolz 
 The gut microbiota is essential for mammalian health and metabolism. 
Thus identifying factors that influence the host microbiota is key to understanding the 
dynamic interplay between the host and its microbiota. Recent studies have shown the 
effect of chronic exposures of trivalent arsenic [As(III)]  in environmentally relevant 
concentrations on host physiology, however, little is known of how it impacts the gut 
microbiota.  
This study examined the hypothesis that environmentally relevant concentrations 
of As(III) in drinking water will directly affect the murine colon microbial composition 
and physiology. The colon microbial communities from 10 and 250 ppb of As(III) 
exposed mice were compared to the control mice after 2, 5 and 10 weeks of As(III) 
exposure. Molecular analysis based on 16S rRNA gene and 16S- 23S intergenic region 
indicated a time and dose dependent shift in microbial community composition. Analysis 
 v 
of 16S rDNA clone libraries demonstrated an increase in Bacteroidetes and 
proportionally fewer Firmicutes in colon microbiota in response to As(III) exposure. 
Microbes have developed mechanisms to tolerate arsenic present in the 
environment. This study is the first to show that the gut microbes express arsenic resistant 
genes (arsA and arsB) in the colon. However, exposure to ppb concentrations of As(III) 
did not induce the expression of these genes in colon microbes. These data suggest that 
the selective effect of As(III) on colon microbiota was not due to direct exposure of colon 
microbes to As(III), but rather a response to changes in the host physiology.  
Since arsenic affects the NO levels in human cell lines, it was hypothesized that 
As(III) will affect the pathways that are linked to NO levels in human body. Many 
microbes present in human body have nitrogen metabolizing genes (nrfA) that contribute 
to NO levels, thus the expression levels of nrfA gene in colon microbes was examined. 
Real time RT-qPCR studies showed a time and dose dependent increase in nrfA 
expression in response to As(III) exposure. Together, the results presented in this study 
demonstrated an indirect effect of As(III) on the composition and physiology of murine 
colon microbiota that may further impact the host health. 
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Chapter 1 : INTRODUCTION 
 
1.1 Arsenic Background 
 
Arsenic (Atomic number 33 and mass 74.92) is the 20
th
 most abundant element in 
the earth’s crust with a concentration of 3.4 parts per million. Arsenic in combination 
with elements such as iron, copper, nickel, cobalt etc. forms more than 245 minerals 
including realgar (As4S4), arsenopyrite (FeAsS), nickel arsenide (NiAs), cobaltite 
(CoAsS) and scorodite (FeAsO4) (Wedepohl, 1991; Nriagu, 2002). Used since antiquity, 
arsenic was first discovered by Albert Magnus in 1250. Being colorless, odorless and 
tasteless in nature, arsenic in the form of As2O3 is considered as the perfect poisoning 
agent (NRC, 1997). Along with some famous cases of homicidal death due to arsenic 
poisoning, many cases of accidental arsenic poisoning have been reported throughout 
history (Nriagu, 2002). Despite its toxicity, arsenic has a long history for its use as a 
curative for diseases such as psoriasis, syphilis and trypanosomiasis (Leonard, 1991). In 
1905, Paul Ehrlich received the Nobel Prize in medicine for the discovery of salvarsan to 
combat syphilis (Azcue & Nriagu, 1994). Arsenic in the form of arsenic trioxide is used 
till today for the treatment of patients with acute promyleocytic leukemia due to its ability 
to induce apoptosis in cancer cells (Antman, 2001). Both inorganic and organic forms of 
arsenic have been used at a large scale in the manufacture of chemical warfare agent, 
semiconductors, glass manufacturing, paints, dyes, wood preservation, feed additives, 
pesticides and herbicides (Nriagu, 2002; Azcue & Nriagu, 1994). Due to concerns about 
the risk posed by arsenic on human health, use of arsenic in certain household 
applications has been completely banned (ATSDR, 2007). Even though the production of 
  
2 
arsenic in United States has been ceased since 1985, it is still the largest consumer of 
arsenic. Most of the imported arsenic is used for commercial purposes such as 
manufacturing glass and semiconductor devices. It is also used in metal and agricultural 
industry sectors (ATSDR, 2007).  
1.2 Arsenic in the environment 
 
In the environment, inorganic arsenic occurs in sedimentary rocks, fossil fuel 
deposits and minerals while organic arsenic in the form of arsenobetaine and 
arsenocholine is found in marine animals and algae (Friberg et al, 1986; Lau et al, 1987). 
In nature, arsenic exists in four different oxidation states: +5, +3, 0 and -3. Of these, 
elemental arsenic [As(0)] is rare whereas arsine [As(-III)] is found at very low levels in 
gases from oxygen deficient environments (Cullen & Reimer, 1989). As(III) and As(V) 
are the most toxic and abundant forms of inorganic and organic arsenic, primarily 
existing as oxyanions in the environment. Depending upon pH and oxygen, arsenate 
usually exists as arsenic acid in 4 different states (H3AsO4, H2AsO4
−
, HAsO3
2−
 and 
AsO4
3−
) whereas arsenite forms arsenous acid species (H3AsO3, H2AsO3
− 
and HAsO3
2−
) 
under reducing conditions (Ni & Sadler, 1991). Compared to arsenite, arsenate is the less 
toxic and more oxidized form of arsenic, occurring mainly in aqueous aerobic 
environments whereas arsenite is prevalent in anaerobic environments (Cullen & Reimer, 
1989). Arsenate due to its ability to adsorb readily to minerals such as ferrihydrite, iron 
oxide and alumina, is less soluble and relatively immobile as opposed to mobile arsenite 
(Smedley & Kinniburgh, 2002). Changes in pH, oxidation-reduction potential, ion 
concentration of iron, nitrate or sulfide and composition of microbiota in the surrounding 
environment influences the release of arsenic from rocks or sediments (Smedley & 
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Kinniburgh, 2002; Oremland & Stolz, 2005). Arsenic species can be transformed from 
one form to another but cannot be removed from the environment. Arsenic is released 
into the environment from natural as well as anthropogenic sources. Natural sources of 
arsenic release include volcanic disruption, dissolution from rocks, leaching from soil and 
minerals into ground water whereas anthropogenic sources include mining, fossil fuel 
combustion, waste incineration, wood treatment and irrigation runoff after pesticide and 
herbicide application (Pacyna, 1987; Welch et al, 2000). In addition, aquatic and 
terrestrial animals also introduce some methylated organoarsenicals in the environment as 
excretory products (Andreae & Klumpp, 1979; Aposhian et al, 2000). Arsenic is one of 
the most common health hazards in the environment and affects millions of people across 
the world. Due to its toxicity and ease of exposure to humans, arsenic ranks first among 
the hazardous elements on Superfund sites (HazDat, 2006). 
1.3 Microbes mediated arsenic cycling 
 
Arsenate enters into prokaryotic cells via phosphate transporters (Pst and Pit) 
while arsenite enters through glycerol transporter (GlpF) (Rosen & Liu, 2009; Meng et al, 
2004; Harold & Baarda, 1966). To deal with arsenic toxicity, a wide variety of 
microorganisms have developed mechanism such as detoxification and methylation to 
remove toxic arsenic species from the cell or to convert it into less toxic forms. In 
addition, an increasing number of microorganisms are being discovered that can use 
arsenic for energy and growth (Stolz & Oremland, 1999; Silver & Phung, 2005). Many 
microorganisms have the ability to both oxidize and reduce arsenic and possess 
machinery to perform a combination of the above mentioned processes (Richey et al, 
2009; Saltikov et al, 2005; Macur et al, 2004). Such microbial properties have led to the 
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establishment of a rigorous microbe mediated arsenic biogeochemical cycle in certain 
extreme arsenic rich environments like Mono Lake CA (Oremland et al, 2004). Recently 
GFAJ-1 a γ proteobacteria isolated from this lake has been shown to replace phosphate 
with arsenic in its genomic material and was able to grow actively after this substitution 
(Wolfe-Simon et al, 2010). Figure 1.1 shows the various pathways adopted by 
microorganism to combat arsenic toxicity.  
Methylation 
Microbe mediated methylation reaction is proposed to involve an alternating 
sequence of reduction and oxidation of As(V) and As(III) respectively with methylation 
(Bentley & Chasteen, 2002; Challenger, 1945), resulting in the production of volatile 
methylated arsine gases and nonvolatile arsenic acids (McBride & Wolfe, 1971). 
Methylation was originally considered as a detoxification method however recent 
evidence suggests that some of these methylated compounds are more toxic then 
inorganic arsenic species (Styblo et al, 2000; Petrick et al, 2001). In the case of Bacteria 
and Archaea transfer of a methyl group from S-adenosylmethionine (SAM) to As (III) is 
catalyzed by ArsM, a methyltransferase (Qin et al, 2006). Methyl cobalamin also serves 
as a methyl donor in some bacterial species but the mechanism by which methyl group is 
transferred to arsenic species is not clear yet (Gadd, 1993; Krautler, 1990).  
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Figure 1.1: Pathways adopted by microorganism to combat arsenic toxicity. (1) Entry of 
arsenite and arsenate via glycerolporin and phosphate transporters. (2) As(V) reduction 
followed by expulsion of As(III) (3) Detoxification of As(III) by sequestration (4) 
arsenite oxidation (5) Dissimilatory As(V) respiration and (6) methylation of arsenic 
species. Figure reproduced from Espino et al; 2009 with permission from the author. 
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Arsenite oxidation 
Arsenite oxidation by bacteria can be used either as a detoxification process or an 
energy generation process (Tamaki & Frankenberger, 1992; Oremland & Stolz, 2003). 
Bacteria from α, β and γ proteobacteria and other phyla representing more than 9 genera 
have been reported to have arsenite oxidizing abilities (Santini et al, 2002; Salmassi et al, 
2002; Gihring & Banfield, 2001). The detoxification reaction, mediated by heterotrophic 
arsenite oxidizers (HAOs) involves oxidation of As (III) to As (V) by periplasmic 
enzyme arsenite oxidase and no energy is generated in the process (Muller et al, 2003). In 
Chemolithotrophic arsenite oxidizers (CAOs), oxidation of arsenite is an energy 
generating process and the process is coupled to reduction of oxygen, nitrate or nitrite. 
The energy generated in the process is used for fixing CO2 into organic material 
(Oremland et al, 2002; Rhine et al, 2006). Arsenite oxidase belongs to the DMSO 
reductase family and consists of aoxA and aoxB genes that encode, respectively, the large 
90 KDa Mo containing and the small 14KDa Rieske (2Fe-2S) subunits of arsenite 
oxidase (Ellis et al, 2001; Santini & vanden, 2004).  
Arsenate reduction 
Dissimilatory As(V)-respiring prokaryotes (DARPs) reduce As(V) to As(III) and 
energy is generated in the process (Oremland & Stolz, 2005; Stolz & Oremland, 1999). In 
DARPs, arsenate reduction is coupled to the oxidation of either organic or inorganic 
compounds (Niggemyer et al, 2001; Hoeft et al, 2004; Liu et al, 2004; Takai et al, 2003). 
The process was first discovered in Sulfurospirillum arsenophilum and has been 
identified in many other bacterial species since then (Oremland & Stolz, 2005; Ahmann 
et al, 1994). Arsenic requirement is not obligate for DARPs as they are capable of using 
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other terminal electron acceptors such as nitrate, selenate, selenite, fumarate, and sulfur 
compounds for energy generation (Oremland & Stolz, 2003). Respiratory arsenate 
reductases belong to DMSO family of mononuclear molybdenum-containing enzymes 
consisting of 87 and 29 kDa subunits. Both periplasmic and membrane bound respiratory 
arsenate reductases have been found. The large catalytic subunit, ArrA, contains motifs 
for binding an iron-sulfur cluster and Mo containing pyranopterin cofactor whereas ArrB, 
the smaller electron transfer subunit, contains three [4Fe-4S] and one [3Fe-4S] iron-sulfur 
clusters (Saltikov & Newman, 2003; Afkar et al, 2003). 
Arsenate reduction via the ars operon is one of the most well studied systems for 
arsenic detoxification and has been identified in wide variety of Bacteria, Archea and 
yeast (Jackson & Dugas, 2003). In bacteria the genes for ars operon are located on 
plasmids or chromosome. The genes that typically form an ars operon include: arsB, 
arsC and arsR (Xu et al, 1998). arsA, arsD and arsH are some other genes that may 
occur in the ars operon of some bacteria. The arrangement and configuration of genes 
involved in arsenic tolerance vary from species to species (Figure 1.2).  
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Figure 1.2: Arrangement of ars operon in bacterial species. arsR (blue), arsB (green), 
ACR3 (yellow), glutaredoxin coupled arsC (orange), thioredoxin coupled arsC (red), 
arsH (purple) and other genes (white). Figure modified from Espino et al, 2009 with 
permission from the author. 
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ArsC, a 12- 16 KDa cytoplasmic arsenate reductase, reduces As(V) to As(III)  (Ji 
& Silver, 1992). As (III) is exported out of the cell via ArsB, an arsenite specific 
transmembrane protein (Rosen, 1999). In some organisms the process of arsenite 
expulsion is coupled to ATP hydrolysis to form an oxyanion- translocating complex and 
the ATPase in these microbes is encoded by arsA (Dey et al, 1994). In bacteria where 
ArsA is not present, the proton motive force across the cell membrane facilitates arsenite 
expulsion (Figure 2A). ArsD is a 13KDa cytosolic metallochaperone that exists as 
homodimer and facilitates the transfer of As(III) to ArsA thus helping in As(III) 
expulsion (Lin et al, 2007). ArsR is a trans acting transcriptional repressor which in the 
absence of As(III) represses the expression of ars operon by binding to the operator 
region within the promoter of the operon (Xu et al, 1996). ArsH is a NADPH-flavin 
mononucleotide oxidoreductase that is required for arsenic resistance in Yersinia 
enterocolitica, Shigella flexneri and Sinorhizobium meliloti but its role in arsenic 
detoxification is not clear yet (Vorontsov et al, 2007; Ye et al, 2007).  
On the basis of structure, reducing power and the location of catalytic cysteine 
residues the arsenate reductases are classified into 3 protein families: (i) E.coli plasmid 
R773 type glutaredoxin coupled arsenate reductase (Gladysheva et al, 1994) (ii) 
Staphylococcus aureus plasmid pI258 type thioredoxin coupled arsenate reductase (Ji et 
al, 1994) (iii) Eukaryotic glutaredoxin coupled arsenate reductase from Saccharomyces 
cerevisiae (Bobrowicz et al, 1997).  
Similar to arsenate reductase, the As(III) membrane efflux protein is currently 
divided into 2 distinct protein families (Rosen, 1999) (i) the typical ArsB protein type 
found in Firmicutes and γ proteobacteria and (ii) ACR3 type present in Actinobacteria, α 
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proteobacteria, Archaea and S. cerevisiae. The 2 protein types although similar in size, 
differ in structure and specificity for metal transport (Wu et al, 1992; Wysocki et al, 
1997). While ACR3 with 10 membrane spanning segments is specific for As(III) only, 
ArsB with 12 membrane spanning segments can transport antimonite in addition to 
arsenite (Ghosh et al, 1999).  
The ars genes are transcribed from a single promoter to form a polycistronic 
mRNA with a very short half-life of less than 4 minutes. ArsR is a 13 KDa protein that 
belongs to winged-helix metalloregulatory proteins and forms a dimer (Busenlehner et al, 
2003). In E.coli, arsenite binds to sulfur thiolates of 3 conserved Cys residues at position 
32, 34 and 37 of the DNA binding domain of ArsR. The binding of As(III) or Sb(III) in 
the DNA binding domain induces a conformational change in ArsR leading to disruption 
of DNA-ArsR interaction. This disruption results in release of ArsR from the promoter 
region, inducing the transcription of ars genes (Shi et al, 1996).  
1.4 Routes of arsenic exposure  
 
Water 
 
Humans are exposed to inorganic forms of arsenic mainly through drinking water 
and food and to a lesser extent via dermal absorption and by inhalation of dust (WHO, 
2001). Natural level of arsenic in surface and ground water is 1-2 µg/L. However the 
levels may reach upto 3400 µg/L in water bodies close to natural or anthropogenic 
sources of arsenic (Matschullat, 2000). Approximately 100 million people across the 
globe are exposed to high levels of inorganic arsenic mainly through drinking water 
contaminated by natural mineral deposits. Besides natural sources, anthropogenic sources 
including industrial waste, mining and agricultural manure release arsenic into the water 
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(Nriagu & Pacyna, 1988). Countries like Taiwan, Japan, Chile, China, Finland, Denmark, 
Bangladesh and India have regions where arsenic concentration in water supplies have 
reached ppm levels (WHO, 2001). In United States, approximately 13 million people 
consume water from public supplies that have arsenic concentration >10 µg/L (Welch et 
al, 2000). High concentrations of arsenic in the US are associated with mining, 
geothermal activities and natural deposits. Due to its toxicity, EPA has reduced the 
permissible exposure limits of As in drinking water supplies from 50 µg/L to 10 µg/L in 
2006, to match that of WHO levels (EPA, 2001). According to the data collected by US 
geological survey from 1973 − 2000 in 31,500 ground water supplies across the US, 
various regions of US including New England, Maine, Nevada, Utah, New Mexico and 
Arizona have arsenic concentrations above the recommended 10 ppb or  10 µg/L (USGS, 
2007) (Figure 1.3). 
Air 
In the atmosphere arsenic is primarily released as arsenic trioxide or less 
frequently as volatile arsine (Pacyna, 1987; Matschullat, 2000). Concentration of arsenic 
in atmosphere ranges from 1-3 ng/m
3
 in remote locations but may reach upto 2000 ng/m
3
 
in areas close to anthropogenic sources of arsenic. In the US about 355 tons of arsenic 
compounds are released into the atmosphere every year (EPA, 2005). Exposure to higher 
levels of arsenic via dust mainly occurs in people involved in production or use of arsenic 
compounds such as workers at pesticide industry, glass production and metal smelters. 
Also people living in vicinity of these industry inhale more arsenic as compared to people 
living in clean environments (Pacyna, 1987).  
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Figure 1.3: Arsenic concentrations in drinking water supplies across United States. 
http://water.usgs.gov/nawqa/trace/pubs/geo_v46n11/fig2.html. 
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Food 
The arsenic concentration in food ranges from 20 to 140 ppb. Rice, apple, grapes, 
lettuce, tomatoes and potatoes may have arsenic concentrations in the ppm range (Schoof 
et al, 1999). Also the food grown in arsenic contaminated soils may accumulate higher 
levels of arsenic (Abedin et al, 2002; Carbonell-Barrachina et al, 1997). Exposure to 
arsenic also occurs via poultry consumption because of widespread use of arsenic as a 
feed additive in poultry industry (Lasky et al, 2003). Exposure to organoarsenicals 
(arsenobetaine and arsenocholine) occurs by consuming seafood but is considered 
nontoxic as organoarsenicals are excreted unchanged (Brown et al, 1990; Yamauchi et al, 
1986). However, in vitro studies with intestinal microbes from humans have 
demonstrated the transformation of arsenobetaine to DMA(V), TMAO and 
dimethylarsinoylacetate under aerobic conditions (Harrington et al, 2008). It is estimated 
that the average dietary intake of arsenic in US ranges from 0.31 – 1.14 μg/kg/day 
(MacIntosh et al, 1997). According to Food and Agriculture Organization (FAO), the 
maximum tolerable daily intake of total arsenic is 2-7 μg/kg body weight/day (WHO, 
2010). 
Soil and dermal absorption 
Levels of arsenic in soil range from 1 to 40 mg/kg but may reach higher levels in 
areas associated with arsenic use such as golf fields, agricultural lands, mining areas and 
waste disposal sites (Mandal & Suzuki, 2002). Arsenic from such sites leaches into the 
sub-surface aquifers and may enter into drinking water supplies. Although dermal 
absorption of arsenic from soils is negligible, it occurs more commonly due to 
occupational exposures (Lowney et al, 2007). In vitro studies with human skin have 
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shown 1.9% absorption of inorganic arsenic over a period of 24 hours (Wester et al, 
1993). 
1.5 Fate of arsenic in humans 
 
Absorption of As(III) 
 
Ingested inorganic arsenic is readily absorbed in the GI tract (Vahter & Norin, 
1980) wherein it binds to proteins and other low molecular weight compounds present in 
the blood and is transported to other organs in the body (NRC, 1999). The amount of 
arsenic absorbed by GI tract, its retention and distribution to other body parts is 
dependent on the type of arsenic species, oxidation state and dose level; with As(III) 
being more efficiently retained and transported (Thomas et al, 2001). Arsenic is also 
absorbed via lungs after inhalation and this inhaled arsenic can subsequently be absorbed 
in the GI tract after clearance from the respiratory tract (Vahter et al, 1986; Yamauchi et 
al, 1989). Like microbes, As(III) is transported in the mammalian cells via 
aquaglycoporins (APQ7 and APQ9) (Liu et al, 2002) whereas As(V) is transported by 
phosphate transporters (Huang & Lee, 1996).  
Arsenic metabolism 
After absorption, inorganic arsenic is transformed in the human body by 
reduction, oxidation, conjugation and methylation reactions (Carter et al, 2003). The liver 
is considered as the main organ where methylation of inorganic As(III) occurs but the 
role of other organs or tissues such as kidneys, lungs, skin and RBCs in arsenic 
metabolism has also been reported (Buchet et al, 1984; Cohen et al, 2006). Two models 
have been proposed for the biotransformation of arsenic in mammalian systems (i) 
Generally accepted pathway suggested by Challenger (Challenger, 1945) (ii) alternate 
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pathway proposed by Hayakawa (Hayakawa et al, 2005). The first step is common to 
both the pathways wherein As(V) is reduced to As(III) in the blood with thiols working 
as electron donors. Glutathione-S-transferase omega (GSTO1) is the arsenate reductase 
enzyme that has been identified to play a role in this transformation (Zakharyan et al, 
2001). In addition several other enzymes including purine nucleoside phosphorylase 
(Radabaugh et al, 2002), glycogen phosphorylase (Gregus & Németi, 2007), 
glyceraldehyde dehydrogenase (Gregus & Németi, 2005) that can reduce arsenate in 
mammalian cells have been reported but their physiological role has not been established 
so far. More recently the catalytic domains of human Cdc25B and Cdc25C phosphatases 
have been proposed to play a role in arsenate reduction. These enzymes are structurally 
similar to ArsC found in yeast (Bhattacharjee et al, 2010). In the generally accepted 
pathway suggested by Challenger, arsenic undergoes alternate oxidation and reduction 
along with methylation to produce methylated arsenic species in a specific order with +5 
oxidation state of an arsenic species generated before the +3 state of the same arsenic 
species (Figure 1.4). Both As3MT (arsenic methyltransferase) and CYT19 have been 
proposed to methylate arsenic species (Zakharyan et al, 1999; Lin et al, 2002). According 
to the Hayakawa pathway, As(V) is reduced to As(III) followed by formation of arsenic 
triglutathione (ATG) in the presence of glutathione. ATG is further converted into 
monomethyl arsenic diglutathione (MADG) and dimethyl arsinic glutathione (DMAG) 
by transfer of methyl group from S-adenosyl methionine As3MT. Both MADG and 
DMAG form equilibrium with MMA(III) and DMA(III) respectively. MMA and DMA 
are readily converted to their pentavalent forms by oxidation (Figure 1.5).  
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Figure 1.4: Arsenic biotransformation pathway suggested by Challenger. Figure 
reproduced from Hayakawa et al, 2005 with permission from the author. 
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Figure 1.5: Arsenic biotransformation pathway proposed by Hayakawa. Figure 
reproduced from Hayakawa et al, 2005 with permission from the author. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
18 
Arsenic excretion 
From liver inorganic arsenic and its methylated metabolites are distributed to 
other organs of the body. The retention time for inorganic arsenic is longer in skin, hair, 
upper GI tract, skeleton and lens of the eye (Lindgren et al, 1982; Yamauchi & 
Yamamura, 1985). The main products of methylation of inorganic As in humans are 
monomethylarsonic acid [MMA(V)], monomethylarsonous acid [MMA(III)], 
dimethylarsinic acid [DMA(V)] and dimethylarsinous acid [DMA(V)] ((Vahter, 2002; Le 
et al, 2000). Of these, MMA(III) and DMA(III) are the most toxic and reactive forms but 
are formed as intermediates only (Styblo et al, 2000; Petrick et al, 2001). MMA(V) and 
DMA(V) are less toxic forms of arsenic and do not react readily with tissues. These 
forms are readily excreted in the urine along with untransformed inorganic arsenic 
(Vahter, 2002). In addition, relatively nontoxic trimethylarsine oxide (TMAO) and highly 
toxic sulfur containing monomethylmonothioarsonic acid [MMMTA(V)] and 
dimethylmonothioarsinic acid [DMMTA(V)] have also been observed in human urine 
(Yoshida et al, 1998; Naranmandura et al, 2007). Elimination of arsenic from the human 
body occurs in three phases: (i) 66% removal within two days (ii) 30% elimination in ten 
days and (iii) 4% removed in 38 days (Mealey et al, 1959; Marafante et al, 1985). In 
humans typically 10-30% of the arsenic is removed in its inorganic form, 10-20% as 
MMA and 55-75% as DMA. However these values may differ in individuals depending 
on genotype, sex, exposure dose and route of exposure (Loffredo et al, 2003). Although 
the majority of absorbed arsenic is removed from the body via urine (80%), a small 
amount of it is also removed via stool and sweat (10%). A small percentage of ingested 
arsenic accumulates in the hair, nails, bones and muscles (ATSDR, 2007). Multi-drug 
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resistance proteins (MRP1 and MRP2) have been documented to be involved in the 
expulsion of As(III) and possibly arsenic glutathione from mammalian cells (Leslie et al, 
2004). 
Arsenic transformation by gut microbes 
In vivo studies with intravenous injection of sodium arsenate in rats demonstrated 
rapid formation of methylated arsenicals in a pattern similar to those found after oral 
administration suggesting that intestinal microbes do not play any significant role in 
methylation of arsenic under in vivo conditions (Rowland & Davies, 1982). However 
studies have shown that metabolism of arsenic in rats differ significantly from human and 
mice (Vahter, 1994). In all mammals, the rate of absorption of arsenic after oral 
consumption via the GI tract depends not only on the oxidation state and speciation but 
also on the bioavailability of the ingested arsenic species (Laparra et al, 2006; Juhasz et 
al, 2006). The reentry of arsenic or its metabolites into the gut via enterohepatic 
circulation also exposes the intestinal microbiota to this toxin (Csanaky & Gregus, 2002). 
An in vivo study with rats showed toxic effects of arsenic (1mg/L) on the total bacterial 
count in stool along with reduced levels of arsenic in the stool samples (Choudhry et al, 
2010). In vitro studies have shown that the gut microflora of arsenic exposed individuals 
can also play a significant role in detoxification and elimination of arsenic from the body. 
Rat and mice cecal microbiota were shown to biotransform As(V) to As(III) with the 
formation of MMA and DMA (Rowland & Davies, 1981; Hall et al, 1997). In addition to 
As(V) reduction, dissimilatory arsenate reduction was observed in hamster fecal samples 
after being fed with 100 mg/L of As(V) via drinking water (Herbel et al, 2002). More 
recently it was demonstrated that the in vitro human intestinal microbial community has 
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the ability for presystemic arsenic metabolism resulting in the formation of MMMTA 
along with MMA and DMA (Van de Wiele et al, 2010). Moreover, formation of thiolated 
methylarsenicals is observed in the presence of intestinal microbiota (Kuroda et al, 2004). 
Together these studies indicate that arsenic transformation by intestinal microbes is 
common at least at high doses of arsenic exposure.  
1.6 Mechanism of arsenic toxicity and human health 
 
Twenty four years ago, arsenic was classified as group I carcinogen by 
International Agency for Research on Cancer (IARC, 1987). An acute exposure to arsenic 
(1-3 mg/kg body weight/day) leads to immediate effects such as vomiting, diarrhea, GI 
hemorrhage, multiple organ damage and death. The symptoms may appear within few 
minutes to hours after ingestion (Levin-Scherz et al, 1987; Armstrong et al, 1984). 
Regardless of the route of exposure, chronic exposure to arsenic in the range of 0.01–0.04 
mg/kg/day results in arsenicosis/arseniasis, skin lesions, skin, lung, liver, kidney, prostate 
and bladder cancer in humans (Wu et al, 1989). Additionally various epidemiological 
studies have linked chronic arsenic exposure to reproductive defects, developmental 
defects, neurological defects, respiratory effects, type II diabetes, weight loss and several 
cardiovascular diseases including atherosclerosis, portal cirrhosis and blackfoot disease 
(WHO, 2001). Transplacental studies have shown that arsenic crosses the placenta and 
acts as a carcinogen inducing tumors at various sites in the progeny (Waalkes et al, 
2004). Recently a number of studies have shown that drinking water containing 
environmentally relevant concentrations of As(III) in parts per billion range have 
significant effect on  various organs of mammalian model systems (Table 1.1).  
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Dose 
Exposure 
time 
Organ 
studied 
Effect Reference 
50 ppb 
5&8 
weeks 
Lung and 
heart 
Disruptive Extra Cellular 
Matrix 
Hays et al, 2008 
50 ppb 4 weeks Lungs 
Altered protein expression 
(RAGE, GST omega 1, 
enolase 1, peroxyredoxin 6) 
Lantz et al, 2007 
10, 50, 
200 ppb 
9 weeks Lungs 
Increased growth of 
implanted tumors 
Kamat et al, 2005 
50 ppb* 8 weeks Liver 
Increased glutathione and 
early hepatocyte 
degeneration 
Bashir et al, 2006 
50 ppb 16 weeks Brain 
Spontaneous locomotor 
activity, decreased 
dopamine and antidoxidants 
Bardullas et al, 2009 
10 &50 
ppb 
3 weeks Kidney Increased hexokinase II Pysher et al, 2007 
100 ppb 5 weeks Lung 
Altered expression of genes 
involved in cell adhesion, 
migration  
Kozul et al, 2009b 
100 ppb 5 weeks 
Immune 
system 
Reduced immunity to 
Influenza virus 
Kozul et al, 2009a 
50, 250, 
500 ppb 
5, 10, 20 
weeks 
Heart 
Differential expression of 
angiogenic and tissue 
remodeling genes 
Soucy et al, 2003 
10&250 
ppb 
2&5 
weeks 
Liver 
Angiogenesis and vascular 
remodeling 
Straub et al, 2007b; 
Straub et al, 2007a; 
Straub et al, 2008 
50, 100, 
300 ppb* 
~6 weeks Brain Increased glutathione 
Chaudhuri et al, 
1999 
 
Table 1.1: Changes induced in different organs of mammalian biological model sytems 
in response to As(III) exposure.* indicates studies done in rats. All other studies were 
done in mice. 
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The understanding of the molecular mechanisms behind the etiology of these 
diseases and organ dysfunction is very limited. However, various mechanisms for arsenic 
toxicity have been proposed including protein binding of arsenic, chromosome 
abnormalities, altered DNA repair, mitochondrial damage, DNA hypo and hyper 
methylation, oxidative stress and altered signal transduction pathways that lead to cell 
proliferation and tumorogenesis (Kitchin & Wallace, 2008; Liu et al, 2005; Hughes, 
2002). 
Arsenate exhibits structural similarity to phosphate and enters into the cell via phosphate 
transporters. Within the cell arsenate interferes with phosphate uptake and affects the 
processes that involve phosphate such as oxidative phosphorylation (Tamaki & 
Frankenberger, 1992). Arsenite is neutral and structurally similar to non-ionized glycerol 
at a pH less than 9.2. Arsenite can enter into the cell either by diffusion or through 
glyceroporin membrane channels (Ramírez-Solís et al, 2004; Mukhopadhyay et al, 2002). 
AQP9, a mammalian aquaglycerporin, has been shown to transport arsenite into the cells 
((Liu et al, 2002). Arsenite has the ability to bind to the sulfhydryl and thiol groups of 
amino acids and disrupt protein structure and function (NRC, 1999). It is estimated that 
arsenic affects more than 200 enzymes just by binding to them (Abernathy et al, 1999).  
Studies with vascular endothelial cells have shown that arsenite interacts 
extracellularly with sphingosine-1-phosphate (S1P1), a G protein coupled receptor and 
affects Rac1 GTPase activity (Straub et al, 2009). Rac1 GTPase is involved the in cell 
survival signal transduction pathway (Sun et al, 2006). At sublethal doses, arsenite alters 
the expression of stress response transcription factors (NFkB, Nrf2 and AP 1) and 
mitogen activated protein kinases. These proteins play an important role in cell cycle 
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control but the mechanism by which arsenite affect these pathways is not clear (Druwe & 
Vaillancourt, 2010).  
Altered DNA methylation has been associated with reduced levels of SAM due to 
its use in biomethylation of arsenic in the body. Change in the expression of enzymes 
involved in DNA methylation is considered as another factor involved in altered DNA 
methylation (Ren et al, 2010). Aberrant chromosomes occur due to arsenic induced 
deletion mutations, altered DNA repair enzymes, endoreduplication, aneuploidy and 
micronuclei formation (Moore et al, 1997; Zhang et al, 2007). 
Arsenite exposure at low levels has been shown to be associated with reactive 
oxygen species (ROS) and OH- free radical production by various mechanisms, resulting 
in oxidative damage and inactivation of proteins (Samikkannu et al, 2003; Shi et al, 
2004). In human vascular smooth muscle cells, arsenite has been shown to activate 
NADPH oxidase which reduces O2 to superoxide anion (Lynn et al, 2000). ROS alters the 
redox potential of the cell by affecting GSH reductase and thioredoxin reductase thus 
reducing the levels of thiols in the cell (Lin et al, 1999). ROS can directly damage DNA 
or can alter signal transduction pathways (Hwang & Kim, 2007). 
Arsenite has been reported to exhibit its toxicity via regulation of eNOS 
(endothelial NO synthase) and iNOS (inducible NO synthase), thus directly affecting the 
production of nitric oxide (NO) (de et al, 1996; Souza et al, 2001). Depending upon the 
cell type and dose, the effect of arsenite on NO levels can vary from increased to 
decreased or have no effect on NO production (Gurr et al, 2003). In addition, arsenite has 
been demonstrated to have an indirect effect on cellular NO levels. In vascular 
endothelial cells arsenite induces the expression of NOX, a superoxide generating 
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enzyme (Smith et al, 2001). The superoxide anion generated in the process combines with 
NO generated from the eNOS thus reducing the availability of NO for its normal 
physiological functions (Pryor & Squadrito, 1995). NO causes DNA damage either by 
directly binding to the amino groups of DNA, by forming N-nitroso compounds that 
alkylate DNA or by forming reactive oxidative species such as peroxynitrite which causes 
oxidative DNA damage (Tamir & Tannenbaum, 1996). 
1.7 Mammalian GI tract microbiome 
 
 The GI tract of mammals hosts a variety of microorganisms including bacteria, 
archaea, viruses, fungi, yeast and protozoa. Of these, bacteria are the predominant forms 
with the number of bacterial cells in the GI tract far exceeding the number of eukaryotic 
cells in human body (Savage, 1977). The GI tract of the neonate is usually sterile but 
bacterial colonization starts during birth with intestinal microbiota of infants showing 
similarity to their mothers (Palmer et al, 2007; Turnbaugh et al, 2009). The microbial 
profile of infants delivered vaginally differed significantly from those delivered by 
cesarean section and is also affected by infant diet, hygiene and medication (Penders et 
al, 2006). Bacterial profiling by molecular techniques showed that infant microflora is in 
constant flux but becomes more stable and resembles to adult towards the end of infancy 
(Palmer et al, 2007). Throughout life, a number of factors have been shown to influence 
the microbiota of the host including age, diet, antibiotic use and genotype (Mariat et al, 
2009; Turnbaugh et al, 2008; Dethlefsen et al, 2008; Zoetendal, 2001). Beside these 
external and genetic factors, environmental factors within the gut such as oxygen, pH, 
nutrient availability, redox potential and presence of other microbes also play a key role 
in determining the microflora of the gut (Hill, 1995). A large number of commensal, 
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symbiotic and opportunistic bacteria inhabit the GI tract of mammals, with density of 
bacteria increasing from stomach to large intestine (O'Hara & Shanahan, 2006). The 
diversity and type of bacteria differs not only longitudinally from stomach to the distal 
portion of the large intestine but also radially from mucosa to luminal (fecal) regions 
(Frank et al, 2007; Zoetendal et al, 2002). Culture independent high throughput 16S 
rRNA gene sequencing of human and mice intestinal microbiota have shown that gram 
negative Bacteroidetes and low GC gram positive Firmicutes are the major phyla in the 
GI tract, together constituting about 90% of the total sequenced population. Within 
Firmicutes, genera belonging to clusters XIVa and IV of the clostridial group 
predominate. Proteobacteria, Verrucomicrobia, Deferribacteres, Actinobacteria, 
Fusobacteria and other gram negative bacteria are also found in the GI tract but in very 
low abundance (Nava et al, 2011; Eckburg et al, 2005). Although the number of bacterial 
phyla in mammalian gut is very low, there are approximately 1800 different genera found 
in the gut with the number of species reaching close to 15,000. Out of these only about 
2000 different phylotypes are harbored by any particular individual at any point (Frank et 
al, 2007; Frank & Pace, 2008). The predominating bacterial genera found in the 
mammalian gut include Clostridium, Bacteroides, Ruminococcus, Lactobacillus, 
Acinetobacter, Enterobacter, Bifidobacterium with more anaerobes as compared to 
aerobes (Eckburg et al, 2005; Gordon & Dubos, 1970). The bacterial composition is 
generally conserved at the phylum level; it is the genera and species that vary greatly 
from individual to individual. Molecular 16S rRNA gene based studies of gut microbiota 
have shown sequences that do not show identity to the previously described microbes 
indicating the uniqueness of gut microbiota for each individual (Nava et al, 2011; 
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Eckburg et al, 2005; Frank & Pace, 2008). In addition, the proportion of different bacteria 
can vary from individual to individual at all levels of bacterial taxonomy. A recent 
metagenomic study has shown that although the bacterial populations differ widely 
between individuals the overall metabolic pathways encoded by these microbes tend to 
remain the same (Qin et al, 2010). A reciprocal gut microbiota transplant study done by 
using germ free mice and zebrafish showed that the gut of a given host can be colonized 
by the microbiota of another host but eventually the recipient host modulates the 
colonized microbiota such that it resembles to its own natural microbiota (Rawls et al, 
2006). These emergent properties of the intestinal microbiota while providing valuable 
information regarding evolutionary history of gut residing microbes also helps in 
discerning the mechanistic aspect of differential patterns of microbial localization within 
the gut in response to various factors.   
1.8 Role of intestinal microbiota in health and disease 
 
In a healthy adult the host bacterial interaction is primarily a symbiotic 
relationship. Intestinal bacteria play a variety of protective, structural and metabolic 
functions that provide benefits to the host (McCracken & Lorenz, 2001). The protective 
function of intestinal bacteria helps in immunity development, GI tract homeostasis and 
prevention against pathogen colonization (Hand & Belkaid, 2010; Rakoff-Nahoum et al, 
2004; Medellin-Pena & Griffiths, 2009). The metabolic function of microbes helps in 
release of key nutrients and energy from the diet, which is used by host and microbes for 
growth and sustenance (Hooper et al, 2002). However information about the role of 
individual bacterial species in host related physiological function is limited due to the 
difficulty in culturing these strict anaerobes in laboratory environments (Duncan et al, 
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2007). Section 1.9 discusses the general properties of a few bacterial genera that have 
been characterized and are commonly found in the mammalian colon.  
Within the gut environment the metabolic function of microbes produce short 
chain fatty acids (acetate, butyrate, propionate), CO2, H2 and CH4. In addition to 
generating energy from complex dietary sources, intestinal microbes also account for 
uptake and storage of this energy (Hooper et al, 2002; Bäckhed et al, 2004). Intestinal 
microbes such as B. thetaiotamicron have been shown to adapt their metabolism 
according to nutritional availability (Bjursell et al, 2006). The metabolic characters of 
different bacterial groups differ significantly with some species being more efficient in 
one pathway of energy generation than others (Mahowald et al, 2009). Studies have 
shown that obesity is related to the relative distribution of Bacteroidetes and Firmicutes 
in the gut, with obese mice and humans having less Bacteroidetes and more Firmicutes 
(Ley et al, 2005; Ley et al, 2006). Within the Firmicutes, mollicutes were found in 
increased proportions in high fat/ high sugar diet related obese mice. In these mice the 
diet induced the selection of microbes that were more efficient in metabolizing the 
readily available carbon source (Turnbaugh et al, 2008). The intestinal microbiota has 
also been found to be involved in detoxification and biotransformation of toxic metals, 
modulation of host metabolic phenotypes, metabolism of otherwise indigestible dietary 
compounds and metabolism of xenobiotics that can have profound effect on host health  
(Diaz-Bone & Van de Wiele, 2010a; Li et al, 2008; Sidhu et al, 2001; Nicholson et al, 
2005). Until recently, a number of diseases were found to be associated with a single type 
of microorganism such as C. difficile caused antibiotic associated diarrhea and H. pylori 
induced gastric carcinoma (McFarland, 2008; Correa & Houghton, 2007). However some 
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of the recent studies on human and mice GI tract have shown a link between changes in 
multiple microbial populations of the host and diseases such as autism, inflammatory 
bowel diseases, type I diabetes and atopy (Table 1.2). In most of these diseases the 
patient shows altered microbial composition and diversity of the gut microbiota when 
compared to healthy individuals. However it is not known whether this dysbiosis (change 
in microbiota) is responsible for the disease, plays a role in the progression of the disease, 
or is merely a result of the disease. The GI microbiota is known to be resilient but 
bacterial profiling after antibiotic treatment has shown that certain species may take 
anywhere from few weeks or months to years to reappear at normal levels (Dethlefsen et 
al, 2008; De La Cochetiere et al, 2005; Jernberg et al, 0000). Additionally comparative 
studies between germ free and pathogen free animals have shown that gut microbes 
contribute to the development and maintenance of other organ systems in the host by 
releasing metabolites that influence gene regulation (Wikoff et al, 2009). These studies 
have linked gut microbiota with cardiac output, immune system development, appetite 
control, development of nervous system, host response to stress and mood disorders 
(Gordan et al, 1963; Macpherson & Harris, 2004; Fetissov et al, 2008; Rhee et al, 2009; 
Sudo, 2006; Forsythe et al, 2010).  
Manipulation of host microflora by using pro and prebiotics is rapidly increasing 
as a treatment of diseases such as atopic eczema, neurological defects and various 
gastrointestinal diseases (Kalliomäki et al, 2003; Forsythe & Bienenstock, 2008; Preidis 
& Versalovic, 2009). However a complete understanding of the mechanisms lying behind 
host microbe interaction is needed for the development of individual based treatment 
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strategies. Nevertheless, the microbial community residing in the GI tract contributes to 
host health and disease and can be a useful tool in the prognosis of the diseased state. 
 
Host Disease 
Part of GI 
tract 
studied 
Type of bacteria 
affected 
Reference 
Mice Obesity Caecum 
Bacteroidetes(↓) 
Firmicutes(↑) 
Ley et al, 2005 
Human Obesity Stool 
Bacteroidetes(↓) 
Firmicutes(↑) 
Ley et al, 2006 
Children 
 (0-7yrs)
@
 
Obesity Stool 
Bifidobacteria(↓) 
Staphylococcus 
aureus(↑) 
Kalliomäki et al, 
2008 
Children  
(2-13 yrs)  
Autism feces 
Bacteroidetes(↑)  
Firmicutes(↓) 
Actinobacteria(↓) 
Proteobacteria(↑) 
Overall diversity(↑) 
Finegold et al, 
2010 
Human* 
Liver  
Cirrhosis 
feces 
Bifidobacterium(↓) 
Enterobacter(↑) 
Enterococcus(↑) 
Clostridia(↑) 
Zhao et al, 2004 
IL-10 
deficient 
129 Sv/Ev 
mice 
$
 
Colitis 
Large 
intestine 
Bacteroides(↑) 
Bifidobacterium(↑) 
Clostridium(↑) 
Eubacterium(↓) 
Acidophilus(↓) 
Bibiloni et al, 
2005 
Human 
Crohn’s 
disease and  
Ulcerative 
Colitis 
colon 
Bacteroidetes(↓) 
Lachnospiraceae(↓) 
Proteobacteria(↑) 
Bacillus(↑) 
Frank et al, 2007 
 Human  
Colorectal 
cancer 
Colorectal 
Mucosal 
biopsies 
Bacteroides(↓) 
Proteobacteria(↑) 
Dorea(↑) 
Faecalibacterium(↑) 
Coprococcus(↓) 
Bacteroides(↑) 
Overall diversity(↑) 
Shen et al, 2010 
Children 
Type I 
diabetes 
Stool 
Bacteroidetes(↑)  
Firmicutes(↓) 
Ruminococceae (↓) 
Lachnospiraceae(↓) 
Eubacteriaceae(↓) 
Veillonellaceae(↑) 
Giongo et al, 
2011 
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Bacteroideaceae(↑) 
Porphyromonadaceae(↓) 
Rikenellaceae(↓) 
Infants
^
 
Atopic 
eczema 
Feces 
E.coli(↑) 
C.difficile(↑) 
Penders et al, 
2007 
Infants* 
Wheezing/ 
Allergy 
Feces 
Bifidobacterium(↓) 
Clostridium(↑) 
Verhulst et al, 
2008 
Human 
Type II 
diabetes 
Stool 
Bacteroidetes(↑)  
Firmicutes(↓) 
Proteobacteria(↑) 
Bacteroidia(↑) 
Prevotella(↑) 
Clostridia(↓) 
Roseburia(↓) 
Bacilli(↑) 
Larsen et al, 
2010 
Preterm 
Infants 
Nectrotizing 
enterocolitis 
Stool 
Bacteroides(↓) 
Firmicutes(↓) 
Fusobacteria(↓) 
Proteobacteria(↑) 
Overall diversity(↓) 
Wang et al, 
2009 
 
Table 1.2: Changes in the composition of gut microbiota associated with various 
diseases. * indicates culture dependent studies, $ represents DGGE analysis, @ indicates 
results based on RT-qPCR and FISH, ^ represents RT-qPCR based study whereas all 
other studies were based on clone library. (↑) indicates increase in population and (↓) 
represents decrease in microbial population. 
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1.9 Predominant microbes in mammalian colon 
 
Bacteroidetes 
The phylum Bacteroidetes includes gram negative bacteria found in aqueous 
environments, soil, sediments and the intestines of animals. The phylum consists of three 
classes Bacteroidia, Flavobacteria and Sphingobacteria (Krieg et al, 2010). Of these, 
Bacteroidia is the predominant class found in the mammalian GI tract (Frank et al, 2007). 
Within class Bacteroidia, members of Bacteroidaceae, Porphyromonadaceae and 
Prevotellaceae are routinely found in the mammals (Nava et al, 2011). 
Bacteroides 
Members of the genus Bacteroides are rod shaped non-motile, gram-negative 
cells with rounded ends that occur singly or in pairs. The % mole GC of DNA varies 
from 39 to 49%. These strict anaerobes form smooth, white to gray colonies that are 1-3 
mm in diameter and are nonhemolytic. These bacteria are characterized by their ability to 
grow on media containing 20% bile. Most of the species are chemoorganotrophic and 
saccharolytic but weakly proteolytic (Song et al, 2010). Bacteroides are notorious for 
antibiotic resistance and have an ability to transfer antibiotic resistant genes via 
transposons and plasmids. Members of this genus can utilize a wide variety of complex 
polysaccharides as energy sources (Xu et al, 2003). The main members of this genus are 
B. thetaiotamicron, B. vulgaris, B. intestinalis, B. distasonis, B. ovatus and B. fragilis.  
Porphyromonas 
Members of the Porphyromonas are sensitive to bile, asaccharolytic and 
pigmented. The % mole GC of DNA is 40−55. The species belonging to this genus are 
short, non-motile, non-spore forming rods or coccobacilli. Most species yield n-butyric 
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acid, acetic acid, propionic acid and other organic acids upon fermentation (Summanen & 
Finegold, 2010).  
Prevotella 
Members of the Prevotella are sensitive to bile, moderately saccharolytic and may 
have pigmented or non-pigmented species. The % mole GC of DNA is 39.2. The species 
from this genus are short, non-motile, non-spore forming anaerobes that are rod shaped 
(Shah et al, 2010). 
Firmicutes 
The phylum Firmicutes includes both low and high GC gram positive bacteria. 
Members of this phylum vary in shape ranging from cocci to straight, helical or curved 
rods. Most of the members are chemoorganotrophic, form endospores and may be motile 
or non-motile. The % mole GC ratio is generally < 50%. Some members can grow under 
thermophilic and halophilic conditions (Schleifer, 2009). The phylum consists of 26 
families and 223 genera. Bacilli, Clostridia and Erysipelotrichia are the three classes that 
are classified under Firmicutes. Class Bacilli includes two orders: Bacillales and 
Lactobacillales. Class Clostridia consists of three orders: Clostridiales, Halanaerobiales 
and Thermoanerobacterales. Within each order there are several families however only 
one family has been assigned to Erysipelotrichia (Ludwig et al, 2009). The important 
genera that are found in the colon of mammalian hosts from this phylum include 
Lactobacillus, Ruminococcus, Coprococcus, Clostridium, Dorea, and Roseburia. 
Lactobacillus  
Lactobacillus is taxonomically classified under the order Lactobacillales and 
family Lactobacillaceae. Most of the species belonging to this genus are non-motile, non-
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spore forming, obligate saccharoclastic and facultative anaerobes with a % mole GC 
content ranging from 32−55%. Optimal growth conditions are 30-40oC with pH ranging 
from 5.5-6.2. Members of this genus cannot reduce nitrate but have the ability to use 
nitrite as final electron acceptor during lactate oxidation. Cells vary in shape and may 
exist in chains and form convex, smooth, non-pigmented opaque colonies that are 2-5 
mm in diameter. These bacteria metabolize carbohydrates via Embden Meyerhof 
pathway and phosphogluconate pathway. Both homo and hetero fermentative species are 
found in this genus (Hammes & Hertel, 2009).  
Ruminococcus 
Member of the Ruminococcus are gram positive, strict anaerobes isolated from the 
GI tract of animals and classified under order Clostridiales and family Ruminococceae. 
Cells are coccids that exist in pairs or chains and are motile with 1−3 flagella. Most 
species are chemoorganotrophic and yield small chain fatty acids (SCFA) such as acetate, 
formate, lactate, succinate and ethanol upon carbohydrate fermentation. The % mole GC 
content of the DNA is 39-47%. Species from this genus do not have the ability to ferment 
amino acids or peptides (Tayayuki, 2009a).  
Coprococcus 
The Coprococcus genus is assigned to the order Clostridiales and family 
Lachnospiraceae. Coprococcus species are gram positive, non-motile, cocci that may 
occur in pairs or chains and are obligate anaerobes with 39-42% mole GC content in the 
DNA. Members are chemoorganotrophic and yield butyric, acetic, formic and propionic 
acid on fermentation (Tayayuki, 2009b).  
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Clostridia  
Classified under order Clostridiales and family Clostridiaceae, Clostridia consists 
of 168 species assigned to ten clusters. With 22−53% mole GC content in DNA, these 
gram positive, endospore forming rods are either motile or non-motile. Most members are 
obligate anaerobes and chemoorganotrophs, however, some species are aerotolerant and 
chemoautotrophic or chemolithotrophic. The species vary in their metabolic properties 
from being saccharolytic to proteolytic or neither or both (Rainey et al, 2009).  
Roseburia 
 The Roseburia genus is taxonomically assigned under order Clostridiales and 
family Lachnospiraceae. Roseburia species including are gram negative, anaerobic, 
chemoorganotrophic, motile, curved rod shaped cells that occur singly or in pairs. The % 
mole GC content of DNA varies from 29−42%. Members of this genus can hydrolyze 
and ferment starch and can use oligosaccharides such as maltose and xylose as energy 
and carbon source (Stanton et al, 2009).  
Dorea 
 Members of the Dorea genus are gram positive, non-spore former, non-motile, 
obligate anaerobes that belong to order Clostridiales and family Lachnospiraceae. Cells 
are rod shaped that occur singly or in pairs (0.5-1.0 x 1.0-4.5 µm). Species from this 
genus cannot hydrolyze complex polysaccharides such as starch and cellulose. Ethanol, 
formate, acetate, H2 and O2 are produced after fermentation but no butyrate production 
occurs. The % mole GC content of the DNA is 40-45.6% (Blaut et al, 2009). 
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1.10 Role of gut microbes in nitric oxide (NO) generation 
 
NO is a key signaling molecule that plays an important role in numerous 
physiological processes such as neurotransmission, vasodilation, signaling, respiration 
and immunity (Moncada, 1999). Within blood NO is rapidly oxidised to nitrite or nitrate 
by heamoglobin (Hb) (Doyle & Hoekstra, 1981). Due to a very short half life, NO mainly 
acts as a paracrine signaling molecule and affects the sites or cells in its close proximity 
(Lundberg & Weitzberg, 2005). Classically it was assumed that in humans NO is 
generated by eukaryotic oxygen dependent NO synthases (NOS) wherein L-arginine 
combines with O2 to produce NO and citrulline (Palmer et al, 1988). However in the past 
decade or so, evidence for the role of host commensal bacteria as a source of NO has 
emerged.  
In humans, diet is the major source of nitrate mainly derived from green leafy 
vegetables (Ysart et al, 1999). Nitrate present in the diet is reduced to nitrite by bacteria 
residing in the oral cavity (Lundberg & Govoni, 2004). The enzymes involved in 
reducing nitrate to nitrite are cytoplasmic Nas, periplasmic Nap and membrane associated 
Nar (Potter et al, 1999; Stolz & Basu, 2002). No mammalian homologues of these 
enzymes are found indicating the process is exclusive to bacteria residing in the host. 
Following ingestion of a nitrate rich meal the levels of nitrite in saliva increase about 
10−20 fold from 50−150 µm to 1−2 mM range (Spiegelhalder et al, 1976). Nitrite 
obtained from any source (diet, oxidized product of NO or reduced product of nitrate) 
under acidic conditions of the stomach is non-enzymatically protonated to form nitrous 
acid (Benjamin et al, 1994). The nitrous acid thus formed is converted to various 
compounds including NO. In addition, xanthine oxidase (XO), aldehyde oxidase and 
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deoxygenated Hb have been shown to convert nitrite to NO in various cells and tissues 
under hypoxic conditions (Zhang et al, 1997; Zweier et al, 2010; Huang et al, 2005). In 
the stomach NO has been demonstrated to have a gastroprotective effect and plays a role 
in mucosal blood flow, mucus production and host defense against pathogen (Bjoerne et 
al, 2004; Petersson et al, 2007). Typical concentrations of NO in stomach lumen is 20-
400 ppm but is found in very low levels in the lower GI tract (Benjamin et al, 1994; 
Lundberg et al, 1994).   
Recent studies with human feces showed generation of NO in the presence of 
nitrate or nitrite at pH equivalent to those found in the lower GI tract under anaerobic 
conditions (Sobko et al, 2005).  In vivo studies with germ free and conventional animals 
showed increased NO levels in the latter indicating that bacteria in the lower GI tract play 
a role in NO generation (Sobko et al, 2004). In the lower GI tract besides eukaryotic NO 
generation, gut microbes can produce substantial amounts of NO by any of the 3 
processes: bacterial NOS, denitrification or dissimilatory nitrate reduction to ammonia 
(DNRA). Bacterial NOS have been identified in many organisms and show similarity to 
eukaryotic NOS (Choi et al, 1997; Yarullina et al, 2006; Gusarov et al, 2008). Species of 
Streptomyces, Bacillus and Deinococcus have been shown to generate NO from arginine 
under in vivo conditions. (Johnson et al, 2008a; Adak et al, 2002a; Adak et al, 2002b) A 
variety of environmental bacteria have been shown to possess either the copper 
containing NirK or the cytochrome cd nitrite reductase NirS in the periplasm and convert 
nitrite to NO during denitrification (Berks et al, 1995; Potter et al, 2001). Another set of 
bacteria possess nitrite reductase (pentaheme NrfA or siro heme NirBD) that converts 
nitrite to ammonia but are known to produce enzyme bound NO as an intermediate (Cole 
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& Brown, 1980; Einsle et al, 2002). In vitro study with E.coli has demonstrated that NrfA 
can reduce exogenously supplied NO to ammonia, an important mechanism for cellular 
detoxification (Poock et al, 2002). Studies to date have showed that most of the 
commensal bacteria reduce nitrate mainly via the DNRA pathway under conditions 
similar to those found in GI tract (Allison & Macfarlane, 1988; Parham & Gibson, 2000). 
At low concentrations of nitrate and nitrite, similar to those found in human body the 
periplasmic enzymes for nitrate (Nap) and nitrite reduction (Nrf) are activated. At high 
concentrations of nitrate and nitrite the cytoplasmic enzymes (Nar and NirBD) are 
expressed (Potter et al, 1999). In vitro studies involving N15 tracer experiments with 
human fecal microbiota showed that the most plausible explanation for the formation of 
NO by gut bacteria is enzymatic reduction of nitrate to ammonia wherein NO is produced 
along the pathway  (Joan Vermeiren et al, 2009).  Despite an increasing amount of 
evidence showing a role of gut microbes in NO generation, the significance of this 
alternate pathway of microbes mediated NO generation in lower GI tract is not well 
understood.  
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1.11 Overview of specific aims and hypothesis 
 
Chronic exposure to arsenic via drinking water is a global health problem (NRC, 
2001). Although, the effect of environmentally relevant chronic exposures to arsenic via 
drinking water on various organs has been well established, its effect on the microbiota of 
the GI tract is not well studied. There is evidence that suggests arsenic exposure via 
drinking water may affect the host microbiota either by being toxic or by affecting 
physiology. An in vivo study with rats has showed toxic effects of arsenic (1 mg/L) on 
the total bacterial count in stool samples (Choudhry et al, 2010). A wide variety of 
microorganisms have developed detoxification mechanism to deal with As toxicity and 
arsenate respiring bacteria have been isolated from the stools of Syrian Hampsters 
exposed to As(V) (Oremland & Stolz, 2003; Herbel et al, 2002). In vitro studies have 
shown that the gut microflora of the arsenic exposed individual can play a role in 
detoxification and elimination of the arsenic from the host body (Diaz-Bone & Van de 
Wiele, 2010). Thus the purpose of this work was to investigate the in vivo effect of 
chronic ingestion of environmentally relevant concentrations of arsenic via drinking 
water on the composition and physiology of the microbial community of the lower GI 
tract by molecular techniques. To accomplish this aim, microbial community composition 
and gene expression (arsA, arsB and nrfA)  in colon samples from 10 and 250 ppb of 
As(III) exposed mice were compared to the control mice after 2, 5 and 10 weeks of 
As(III) exposure via drinking water. Four specific aims were proposed to test the 
following hypotheses: 
Hypothesis 1: As(III) exposure will change the microbial community profile of mouse 
colon in dose and time dependent manner. 
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Specific Aim 1: Compare the microbial community profile of mice colon exposed to 10 
and 250 ppb of As(III) for a period of 2, 5 and 10 weeks to that of control mice by RISA 
and ARISA.  
Hypothesis 2:  As exposure will promote the selection of arsenic metabolizing microbes. 
Specific Aim 2: Determine the microbial community structure and composition of control 
and As(III) exposed mice using molecular techniques (DGGE and 16S rRNA gene based 
clone libraries) and perform statistical methods to determine the populations that are 
significantly affected by As(III) exposure. 
Hypothesis 3:  As (III) associated microbiota will have more widespread distribution of 
ars operon and arsenic resistant genes (arsA and arsB) will be induced in time and dose 
dependent manner in the presence of As(III). 
Specific Aim 3: Bioinformatically determine the distribution of ars operon in colon 
microbes and design species specific primers and perform comparative Ct to compare the 
expression levels of arsA and arsB gene. 
Hypothesis 4:  Increased Nitric oxide production in endothelial cells is one of the many 
pathways that play a role in arsenite induced toxicity. As(III) induced altered NO level in 
the host may affect the physiology of colon microbes by altering the transcription of 
genes such as nrfA that are involved in NO generation or are regulated by NO levels. 
Thus it was hypothesized that As(III) exposure will change the physiology of colon 
microbes. 
Specific Aim 4: To design species specific primers and perform comparative Ct for 
determining the expression levels of nrfA. 
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Chapter 2 : MATERIALS AND METHODS 
 
2.1 Mice exposure 
 
Sodium arsenite at a concentration of 0, 10 and 250 ppb was added to the drinking 
water and was fed for a period of 2, 5 and 10 weeks to groups of five C57BL/6NTac male 
mice that weighed approximately 20 g and aged 6-8 weeks. However, only four mice 
were exposed to As(III) for 2 week 0 ppb group to obtain colon samples. The 0 ppb group 
for each time point was considered as the control group. Sodium arsenite solution was 
prepared using the regular tap water supplied by the Municipality of Pittsburgh, PA. The 
mice from each group were euthanized by IP injection of sodium pentobarbital and their 
colons were removed. All mouse exposure experiments were done at the University of 
Pittsburgh by members of Dr. Aaron Barchowsky’s group in accordance to the 
institution’s guidelines for animal safety. Freshly removed colon samples were flash 
frozen in liquid nitrogen and stored at −80oC until used. The microbial composition and 
structure of these mice was characterized using molecular approaches and compared to 
those of control mice (0 ppb group). These exposure experiments were performed twice 
on two different sets of mice (study 1 and 2). Due to the fewer number of mice and 
absence of 10 ppb As(III) exposed mice, the results of study 1 are described in appendix 
1. From here on things relevant to study 2 are mentioned. 
2.2 DNA extraction 
 
 Microbial community DNA was isolated from 2, 5 and 10 week mouse colon 
samples (control and As(III) exposed) using the QIAamp DNA stool mini kit according 
to the manufacturer’s instructions (Qiagen Inc., Valencia, CA, USA). Flash frozen 
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samples were thawed on ice and about 40 mg of each colon sample was homogenized in 
a 2.0 ml eppendorf tube using a pipette tip followed by addition of 1.4 ml of buffer ASL 
(provided with the kit) for cell lysis. The samples were vortexed for 1 min to obtain 
uniform suspension followed by heating at 80
o
C for 5 minutes. The tubes were 
centrifuged at 10,000 x g for 2 minutes. The supernatant was transferred to a new 
eppendorf tube and 1 inhibit EX tablet was added to remove PCR inhibitors from the 
colon samples. The tubes were vortexed for 1 minute, incubated at room temperature for 
one minute and centrifuged at 10,000 x g for 6 minutes. The supernatant was transferred 
to a fresh tube and 30 µl of proteinase K and buffer AL (equal to the volume of 
supernatant) was added. After vortexing the tubes for few seconds the samples were 
incubated at 70
o
C for 10 minutes. DNA was precipitated from the above lysate by adding 
equal volumes of 100% ethanol. DNA was purified from the above lysate by passing the 
lysate through a QIAamp spin column and spinning the column at 10,000 x g for 1 min. 
The column was washed twice with 500 µl of buffer AW1 and once with 500 µl of buffer 
AW2. Each washing was followed by centrifugation at 10,000 x g for the removal of 
filtrate. After all the washings, DNA was eluted into a 1.5 ml eppendorf tube with 200 µl 
of buffer AE by centrifuging the column at 10,000 x g for 1 minute. The quantity of 
nucleic acid was estimated by using Perkin Elmer UV/Vis spectrophotometer lambda 2S 
(260/280 nm, 50 µg DNA = O.D. of 1). A 0.8% agarose gel was used to check for high 
MW genomic DNA. The extracted DNA was then used for the downstream processes. 
2.3 Ribosomal intergenic spacer analysis (RISA) 
 
Bacterial community estimation by RISA and ARISA technique were based on 
the principle that the length of the spacer region between 16S and 23S rRNA gene varies 
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from species to species (Borneman, J. and Triplett, E. W., 1997). However RISA and 
ARISA estimation of bacterial community in a sample can differ from the actual 
estimation as the same bacterial species can have a different spacer length or different 
bacterial species can have same spacer length (Kovacs et al, 2010). For this study 
differences in RISA and ARISA profiles were assumed to reflect the differences in 
bacterial community of the samples and were used for comparison of samples and 
bacterial diversity estimations. Although both RISA and ARISA are based on the same 
principle, the output of the results differs between the two techniques. RISA results are 
interpreted from a polyacrylamide gel whereas ARISA results are obtained from a genetic 
analyzer. In this study different primer pairs were used for the two techniques.  
The spacer region between the 16S and 23S rRNA gene was amplified from the 
microbial community DNA of each of the colon sample using ITSF (binds to 3’ end of 
16S rRNA gene) and ITSReub primer pairs (specific for 23S rRNA gene) (Table 2.1) 
(Cardinale et al, 2004). The reaction mixture consisted of 150 ng of genomic DNA, 10 μl 
of 5X buffer, 35 pmol each of forward and reverse primers, 1 μl dNTPs from a 200 μM 
stock, 1.25U of GoTaq DNA polymerase (Promega, Madison, WI, USA) and sterile 
water to a final volume of 50 μl. The touchdown program was used for amplification to 
increase the diversity of microbial estimation (Hecker & Roux, 1996). The reaction was 
performed on Techgene thermal cycler (Techne incorporated, Princeton, NJ, USA) with 
initial denaturation at 94
o
C for 5 minutes followed by 20 cycles of denaturation at 94
o
C 
for 1 minute, annealing temperature decreasing from 60
o
C to 50
o
C at a rate of 0.5
o
C 
decrease/cycle for 1 minute, extension at 72
o
C for 1 minute then 15 cycles of denaturing 
(1 min), annealing (1 min) and extension (3 min) at 94
o
C, 50
o
C and 72
o
C and a final 
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extension of 7 minutes at 72
o
C. The absence of contaminants in the reagents was 
confirmed by using no template (water) as a negative control. After PCR the products 
were checked for amplification by visualizing on a 1.8% agarose gel after ethidium 
bromide staining.  
Amplified products of the 16S-23S intergenic region from 2, 5 and 10 weeks 
mouse colon samples were loaded separately on a 5% polyacrylamide gel (Appendix 2). 
The gel was run at 70V for 105 minutes in 1X TBE buffer on a Mini-PROTEAN gel 
system (Biorad, Hercules, CA, USA) and the products were separated on the basis of 
their length. The resulting gels were stained in ethidium bromide solution (0.5 µg/ml 
EtBr in DI water) and were photographed using a Kodak gel documentation and analysis 
system 120.  
2.4 Dendrogram analysis 
 
The digital images of RISA and DGGE gels from 2, 5 and 10 weeks were loaded 
into the Quantity one software (Biorad, Hercules, CA, USA). The background was 
subtracted from the images, bands were detected automatically as well as manually and 
matching of bands between the lanes was done with 1% matching tolerance. Similarity 
values for the community was obtained with the Quantity one software using a similarity 
matrix calculated using the Dice coefficient based on the presence and absence of bands. 
Dendrograms were constructed by the unweighted pair group method (UPGMA) using 
similarity matrix. The dice coefficient is a similarity coefficient calculated by the 
following formula:  
Dsc  =  [2j / (a+b)],  ------------------------------------------------------ (2.4.1) 
Where a = number of DGGE bands in lane 1, 
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b = number of DGGE bands in lane 2, and   
j = number of DGGE bands that are common in lane 1 and lane 2.  
A Dsc value of 1 indicates that the DGGE profiles are identical (Dice, 1945). 
UPGMA is a hierarchical clustering method in which the two most similar lanes are 
grouped together based on the highest similarity index to form a composite group and 
sequentially more such groups are determined until only two groups are left that are then 
joined to form a rooted dendrogram (Sokal, R. and Michener, C., 1958). 
2.5 Automated ribosomal intergenic spacer analysis (ARISA) 
 
 PCR for ARISA was done following the protocol used by Fisher and Triplett 
(1999). The reaction mixture consisted of 150 ng of genomic DNA, 5 μl of 5X buffer, 2.5 
mM MgCl2, 0.5ug of BSA per µl, 12.5 pmol each of forward and reverse primers, 0.5 μl 
dNTPs from a 200 μM stock, 1.25U of GoTaq DNA polymerase (Promega, Madison, WI, 
USA) and sterile water to a total volume of 25 μl. The primers used were 1406F and 
23Sr, with 1406F being labeled at the 5’end with the phosphoramidite dye 5-FAM (Table 
2.1). The reaction mixture was denatured at 94
o
C for 2 minutes, followed by 30 cycles of 
denaturation at 94
o
C for 15 sec, annealing at 55
o
C for 15 sec, extension at 72
o
C for 45 sec 
and a final extension at 72
o
C for 2 min. Water was used as negative control to check for 
the absence of contamination in the reagents. 
 Equal amounts of PCR product along with 0.75 μl of the internal size standard 
LIZ-1200 (Applied Biosystems, Foster City, CA, USA) and 8 ul of DI formamide were 
added to final volume of 10 μl and the reaction mixture was denatured at 95oC for 5 
minutes followed by cooling on ice. LIZ-1200 is a size standard containing 68 LIZ dye 
labeled single stranded DNA fragments that range in size from 20 to 1200 base pairs. The 
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fragments were separated using a 3100-Avant Genetic Analyzer under gene scan mode 
and the results were analyzed by using the peak scanner software (Applied Biosystems, 
Foster City, CA, USA). An electropherogram with a series of peaks was obtained for 
each sample wherein each peak represents a different operational taxonomic unit (OTU). 
The program provides the sizes of these peaks based on the fragment sizes of the internal 
standard along with the fluorescence of each peak in the form of peak height and peak 
area. In order to remove the background noise, ARISA peaks exceeding the peak height 
of 50 fluorescence units were considered for analyses. All the experiments were done in 
triplicates and the peaks for individual sample replicates were averaged for relative peak 
height and relative peak area using TREX software (Culman et al, 2009). The heat maps 
for the relative peak height dataset were generated using permut matrix software (Caraux 
& Pinloche, 2005). The matrices obtained for presence/absence of peaks, relative peak 
height and area were used for Principle Component Analysis (PCA) using Ade 4 software 
package (Chessel et al, 2004). PCA is an ordination method that determines two major 
principle components from multivariate datasets under the constraint that these principle 
components are linear combination of all variables and account for most of the variation 
observed in the variables (Pearson K., 1901). In the present study different OTUs 
(presence/absence matrix) and their abundance (peak height and area matrix) were 
considered as variables.  
2.6 Denaturing gradient gel electrophoresis (DGGE) 
 
 DGGE is one the most widely used molecular technique to determine the 
microbial community of environmental samples. This technique is based on the principle 
that under denaturing conditions DNA fragments of equal sizes denature differently on 
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the basis of their % mole GC content. Such fragments when run on a denaturing gel will 
move differently. The high % mole GC fragments, due to less denaturation, migrate 
towards the bottom of the gel whereas the low % mole GC fragments stay towards the top 
of the gel due to high denaturation (Fischer & Lerman, 1983). In order to protect the two 
strands of DNA fragments from falling apart, a GC clamp (stretch of about 40 GC rich 
nucleotides) is added to one of the primers used during amplification. In this study, 
similar sized PCR products amplified from same region of the 16S rRNA gene were used 
for comparison of microbial community among colon samples. Since GC content of the 
same 16S rRNA region varies from species to species the profile obtained from DGGE is 
an indicator of microbial diversity. However like RISA and ARISA, DGGE estimation of 
bacterial community in a sample can differ from the actual estimation as the same 
bacterial species can have multiple 16S rRNA genes and each gene within a species can 
have a different GC content or different bacterial species can have the same GC content 
(Muyzer & Smalla, 1998). 
DGGE was performed according to protocol followed by Muyzer et al (Muyzer et 
al, 1993) with some modifications. Variable region 3 (V3) of the 16S rRNA gene was 
amplified from the colon bacteria using HDA1-GC and HDA2 primers (Table 1) (Walter 
et al, 2001). The reaction mixture consisted of 150 ng of genomic DNA, 10 μl of 5X 
buffer, 25 pmol each of forward and reverse primers, 1 μl dNTPs from a 200 μM stock, 
1.25U of GoTaq DNA polymerase (Promega, Madison, WI, USA) and sterile water to a 
total volume of 50 μl. The touchdown program was used for amplification with annealing 
temperature decreasing from 60
o
C to 50
o
C at a rate of 0.5
o
C decrease/cycle. Absence of 
contamination in reagents was confirmed by using sterile water as negative control. After 
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PCR, the amplification was confirmed by visualizing the products on a 1.8% agarose gel 
after EtBr staining. 
Amplified products of 16S rRNA gene from 2, 5 and 10 weeks mouse colon 
samples were loaded separately on a 10% acrylamide-bis acrylamide denaturing gel 
containing 40% - 60% Urea- formamide gradient (Appendix 3). A non denaturing 10% 
acrylamide spacer gel was applied on top of the denaturing gel and was allowed to 
polymerize for 2 hours. The gel was run at 70V for 990 minutes at 60
o
C in 1X TAE 
buffer using a DCode universal mutation detection system (Biorad, Hercules, CA, USA). 
The resulting gels were stained in a 1: 10,000 dilution of SYBR green in 1X TAE buffer 
and were photographed using Kodak gel documentation and analysis system 120.  
2.7 Clone library Construction 
 
Near full length 16S rRNA genes were amplified from the microbial community 
DNA isolated from each of the 2, 5 and 10 week colon sample using universal primers 8F 
(Edwards et al, 1989) and 1492R (Stackebrandt & Liesack, 1993). The reaction mixture 
consisted of 50 ng of genomic DNA, 4 μl of 5X buffer, 10 pmol each of forward and 
reverse primers, 0.4 μl dNTPs from a 200 μM stock, 0.5U of GoTaq DNA polymerase 
(Promega, Madison, WI, USA) and sterile water to a total volume of 20 μl. The 
touchdown program was used for amplification with annealing temperature decreasing 
from 60
o
C to 50
o
C at a rate of 0.5
o
C decrease/cycle. The PCR products obtained from 
each of the sample were ligated into the pCR2.1®-TOPO vector. The ligation reaction 
mixture consisting of 4 µl of  PCR product, 1 µl of salt solution and 1 µl of TOPO vector 
provided with the kit was incubated for 15 minutes at room temperature and was used 
immediately or stored at −20oC until transformation was done. 
  
48 
Transformation 
 Ligation reaction (2 µl) described above was added to a tube of OneShot top10 
chemically competent E.coli cells provided with the kit.  The reaction was incubated for 
15 to 30 minutes on ice, and then heat shocked in a water-bath at 42
o
C for 30 seconds.  
To the transformed cells, 250 µl of SOC media (provided with the kit) was added and the 
tube was incubated horizontally on a shaker at 37
o
C and 200 rpm for one hour.  
Transformed cells (50 µl) were then spread on prewarmed ampicillin selective, X-gal 
spread LB plates and 50 µl of untransformed cells were spread on an LB plate to verify 
cell viability (Appendix 4). The plates were incubated at 37
o
C overnight. Approximately 
24 positive clones were picked randomly from each sample and transferred with a sterile 
toothpick to a fresh ampicillin selective plate and 5 ml of LB broth containing ampicillin 
at a concentration of 100 µl/ml. The plates and the LB broth inoculated with single 
colony were then incubated at 37
o
C overnight. 
Plasmid extraction 
Plasmid extraction was performed using the Promega Wizard SV DNA column 
purification kit (Promega, Madison, WI, USA).  The culture obtained from overnight 
grown colonies in LB-amp media was spun down at 7,000 rpm for 5 minutes.  The pellet 
was then resuspended in 250 µl of cell resuspension buffer and the cells were lysed with 
250 µl of cell lysis buffer. The mixture was incubated for 3-5 minutes at room 
temperature and 10 µl of alkaline protease was added, followed by 5 minute incubation.  
Neutralization solution (350 µl) was then added, and the tubes were spun at 12,000 rpm 
for 15 minutes.  The supernatant was removed to a fresh tube and spun a second time 
under the same conditions.  The supernatant from the second spin was added to the 
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column.  The column was washed twice with wash buffer, and the plasmid was eluted 
with 100 µl nuclease free water and stored at −20oC.   
Sequencing from plasmid DNA  
The purified plasmid DNA was sequenced using M13 forward and reverse 
primers at the Genomics and Proteomics Core Laboratory, University of Pittsburgh, PA 
using ABI 3730 sequencer (Applied Biosystems, Foster City, CA, USA). 
2.8 Sequence analysis 
 
Sequences obtained from the clone libraries were analyzed in Chromas version 
2.01 (http://www.technelysium.com.au/chromas_lite.html). Sequences obtained from the 
reverse primer were converted into forward reading sequence and were aligned to the 
forward complementary strand using CLUSTAL W (Larkin et al, 2007). Low quality 
sequences with ambiguous bases (N) were not analyzed further. The consensus sequences 
were edited to exclude the primer binding sites and were compared to those in the 
GenBank databases by using the BLAST (Johnson et al, 2008b). The sequences were 
assigned to taxonomic classification using the Ribosomal Database Project II (RDPII) 
classifier with a confidence threshold of 90% (Wang et al, 2007). Multiple sequence 
alignment of nearly full length 16S rRNA sequences obtained from clonal libraries was 
done by Clustal X (Larkin et al, 2007) and NAST alignment (DeSantis et al, 2006). 
Sequences aligned by Clustal X were edited manually using seaview program (Gouy et 
al, 2010) to check for any ambiguity in the aligned sequences. All sequences were 
checked for possible chimeric artifacts using the Bellerophon (DeSantis et al, 2006), 
mallard (Ashelford et al, 2006) and chimera slayer programs (Schloss et al, 2009). 
Significant difference in the composition of control, 10 ppb and 250 ppb As(III) exposed 
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clone libraries was determined using LIBSHUFF program of Mothur software (Schloss et 
al, 2009). Comparison between libraries at the taxonomic level was also done by 
libcompare tool from RDP II database (Cole et al, 2009). 
2.9 Phylogenetic analysis and diversity estimation 
 
 The distance matrix of nearly full length 16S sequences was prepared with 
DNADIST program from PHYLIP package (Felsenstein, 1989) based on Jukes-Cantor 
model (a substitution model based on the assumption that the rate of transition and 
transversion is same) (Jukes & Cantor, 1969). A neighbor-joining tree was generated 
using MEGA 4.0 software (Tamura et al, 2007) and the evolutionary distances were 
computed using Jukes-Cantor model. Based on distance matrix generated with Phylip 
package, clones with 97% (species level), 95% (genus level) and 90% (family level) 
sequence similarity were grouped into the same phylotype/operational taxonomic units 
(OTUs) using Mothur program (Schloss et al, 2009). Good’s coverage (C) of the clone 
libraries was calculated by the formula:  
C = (1− n/N)*100,  ------------------------------------------ (2.10.1) 
Where n= no. of sequences that are found only once in a library and  
N= Total number of sequences in a library (Good, 1953). 
Microbial richness and diversity in each of the clone library and the combined 
datasets was estimated by rarefaction curve, Chao I estimator, Shannon and Simpson 
diversity index using the Mothur program (Schloss et al, 2009). Rarefaction curve is 
based on species richness (total no. of species in a sample) and gives information about 
sampling efforts in a clone library and can be used to compare species richness among 
different clonal libraries for a given level of sampling effort. Rarefaction curve represents 
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the average number of OTUs/species observed when n clone are sequenced from the 
same library (Gotelli & Colwell, 2001). Steep slope of the rarefaction curve indicates that 
a large fraction of the species diversity remains to be discovered whereas flattening of the 
curve towards end of the sampling indicates that enough clones have been sequenced and 
additional sequencing will only yield fewer new OTUs. Chao I is a measure of species 
richness and is based on the concept that the number of rare species in a clone library are 
the best indicator of diversity. Chao I is calculated by the formula:  
S = Sobs + (a
2
/2b),  ------------------------------------------------------- (2.10.2) 
Where Sobs = number of OTUs observed,  
a = number of OTUs observed only once,  
b = number of OTUs observed only twice and  
S = estimated number of OTUs in a clone library (Chao, 1984).  
Microbial diversity in a clone library is measured by taking into account two main 
factors: richness and abundance. Shannon and Simpson diversity index are the two most 
commonly used measures of diversity but differ due to the weightage given by the two 
methods to species richness and abundance in the mathematical calculations. Simpson 
diversity index gives more weightage to abundance whereas Shannon diversity index 
gives equal weight to richness and abundance. Simpson diversity index is calculated by 
the formula:  
D= 1 – Ʃ(ni/N)
2
,  ---------------------------------------------------- (2.10.3) 
Where ni = proportion of OTU i relative to the total number of OTUs (N).  
D ranges from 0 to 1 and decreases with increasing diversity (Simpson, 1949).  
Shannon diversity index is calculated by the formula:  
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H = −Ʃ pi ln pi, ---------------------------------------------------- (2.10.4) 
Where pi = proportion of sequences found in the ith OTU.  
H ranges from 1.5 to 5 and increases with increasing richness and evenness (Weaver & 
Shannon, 1949). 
Data deposition 
The bacterial 16S rRNA gene sequences obtained in this study are deposited in 
Genbank database with accession numbers HQ681318 - HQ681412 (2 week control), 
JN012608 - JN012688 (2 week 10 ppb), HQ681413 - HQ681511 (2 week 250 ppb), 
JN012882 - JN012991 (5 week control), JN012689 - JN012791 (5 week 10 ppb), 
JN012792 - JN012881 (5 week 250 ppb), JN001204 - JN001304 (10 week control), 
JN012992 - JN013087 (10 week 10 ppb) and JN013088 - JN013183 (10 week 250 ppb). 
2.10 RNA extraction and cDNA preparation  
For each time (2, 5 and 10 weeks) and dose combination (0, 10 and 250 ppb) set 
of four mice were euthanized. The colon was removed and stored in 1 ml of RNA later 
solution (Qiagen Inc., Valencia, CA, USA) at 4
o
C for 1 day and then transferred to −20oC 
until used. For extraction of total RNA the sample was removed from RNA later solution 
right before processing. Total RNA was extracted from 250 mg of colon sample using 
trizol (Invitrogen, Carlsbad, CA, USA) according to manufacturer’s instruction with 
some modifications.  Each colon sample was homogenized using an electrical hand held 
homogenizer in the presence of 250 µl of trizol. After homogenization, additional 1.25 ml 
of trizol was added and the samples were vortexed for 2-3 minutes to achieve uniform 
suspension. The samples were centrifuged at 12,000 x g for 10 minutes and the 
supernatant was transferred to new 2.0 ml centrifuge tube. Chloroform (0.3 ml) was 
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added to the supernatant and the tubes were shaken vigorously. The samples were 
incubated at room temperature for 2-3 minutes followed by centrifugation at 12,000 x g 
for 15 min at 4
o
C. Upper aqueous phase that contains the RNA was transferred to a new 
2.0 ml centrifuge tube. RNA was precipitated by adding 675 µl isopropanol and few 
grains of glycogen. The tubes were incubated at room temperature for 10 minutes and 
subsequently centrifuged at 10,000 x g. The supernatant was removed and the RNA pellet 
was washed with 1 ml of 75% ethanol prepared from RNase free water and centrifuged at 
7,500 x g for 5 minutes. The RNA pellet was dried in air and then resuspended in 35 µl of 
RNase free water. Extracted RNA was quantified by reading the absorbance at 260 and 
280 nm using Perkin Elmer UV/Vis spectrophotometer lambda 2S (260/280 nm, 40 µg 
RNA = O.D. of 1). To remove any residual DNA in the extracted RNA, 15 µg of RNA 
was treated with 6 Units of DNase I (Qiagen Inc. Valencia, CA, USA) in a total volume 
of 20 µl and incubated at 37
o
C for 20 minutes. DNase activity was stopped by adding 2 
µl of 25 mM EDTA to a total volume of 20 µl and incubating at 65
o
C for 10 minutes. 
Equal amounts of DNase treated RNA (~ 4µg) was used as starting material for 
the conversion to cDNA. Superscript III first strand synthesis super mix (Invitrogen, 
Carlsbad, CA, USA) was used for obtaining cDNA following the manufacturer’s 
instructions. To ~ 4 µg of DNase treated RNA, 50 ng of random hexamer, 1 µl of 10 mM 
dNTP mix and RNase free water was added to a total volume of 10 µl. Annealing of the 
random hexamers to the RNA was facilitated by incubating the reaction at 65
o
C for 5 
minutes. cDNA synthesis mix containing reverse transcriptase (10 µl) was added to the 
reaction and the tubes were incubated at room temperature for 10 minutes, at 50
o
C for 50 
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minutes and finally at 85
o
C for 5 minutes to stop the reaction. To verify the absence of 
DNA, RNA samples without reverse transcriptase (-RT) were used as negative controls. 
2.11 Primer design and optimization 
 
Primers for amplification of target genes (arsA, arsB and nrfA) and internal 
control/reference genes (rpoB) from Bacteroidetes thetaiotamicron were designed using 
the primer3 program (Table 2.1) (Rozen & Skaletsky, 2000). The sequences for these 
genes were obtained from the DOE Joint Genome Institute (http://img.jgi.doe.gov/). The 
specificity of each primer pair was tested by amplifying the gene from microbial 
community DNA from murine colon and confirmed by: (i) visualizing the expected 
product size on 1.8% agarose gel and (ii) sequencing the amplified product and 
performing a BLAST search. Optimal concentration of the primer pairs was determined 
by comparing the Ct and relative fluorescence (Rn) values of both forward and reverse 
primers at 4 different concentrations: 2.5, 5.0, 7.5 and 10 pmol/µl. The primer 
concentration that resulted in low Ct and high Rn value was used for relative 
quantification. Efficiency of each primer pair was tested by preparing a 10 fold dilution 
series of the template and amplifying the template with its specific primer pair. The cycle 
threshold (Ct) value for each dilution was determined by real time PCR system and 
plotted against log template dilution. The slope of the line was determined and PCR 
efficiency of the primer pair was determined by the formula:  
m = − (1/log E)    --------------------------------------------------------- (2.12.1) 
where m is slope and E is efficiency.  
The efficiency of the internal control gene and target genes were within 10% of 
each other. Expression of target genes and internal control genes in colon cDNA samples 
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was tested by regular PCR and visualizing the PCR product on a 1.8% agarose gel. 
Specificity of the primer pair was again checked by sequencing the amplified product. 
Relative quantification of expression levels of target genes among different samples was 
done by comparative Ct method (∆∆Ct) on step one real time PCR system.  
2.12 Relative quantification by Comparative Ct 
 
Real-time PCR reactions were prepared in 96 well, thin walled microplates and 
carried out on step one real time PCR system (Applied Biosystems, Foster City, CA, 
USA). The reaction mixture consisted of 7.5 µl of power SYBR green PCR master mix 
(Applied Biosystems, Foster City, CA, USA), 5 pmol each of forward and reverse primer, 
3 µl of cDNA and sterile water to a final volume of 15 µl. Each reaction was performed 
in triplicate under thermocycling conditions consisting of initial step at 95
o
C for 5 
minutes followed by 50 cycles of 95
o
C for 15 sec, 57
o
C for 25 sec and 72
o
C for 30 sec 
with data collection point. To check for the specificity of each reaction a final melt curve 
analysis was performed at the end of the amplification cycles with fluorescence data 
collected at 0.3
o
C intervals between 60 and 100
o
C. The negative controls included the no 
template (water) and samples without any reverse transcriptase added. The Ct values of 
target genes (arsA, arsB and nrfA) were normalized to internal control gene rpoB (∆Ct) 
and were subsequently normalized to the control (0 ppb) mouse sample (∆∆Ct). The 
∆∆Ct values were then transformed to 2−∆∆Ct which was used for statistical analysis. The 
value of 2
−∆∆Ct
 was obtained from the software provided with the step one real time PCR 
system (Applied Biosystems, Foster City, CA, USA). 
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2.13 Statistical analysis of real time data 
 
Dose dependent changes in arsA, arsB and nrfA expression in mouse colon were 
compared by one way analysis of variance (ANOVA) followed by Tukey’s correction. 
The statistical analysis was performed using Graphpad Prism 5.0 software (Graphpad, 
SanDiego, CA, USA). 
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Gene Primer Sequence (5’ to 3’ end) 
Tm 
(
o
C) 
Reference 
16S-
23S 
rRNA 
ITSF 
ITSReub 
GTCGTAACAAGGTAGCCGTA 
GCCAAGGCATCCACC 
54.1 
53.8 
Cardinale et al, 
2004 
1406F 
23Sr 
TGYACACACCGCCCGT 
GGGTTBCCCCATTCRG 
59.1 
53.6 
Fisher & 
Triplett, 1999 
16S 
rRNA 
 
  HDA1* 
HDA2 
ACTCCTACGGGAGGCAGCAGT 
GTATTACCGCGGCTGCTGGCAC 
62.6 
63.1 
Walter et al,  
2001 
8F 
1492R 
AGAGTTTGATCCTGGCTCAG 
GGTTACCTTGTTACGACTT 
52 
47 
Edwards et al, 
1989 
Stackebrandt & 
Liesack, 1993 
arsA 
BTarsAF-
1089 
BTarsAR-
1211 
TGACCCGGCAAATCACCTGAACTA 
GTTTCGGCAGCTTTGCTACGAACT 
60.4 
60.1 
This study 
arsB 
BTarsBF-
684 
BTarsBR-
827 
GGTTGGCGGATTGCTATTAACGCT 
GCCCAACCGTAGGCAACAAAGAAT 
59.9 
60.2 
This study 
nrfA 
BTnrfAF-
376 
BTnrfAR-
538 
TCACTTCGTACCGGTTCTCC 
TCGGATTCACGATTTCATCA 
56.4 
51.6 
This study 
rpoB 
BTrpoBF-
477 
BTrpoBR-
661 
CAAATTTCACGCCCAAAGTT 
AGGTCGTCACGGTAACAAGG 
52.2 
56.9 
This study 
 
Table 2.1: List of primers used in this study. * indicates addition of GC clamp 
(CGCCCG GGGCGCGCCCCGGGCGGGGCGGGGGCACGGGGGG) towards 5’ end 
for DGGE. F and R stand for forward and reverse primer respectively. 
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Chapter 3 : RESULTS  
 
3.1 Estimation of bacterial community profile by RISA 
 
The spacer regions between the 16S and 23S rRNA genes were amplified from 2, 
5 and 10 week mouse colon community DNA to rapidly compare the bacterial profile of 
control and As(III) exposed mouse colon. PCR products thus obtained were separated on 
a 5% polyacrylamide gel on the basis of their size. The product size from spacer region 
amplification ranged from 300 bps to > 1500 bps. In addition to the spacer region, the 
primers used for RISA study also amplify approximately 120 bps from the 16S and 23S 
rRNA genes (Cardinale et al, 2004). Therefore the product range from 300 to 1500 bps 
on the polyacrylamide gel corresponds to an intergenic region ranging from 150 to 1350 
bps. Variations in RISA profiles in the form of absence/presence of bands and band 
intensity were observed in As(III) treated groups and control mice groups and also 
between individuals of the same group. However, these alterations in band pattern and 
intensity were more consistent between the groups rather than within the same group. 
Due to a high number of bands and low resolution of these bands on the gel, dendrogram 
analysis of RISA profiles was done to confirm that the variations observed in band 
patterns and intensity were linked to arsenic exposure and not a result of inherent 
variation between the individual mice (Figure 3.1). 
 Dendrogram analysis of RISA gels showed separate clustering of control and 250 
ppb As(III) exposed groups after 2, 5 and 10 weeks of arsenite exposure. However, 
samples from 10 ppb As(III) exposed groups either clustered with both control and 250 
ppb exposed samples (as in  case of 2 and 5 week samples) or formed a cluster with 250 
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ppb group as in 10 weeks of As(III) exposed mice (Figure 3.1). At each time point (2, 5 
and 10 week) three separate clusters were formed in each of the dendrograms.  
The mice from the 2 weeks of 250 ppb of As(III) exposed group formed a 
separate cluster with a similarity of 50% between the individuals and showed only 36% 
similarity with the rest of the control and 10 ppb group. However one mouse from the 10 
ppb group clustered with 250 ppb group. This was expected from the 10 ppb group as 
they are in transition phase from normal control group to a group that has been affected 
by arsenic exposure.  
In the 5 week RISA dendrogram, the three clusters within the dendrogram were 
separately predominated by the three groups (control, 10 ppb and 250 ppb). However 
some level of mixed clustering was observed between the groups. Four out of five mice 
from the 250 ppb As(III) exposed group clustered together and showed > 50% similarity 
whereas the fifth mouse clustered with the 10 ppb As(III) exposed mice.  
The dendrogram from the 10 week RISA showed separate clusters for control and 
10 ppb group and a third cluster with all the mice from 250 ppb exposed group and two 
mice from 10 ppb exposed group. The control group shared > 40% similarity to each 
other but only 20% similarity with the 10 and 250 ppb groups.  
These results suggest that changes in microbial profile as determined by RISA in 
response to 250 ppb of As(III) are dramatic after exposures for 2 weeks and continue till 
10 weeks of 250 ppb exposure. Microbial changes in response to 10 ppb of As(III) 
exposure although started appearing at week two but became distinct and consistent only 
after 10 weeks of As(III) exposure. 
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A. 2 week 
 
 
 
 
B. 5 week 
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C. 10 week 
 
 
 
Figure 3.1: RISA gels and dendrogram analysis of negative image of RISA fingerprints 
generated from 16S-23S intergenic region of control (C1-C5), 10 ppb (E1-E5) and 250 
ppb (M1-M5) arsenic exposed mice at A) 2 week, B) 5 week, and C) 10 week. L= 100 bp 
DNA ladder. Numbers on left side of the DNA ladder represent size of the marker band 
in base pairs. Scale bar on dendrograms represents similarity index values.  
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3.2 Bacterial community composition of mouse colon as determined by ARISA 
 
The spacer region between the 16S and 23S rRNA genes was amplified from 2, 5 
and 10 week mouse colon community DNA. The PCR products thus obtained were 
separated on a genetic analyzer to obtain a community profile for each colon sample. A 
representative ARISA electrophoregram showing bacterial peaks obtained from mouse 
colon is depicted in Figure 3.2 . 
Regardless of time and dose exposures, ARISA electrophoregrams of the mouse 
colon showed a total of 117 OTUs (peaks) with fragment size ranging from 287 bps to 
1155 bps representing intergenic spacer region of approximately 37 bps to 905 bps. The 
majority of the peaks ranged from 500 – 800 bps in size. Peaks shorter than 287 bps were 
observed in a small number of samples. These peaks were attributed to nucleotides, 
primers, primer dimers and chimeras and were excluded from further analyses. The 
reproducibility of ARISA profiles was high among the replicates of the same sample. In 
general, peaks with high fluorescence intensity were present constantly across all PCR 
replicates of a sample, however, a very small number of less intense peaks (< 50 
fluorescence units) varied in between the replicates. To overcome this variability and to 
reduce the background noise, peaks less than 50 fluorescence units were not included in 
the analyses. For all time points, a number of peaks were identified that were present only 
in control samples and not in experimental mice and vice versa. In addition some of the 
peaks that were present in all three dose groups differed in intensity between the three 
sets of mice groups (0, 10 ppb and 250 ppb). Figure 3.3 shows heat maps (based on 
relative peak height) obtained from ARISA profiles of colon samples.  
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Figure 3.2: A typical bacterial community ARISA electropherogram obtained from 
mouse colon. X axis at the top shows size of the intergenic region in bps and Y axis 
corresponds to fluorescence intensity. (A) Full view of ARISA profile obtained from 
mouse colon. Orange lines are internal size standard peaks and blue lines are intergenic 
region peaks (B) Zoomed view of ARISA profile ranging from 640 to 710 bps. H= Peak 
height, A= Peak area (shown with filled blue) and S=Peak size. Values for H, A and S are 
shown at the bottom of each peak. 
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Figure 3.3: Heat map showing ARISA peaks obtained from the colon of control (C1-
C5), 10 ppb (E1-E5) and 250 ppb (M1-M5) arsenite exposed mice at (A) 2 weeks (B) 5 
weeks and (C) 10 weeks. Numbers towards the right of the image are equivalent to the 
length of 16S- 23S ribosomal intergenic region amplified by primers 1406F and 23Sr. 
Black indicates absence of peak and red indicates presence of peak. The color intensity 
indicates differences in the relative fluorescence intensity of the peak. 
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ARISA diversity  
Not considering dose as a factor, the total number of peaks/OTUs detected in 2, 5 
and 10 week colon samples were 66, 70 and 50 respectively. Approximately 22 peaks 
were common between 2, 5 and 10 week samples. The number of OTUs shared between 
different time points varied, with maximum number of OTUs (34 OTUs) shared by 10 
and 5 week samples and least OTUs were shared between 10 and 2 week ARISA profile 
(25 OTUs). Two and 5 week samples shared 32 OTUs (Figure 3.4). For all time points, 
no significant differences were observed between control and As(III) exposed groups 
with respect to the total number of peaks generated by ARISA. The number of OTUs 
ranged from 43, 50, 36 in control samples, 41, 45, 39  in 10 ppb samples and 50, 44, 35 in 
250 ppb As(III) exposed group in 2, 5 and 10 week samples respectively. These results 
indicate that As(III) treatment did not have any detectable effect on peak diversity. In 
addition, the results from ARISA profiles also indicate that arsenic exposure affects 
certain bacterial communities in the colon. Disappearance of some peaks and appearance 
of others in the As(III) exposed group along with variation in the intensity of peaks 
indicates that arsenic exposure disturbs the microbial balance in the mouse colon (Figure 
3.3). 
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Figure 3.4: Venn diagram showing number of peaks/OTUs shared between ARISA 
profiles of 2, 5 and 10 week mouse colon samples irrespective of the As(III) exposure 
dose.  
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Principle Component Analysis (PCA) 
The tables containing the information about the peaks present in all samples and 
their fluorescent intensity in terms of height and area were used for matrix generation. In 
this matrix the height and area for each peak was relativized by dividing the fluorescence 
of an individual peak by total fluorescent intensity of the sample to which that particular 
peak belongs. Also each data set was averaged across its replicates. The matrices obtained 
for presence/absence of peaks, relative peak height and relative peak area from each time 
point were used separately for PCA. PCA ordination plots with all three variables 
presence/absence of peaks (binary), relative peak height and area showed clear separation 
of control and 250 ppb As(III) treated samples at all three time points. However for the 
10 ppb dosage level, separation of control and 10 ppb samples was clear in case of 10 
week samples but not for 2 and 5 week samples (Figure 3.5). The peaks that contributed 
to the Principle Component 1(PC1) and PC2 above the mean % contribution of 1.51, 1.43 
and 2.0 for 2, 5 and 10 weeks respectively are shown in Table 3.1. The peaks contributing 
significantly to PC1 and PC2 were almost identical when peak height and peak area 
matrices were used for PCA. However the peaks contributing to PC1 and PC2 differed in 
number as well as size from the above in the case of the binary matrix. Irrespective of the 
type of matrix used for PCA analysis, the overall relatedness of all the samples was 
similar in all the ordination plots (Figure 3.5).  
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I. 2 week 
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II. 5 week 
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III. 10 week 
 
     
 
 
 
 
 
Figure 3.5: PCA plots generated from ARISA profiles of bacterial communities from (I) 
2, (II) 5 and (III) 10week samples. Control (black squares), 10ppb (grey squares) and 
250ppb (open squares). Percents shown along the axis represent the proportion of 
variation by that axis. PCA plots based on (A) relative peak height, (B) relative peak area 
and (C) presence/absence of peak (binary). Circles represent the groups that cluster 
together. 
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  Peaks (bps) contributing to PC1 and PC2 
2 
week 
Height 504, 546, 583, 588, 613, 678, 682, 710, 713 
Binary 
379, 421, 427, 438, 445, 457, 463, 479, 483, 509, 546, 562, 588, 590, 
603, 613, 634, 645, 652, 660, 674, 678, 682, 713, 744, 767, 783, 810, 
838 
Area 504, 546, 583, 588, 645, 678, 682, 710, 713 
5 
week 
Height 505, 509, 547, 574, 590, 624, 647, 654, 674, 679, 684 
Binary 
366, 379, 505, 509, 511, 519, 547, 574, 582, 608, 613, 633, 654, 661, 
674, 679, 684, 691, 711, 787, 812, 852, 918, 958 
Area 505, 509, 547, 574, 590, 624, 647, 654, 674, 679, 684 
10 
week 
 
Height 508, 547, 574, 609, 623, 627, 633, 647, 674, 679, 684, 692 
Binary 
366, 401, 418, 436, 443, 464, 562, 574, 623, 627, 633, 640, 647, 653, 
661, 674, 692, 702, 730, 765, 778, 813, 855, 925 
Area 508, 547, 574, 609, 623, 627, 633, 647, 674, 679, 684, 692 
 
Table 3.1: Peaks contributing above the mean % contribution values for PC1 and PC2 of 
2, 5 and 10 week PCA plots based on relative peak height, presence or absence of peaks 
(binary) and relative peak area. 
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3.3 Microbial community as determined by DGGE  
 
A small segment from the V3 region of the 16S rDNA was amplified from 2, 5 
and 10 week mice colon bacterial community DNA. The expected product size after PCR 
amplification was ~ 177 bp. PCR products thus obtained were separated on the basis of 
their GC content on a 40 − 60% DGGE gel where the low GC fragments moved towards 
the bottom of the gel. Alterations in DGGE profiles in the form of band intensity and 
presence and absence of bands were observed when As(III) treated mice were compared 
to control mice. These variations were observed between the individuals from the same 
group as well. The differences in community composition were more pronounced for low 
GC bacteria, with a visible shift in low % Mole GC fragments at all three time points. 
However, careful observation of the band patterns indicated differences among high % 
Mole GC species too at the different dose exposure levels. These changes were more 
consistent and dramatic between the three groups with mice exposed to 250 ppb showing 
more variation as opposed to 10 ppb exposed mice when compared with control group 
(Figure 3.6). Similar to RISA, the total number of bands did not vary significantly 
between control and arsenic exposed groups. This suggested that arsenic exposure did not 
have any visible effect on microbial diversity of the murine colon. Although separated on 
different gels, a shift in banding pattern was observed in between the control groups at 
different time points indicating that microbial community of mouse is changing with 
time.  
Similar to RISA gels, dendrogram analysis of DGGE gels indicated that even at 2 
weeks, the 250 ppb exposed mice clustered into separate clades (Figure 3.6). Although 
visible differences in band patterns were found between control and 10 ppb As(III) 
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exposed groups at 2, 5 and 10 weeks but dendrogram analysis showed clustering of 10 
ppb group with control groups. These results indicate that variations observed in 10 ppb 
group are so subtle that it is difficult to link these changes to As(III) exposure alone. 
Dendrogram analysis of DGGE microbial profiles for 2 week control and As(III) treated 
groups resulted in three main groups. Mice exposed to 250 ppb of As(III) clustered 
together whereas control and 10 ppb groups showed mixed clustering and formed other 
two groups. Mice exposed to 250 ppb of As(III) showed 55% similarity in band pattern to 
the other two groups whereas in between the 250 ppb As(III) group the similarity values 
ranged from 76 – 60%. Similarly, dendrogram analysis of 5 and 10 week DGGE gels 
resulted in three different clusters. Mice exposed to 250 ppb of As(III) formed separate 
cluster whereas control and 10 ppb groups formed mixed clustering. 
Results from this study suggest that the observed differences between the three 
dose groups (0, 10 and 250 ppb) are more pronounced than the differences observed 
between the individuals of the same group. DGGE and dendrogram analysis clearly 
demonstrated that As(III) exposure affected the microbial community of mouse colon. 
The As(III) induced effect at 250 ppb exposure levels began at 2 weeks and continued 
until 10 weeks. Despite visible changes in the band pattern of As(III) 10 ppb group from 
the control group, the As(III) 10 ppb group did not form separate cluster from the control 
group at all three time points.
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B. 5 week 
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C. 10 week 
 
 
 
 
    
 
Figure 3.6: DGGE and dendrogram analysis of negative image of DGGE fingerprints 
generated from 16S rDNA PCR of  control (C1-C5), 10 ppb (E1-E5) and 250 ppb (M1-
M5) arsenic exposed mice at A) 2 week, B) 5 week, and C) 10 week. Scale bar on 
dendrograms represents similarity index values.  
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3.4 Firmicutes and Bacteroidetes are the major phyla in mouse colon 
 
For studying the microbial community structure of mice colon, bacterial clone 
libraries generated from nearly full length 16S rRNA gene for each dose and time 
combination were sequenced using the Sanger method. A total of 947 good quality 
sequences were obtained, of which 123 sequences were found to be chimeras and 
removed from the analysis. Table 3.2 shows the number of clones sequenced and the 
number of good quality and non-chimeric sequences obtained from each library.  
Based on RDP II database results, the mice colon microbial community contained 
sequences from 5 bacterial phyla. Regardless of time and dose of As(III) exposure, 
majority of the sequences belonged to the Bacteroidetes (37% of the total sequenced 
population) and Firmicutes (60% of all sequences). Sequences from Deferribacteres, 
Verrucomicrobia and Proteobacteria were observed in very low number, which was not 
surprising given the fact that these phyla are only a minor component of the anaerobic gut 
microbial community. Furthermore, only a few sequences (< 1%) were identified as 
uncultured bacterial clone but showed identity with 16S sequences obtained from other 
mammalian GI tract microbes. At the genus level, 12 different genera including 
Barnesiella, Bacteroides, Ruminococcus, Oscillibacter, Anaerotruncus, Butyricicoccus, 
Roseburia, Dorea, Robinsoniella, Lactobacillus, Akkermansia and Mucispirillum were 
identified in the mice colon representing only 34.6% of the total sequenced population. 
The sequences that were not classified at the genus level were classified to the next 
higher level in the order of family, order, class, phylum or unclassified bacteria.  
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Total no. of 
Clones 
sequenced 
Bad quality 
sequence* 
No. of putative 
chimeric 
sequences 
No. of sequences 
used for analysis 
2week 
Control 
96 9 20 67 
2week 
10ppb 
120 24 15 81 
2week 
250ppb 
120 22 18 80 
5week 
Control 
120 4 6 110 
5week 
10ppb 
120 3 14 103 
5week 
250ppb 
120 12 18 90 
10week 
Control 
120 11 8 101 
10week 
10ppb 
120 15 9 96 
10week 
250ppb 
120 9 15 96 
Total 1056 109 123 824 
 
Table 3.2: Sequencing information for the bacterial clone libraries obtained from colon 
samples. * indicates sequences with ambiguous bases (N). 
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Bacteroidaceae and Porphyromonadaceae were the only families observed in 
phylum Bacteroidetes along with a few sequences that were identified as unclassified 
Bacteroidales. Similarly, Lachnospiraceae was the most abundant family in phylum 
Firmicutes followed by Ruminococcaceae, Lactobacillaceae, Peptostreptococcaceae and 
Peptococcaceae. However unclassified Clostridiales (23.5%) formed a major part of the 
Firmicutes population. Deferribacteres and Verrucomicrobia were exclusively formed of 
a single genus namely Mucispirillum and Akkermansia, respectively. 
When arsenite exposure was not considered as a factor, Firmicutes population 
decreased with time from 2 to 10 week clone libraries. Within Firmicutes, family 
Ruminococcaceae increased with time whereas Lachnospiraceae populations decreased 
from 2 to 10 week clone libraries. Bacteroidetes population showed an increase with time 
and a similar trend was observed for phylum Deferribacteres and Verrucomicrobia. 
Within the Bacteroidetes, populations belonging to the family Porphyromonadaceae 
increased with time from 2 to 10 week libraries whereas an opposite trend was observed 
for the family Bacteroideaceae. Table 3.3 shows the classification of the sequences 
obtained from these clone libraries to various levels of taxonomic hierarchy.  
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Taxonomic group 2 week 5 week 10 week Over all 
Bacteroidetes (P) 18.4% 41.6% 46.7% 37% 
Bacteroidia (C) 18.4% 41.6% 46.7% 37% 
Bacteroidales (O) 18.4% 41.6% 46.7% 37% 
Unclassified Bacteroidales (O) N 0.3% 2.7% 1% 
Bacteroidaceae (F) 4.8% 4.9% 2.7% 4% 
Bacteroides (G) 4.8% 4.9% 2.7% 4% 
Porphyromonadaceae (F) 13.6% 36.3% 41% 32% 
Unclassified Porphyromonadaceae (F) 3.9% 7.26% 12.3% 8.1% 
Barnesiella (G) 9.6% 29% 28.6% 23.5% 
Firmicutes (P) 78.9% 56.4% 49.8% 60% 
Unclassified Firmicutes (P) N 1% 0.3% 0.9% 
Clostridia (C) 75.9% 55.1% 46.7% 57.9% 
Clostridiales (O) 75.9% 55.1% 46.7% 57.9% 
Unclassified Clostridiales (O) 34.2% 24.1% 14.7% 23.5% 
Ruminococcaceae (F) 8.34% 11.9% 14.3% 11.8% 
Unclassified Ruminococcaceae (F) 5.26% 8.58% 11.6% 8.73% 
Butyricicoccus (G) N 1% N 0.4% 
Oscillibacter (G) 1.7% 1.65% 2.7% 2% 
Ruminococcus (G) 0.4% 0.3% N 0.2% 
Anaerotruncus (G) 0.9% 0.3% N 0.4% 
Lachnospiraceae (F) 33.3% 18.8% 17.4% 22.3% 
Unclassified Lachnospiraceae (F) 32% 18.8% 16.4% 21.6% 
Roseburia (G) 0.4% N 1% 0.5% 
Dorea (G) 0.4% N N 0.1% 
Robinsoniella (G) 0.4% N N 0.1% 
Unclassified Peptostreptococcaceae (F) N N 0.3% 0.1% 
Unclassified Peptococcaceae (F) N 0.3% N 0.1% 
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Taxonomic group 2 week 5 week 10 week Over all 
Bacilli (C) 3% 0.3% 2.7% 1.9% 
Lactobacillales (O) 3% 0.3% 2.7% 1.9% 
Lactobacillaceae (F) 2.6% 0.3% 2.7% 1.8% 
Lactobacillus (G) 2.6% 0.3% 2.4% 1.7% 
Unclassified Lactobacillaceae (F) N N 0.3% 0.1% 
Unclassified Lactobacillales (O) 0.4% N N 0.1% 
Deferribacteres (P) N 0.3% 1.3% 0.6% 
Deferribacteres (C) N 0.3% 1.3% 0.6% 
Deferribacterales (O) N 0.3% 1.3% 0.6% 
Deferribacteraceae (F) N 0.3% 1.3% 0.6% 
Mucispirillum (G) N 0.3% 1.3% 0.6% 
Verrucomicrobia (P) 0.4% 0.6% 1.7% 0.9% 
Verrucomicrobiae (C) 0.4% 0.6% 1.7% 0.9% 
Verrucomicrobiales (O) 0.4% 0.6% 1.7% 0.9% 
Verrucomicrobiaceae (F) 0.4% 0.6% 1.7% 0.9% 
Akkermansia (G) 0.4% 0.6% 1.7% 0.9% 
Proteobacteria (P) 0.4% N N 0.1% 
Deltaproteobacteria (C) 0.4% N N 0.1% 
Desulfovibrionales (O) 0.4% N N 0.1% 
Unclassified Desulfovibrioniaceae (F) 0.4% N N 0.1% 
Unclassified bacteria 1.7% 1% 0.3% 0.9% 
 
Table 3.3: Percent distribution of bacterial 16S clone libraries obtained from mouse 
colon to bacterial taxonomy. N = not found, P = phylum (highlighted), C = class, O = 
order, F = family and G = genus.  
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3.5 As exposure is associated with increased Bacteroidetes 
 
  Despite interindividual variations, arsenite exposures clearly affected the 
microbial community of mouse colon. Compared with the control group, for all time 
points 10 ppb and 250 ppb As(III) exposed groups had an increase in the relative 
abundance of Bacteroidetes and proportionally fewer Firmicutes at the phylum level of 
taxonomy. Even at the class level, more Bacteroidia and fewer Clostridia were observed 
in As(III) exposed groups (Figure 3.7). However based on RDP II library comparison 
results, this change was significant (p<0.01) only for the 250 ppb groups at 2, 5 and 10 
week interval whereas for the 10 ppb As(III) exposed groups the change was significant 
only at 10 week interval. Within Bacteroidia, the number of sequences classified under 
the family Porphyromonadaceae increased in response to As(III) exposure whereas no 
such trend was observed for Bacteroidaceae (Figure 3.8). With respect to phylum 
Firmicutes, sequences classified under family Lachnospiraceae and Ruminococcaceae 
decreased after two and five weeks of 250 ppb of As(III) exposure. In the case of 10 
weeks of 10 and 250 ppb of As(III) exposure, only the sequences identified as 
Ruminococcaceae decreased significantly after As(III) exposure whereas no trend was 
observed for Lachnospiraceae. Bacilli were generally abundant in the As(III) exposed 
groups when compared to the control groups. Since many sequences from Firmicutes 
could not be classified beyond the family level it is difficult to determine whether arsenic 
treatment is affecting a single or more than one genus from these families. Paired 
comparison of the control and As(III) treated libraries using libshuff analysis yielded a 
value of <0.0001 which is less than a p value of 0.01 after Bonferroni correction, 
indicating that the libraries are significantly different from each other (Table 3.4).  
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Figure 3.7: Class level taxonomic distribution of clones obtained from clone libraries. 
Stacked bar graphs show relative % distribution of sequenced clones to different 
taxonomic classes. * indicates significantly different from control and 10 ppb for that 
particular class (p<0.01) where ** represents significantly different from control group 
only (p<0.01) 
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Figure 3.8: Family level taxonomic distribution of clones obtained from clone libraries. 
Stacked bar graphs show relative % distribution of sequenced clones to different 
taxonomic families. 
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 2 wk  
control  
2 wk 
10ppb 
2 wk 
250ppb 
5 wk 
control 
5 wk 
10ppb 
5 wk 
250ppb 
10 wk 
control 
10 wk 
10ppb 
2 wk 
10ppb 
 
<0.0001        
2 wk 
250ppb 
 
<0.0001 <0.0001       
5 wk 
Control 
 
<0.0001 <0.0001   <0.0001      
5 wk 
10ppb 
 
<0.0001 <0.0001 <0.0001 <0.0001     
5 wk 
250ppb 
 
<0.0001 <0.0001  <0.0001 <0.0001 <0.0001    
10 wk 
Control 
 
<0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001   
10 wk 
10ppb 
 
<0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001  
10 wk 
250ppb 
<0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.0002* <0.0001 <0.0001 
 
Table 3.4: Paired comparison of clone libraries by libshuff. The 2 libraries were 
considered significantly different if their p value generated by libshuff is lower than the 
corrected p value after Bonferroni correction. After Bonferroni correction the corrected p 
values of 0.00014 and 0.0007 are equivalent to the normal p values of 0.01 and 0.05. * 
indicates that the libraries are significantly different at p = 0.05 whereas all other libraries 
are significantly different at p = 0.01. 
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3.6 Microbial diversity estimation 
 
In order to assess the diversity of bacteria present in the mice colons, 16S rRNA 
gene sequences obtained by sequencing were clustered into groups. Based on distance 
matrix, clones with 97% (species level), 95% (genus level) and 90% (family level) 
sequence identity were grouped into the same phylotype/operational taxonomic units 
(OTUs). The number of OTUs with only 1 sequence at a distance of 0.03, 0.05 and 0.1 
were 236, 163 and 59 respectively. Regardless of As(III) exposure, a total of 313 unique 
phylotypes were identified including 159, 105 and 108 phylotypes from 2, 5 and 10 week 
clone libraries respectively at the distance level of 0.03. However at the genus level (95% 
sequence identity) only 136, 87 and 86 OTUs were found in 2, 5 and 10 week mice colon 
contributing to a total of 241 OTUs in mice colons. The number of OTUs determined in 
2, 5 and 10 week clone libraries at family level were 74, 51 and 47 respectively, totaling 
towards 114 OTUs in mice colon. These results indicate that the diversity of mouse colon 
microbiota decreased after 2 weeks. Also, the number of OTUs shared between different 
libraries varied, with the maximum number of OTUs shared by 10 and 5 week clone 
libraries or 2 and 5 week clone libraries and least OTUs were shared between 10 and 2 
week clone libraries. This pattern of shared OTUs was consistent for all distances. These 
results indicate that the microbial community from 5 week samples is intermediate in 
type and diversity to that of 2 and 10 week microbial populations. Figure 3.9 shows the 
number of OTUs shared between 2, 5 and 10 week clone libraries at a distance of 0.03, 
0.05 and 0.1. 
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Figure 3.9: Venn diagrams showing the number of OTUs shared between 2, 5 and 10 
week 16S rRNA clone libraries irrespective of As(III) exposure dose at a distance of (A) 
0.03 (B) 0.05 and (C) 0.10.  
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Effect of arsenite on microbial diversity of the murine colon 
Microbial diversity, richness and coverage were calculated for the combined data 
set as well as for all the sample subsets based on time (2, 5 and 10 week) and dose 
combinations (0, 10 and 250 ppb) (Table 3.5,Table 3.6). Arsenite exposure did not affect 
the overall richness of murine colon microbiota at the genus and family level as indicated 
by more or less the same number of observed OTUs in control and 250 ppb exposed 
groups. The number of observed OTUs was a little higher for 10 ppb at 0.05 and 0.1 
distance levels in all the libraries except for the 5 week 10 ppb group where the number 
of observed OTUs were equal to the 5 week 250 ppb group.  
Overall the Good’s coverage was 93% for the combined libraries at a distance of 
0.1 indicating that sequencing 100 additional clones will yield only seven new OTUs. 
When each library was considered individually, >83% coverage was observed for 5 and 
10 week clone libraries at a distance of 0.10 but the coverage was lower (66 – 73%) for 2 
week clone libraries. However the Good’s coverage was generally low at the genus level 
for all the libraries except for 5 and 10 week control where 80 and 88% coverage was 
observed respectively.  
To estimate the richness of the clone libraries, rarefaction curves were plotted 
(Figure 3.10). For the combined dataset at 0.03 and 0.05 distance levels the rarefaction 
curve did not reach saturation towards the end of the sampling. However at a distance of 
0.1 the curve almost reached plateau towards the end of sampling for the combined 
dataset as well as for all individual types of clone libraries (Figure 3.10). Both rarefaction 
curves and Good’s coverage estimates indicated that the majority of bacteria at the family 
level of taxonomy have been captured in the current sequencing efforts. However new 
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phylotypes would be detected with continued sampling from these colon samples at the 
genus and species level.  
Similar to rarefaction curves, estimations of species richness by Chao’s estimator 
predicted that sequencing more clones can reveal more unique sequences (Table 3.5, 
Table 3.6). Estimated numbers of OTUs as determined by Chao were relatively close to 
the observed numbers at higher distance level (0.1) whereas the difference between 
estimated and observed OTUs increased at a lower distance level. The percentage of 
observed/estimated OTUs was between 33−76% at cluster distance of 0.1 whereas this 
percentage was reduced to 14−69% at the genus level.  
Bacterial diversity at the family and genus level as measured by Shannon and 
Simpson index was least for 250 ppb group and highest for control group when time was 
not considered as a factor (Table 3.5, Table 3.6). The highest diversity was observed for 
the 2 week libraries and least for the 5 week when As(III) exposure was not included as a 
factor. Within the individual library data sets, bacterial diversity was highest for 2 week 
control and lowest for 5 week 250 group. These results differed from the microbial 
richness wherein observed species richness as determined by rarefaction curve was 
highest in the 2 week 10 ppb group and lowest in 10 week control group. The Shannon 
index is prone to error and bias when the sampling is incomplete (Magurran, 1988). 
Therefore during any discrepancy between the Shannon and Simpson diversity indices 
more weight was given to the trends observed by the latter. Overall the results from 
microbial diversity estimations suggest that more sequencing efforts will generate more 
unique microbial species that in combination could have a profound effect on mouse 
health and disease.  
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Observed 
OTUs 
Chao 
Estimator of 
species 
richness 
Good’s 
Coverage 
(C) (%) 
Simpson 
Diversity 
Index (D) 
Shannon 
Diversity 
Index (H) 
2 wk 
Control 
51 352 36 0.012212 3.797245 
2 wk 
10ppb 
59 227 39.5 0.014815 3.889397 
2 wk 
250ppb 
50 180 50 0.039873 3.539687 
2wk 
All 
136 533.5 53.5 0.013139 4.555065 
5 wk 
Control 
36 64.875 80 0.105755 2.806833 
5 wk 
10ppb 
42 88.42857 75 0.059585 3.20864 
5 wk 
250ppb 
37 112.6 69 0.209488 2.574984 
5 wk 
All 
87 185.076923 83 0.080104 3.270088 
10 wk 
Control 
29 42.2 88 0.077426 2.878059 
10 wk 
10ppb 
42 108.4286 68 0.133991 2.90301 
10 wk 
250ppb 
39 85.42857 73 0.093202 2.986581 
10 wk 
All 
86 164 82 0.053626 3.597955 
All 
Control 
96 243.5 78 0.046256 3.804828 
All 
10ppb 
119 467 68.5 0.051152 3.974711 
All 
250ppb 
97 275.75 75 0.06679 3.648178 
All 241 696.275862 80 0.040893 4.328786 
 
Table 3.5: Indices of richness, diversity and library coverage obtained for 16S clonal 
libraries at a distance of 0.05. D decreases with increasing diversity while H increases 
with increasing diversity. 
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Observed 
OTUs 
Chao 
Estimator of 
species 
richness 
Good’s 
Coverage 
(C) (%) 
Simpson 
Diversity 
Index 
Shannon 
Diversity 
Index 
2 wk 
Control 
32 95.25 66 0.069652 2.987348 
2 wk 
10ppb 
34 80.2 73 0.074383 3.012234 
2 wk 
250ppb 
31 94.25 71 0.089241 2.790469 
2wk 
All 
74 144.714286 80 0.066504 3.454768 
5 wk 
Control 
25 40.6 88 0.137114 2.423934 
5 wk 
10ppb 
23 56 88 0.110603 2.508098 
5 wk 
250ppb 
23 42.5 85.5 0.249438 2.145428 
5 wk 
All 
51 113.142857 90 0.116058 2.767992 
10 wk 
Control 
22 29 92 0.106337 2.546807 
10 wk 
10ppb 
27 47 83 0.218421 2.286577 
10 wk 
250ppb 
22 29.2 91 0.149123 2.371783 
10 wk 
All 
47 66.090909 93 0.09568 2.898701 
All 
Control 
55 86.90909 90 0.076669 3.091312 
All 
10ppb 
66 156.3 85 0.102407 3.025548 
All 
250ppb 
54 103.6 88 0.110427 2.8729 
All 114 214.647059 93 0.079961 3.293593 
 
Table 3.6: Indices of richness, diversity and library coverage obtained for 16S clonal 
libraries at a distance of 0.10. D decreases with increasing diversity while H increases 
with increasing diversity.     
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B. 
 
Figure 3.10: Rarefaction curves obtained from 16S rDNA clone libraries. (A) 
Rarefaction curves obtained from combined dataset at a distance of 0.03, 0.05 and 0.10. 
(B) Rarefaction curves obtained from 3 time points (2, 5 and 10 weeks) and 3 doses (0, 
10 and 250 ppb) at a distance of 0.10. 
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3.7 Phylogenetic tree 
 
To determine the phylogenetic relationship between the OTUs obtained from 16S 
rDNA clone libraries of the murine colon a neighbor joining phylogenetic tree of the 
representative OTU sequences (at 90% sequence similarity) from control, 10 ppb and 250 
ppb group irrespective of the time point was constructed (Figure 3.11). A total of 174 
clones were represented on the neighbor-joining tree. The phylogenetic tree indicated that 
for most of the OTUs identified from the control group, nearly identical OTUs were 
found in As(III) groups too. As expected, Clostridia formed the largest clade in the 
phylogenetic tree consisting of OTUs from all three libraries. However the number of 
sequences within certain phylotypes of Clostridia clade varied between the three groups. 
Similar to Clostridia, clades within Bacteroidia consisted of OTUs from all three libraries 
but the number of sequences within certain phylotypes were drastically different between 
the control and As(III) exposed libraries. For example one of the OTU in Bacterodia had 
133 sequences from the As(III) groups but only 18 sequences from the control group. 
Bacilli formed a small clade in the phylogenetic tree and was exclusively formed by 
OTUs obtained from As(III) exposed groups. 
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Figure 3.11: Neighbor joining tree showing the positions of 16S rDNA phylotypes 
obtained from mouse colon. Clones obtained from control mice are shown on red 
terminal branches, clones from 10 ppb exposed mice are shown on green branches and 
those obtained from 250 ppb As(III) exposed mice are shown on blue branches. Boot 
strap values obtained from 1000 replications and above 50% are shown at the nodes. 
Scale bar represents genetic distance based on 10 substitutions per 100 nucleotides. The 
number after ―│‖ at the end of each of the clone name indicates the number of sequences 
that were found under the same representative OTU. 
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3.8 Distribution of ars operon 
 
Distribution and occurrence of ars operons were determined bioinformatically in 
partially or completely sequenced microorganisms from the DOE Joint Genome Institute 
portal (http://img.jgi.doe.gov/). This was done to determine whether the mechanism for 
arsenic resistance and detoxification occurs in microbes that typically reside in the gut 
environment. The search was restricted to the microbial taxa that were identified from the 
sequencing data of the mouse colon from section 3.4. Due to the high ambiguity in gene 
annotation the search for ars operon in these genomes was done by three methods: COG 
(Cluster of Orthologous Groups) search, protein BLAST using ArsB sequence from B. 
thetaiotamicron and keyword search. The keywords used for the search for ars operon in 
different bacterial species include ars, arsenate reductase and arsenical pump.  
In total, 182 different bacterial species and strains were found on JGI website that 
fall under the taxonomic classification found in the mouse colon. Of these, only 52 
species had the whole genome sequenced. A total of 49 Bacteroidia, 39 Clostridia, 74 
Bacilli, 14 Deltaproteobacteria, 4 Verrucomicrobia and 2 Deferribacters species were 
searched for the presence of ars operon in their genome. The ars operon was defined as 
sequences that occur as cluster of at least two ars genes and are separated by not more 
than 200 bps. Based on this definition, only 18% of the total observed bacteria were 
found to have ars operon. Table 3.7 lists the taxonomic classification used for search of 
ars operon and microbes that were found to have an ars operon along with the 
arrangement of ars genes within the operon.  
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Species (Genome status) ars operon arrangement* 
P= Bacteroidetes, C= Bacteroidia, F= Bacteroidiaceae 
Bacteroides dorei 5_1_36/D4(D) RBCxxxxxR 
B. thetaiotamicron VPI-5482(F) BCADxxxR, BADxxxR 
B. fragilis 3_1_12(D) RBCxxxxxR 
B. eggerthii DSM 20697(D) BCADx 
B. intestinalis 341 DSM 17393(D) BCADxxxR, BADxxxR 
B. sp.1_1_16 (D) BADxxxR 
B. sp. 2_1_33B (D) BCADxxxR 
B. sp. 4_3_47FAA (D) BCADxxxR 
B. stercoris ATCC 43183(D) BCADxxxRx 
B. vulgatus ATCC8482 (F) BCADxxxR 
B. vulgatus PC510 (D) BCADxxxR 
P= Firmicutes, C= Bacilli, F= Lactobacillaceae 
Lactobacillus antri DSM 16041 (D) CBR 
L. fermentum IFO 3956 (F) CBR 
L. johnsonii NCC 533 (F) CBR 
L. reuteri CF48-3A (D) BRCCBR, CBR 
L. reuteri SD2112 (D) BRCCBR, CBR 
L. plantarum WCFS1(F) xDxBADR 
P= Firmicutes, C= Clostridia, F= Lachnospiraceae 
Oribacterium sinus F0268 (D) BAR 
P= Firmicutes, C= Clostridia, F= Ruminococcaceae 
Ruminococcus sp. 5_1_39BFAA(D) CBxxxxxR 
Ethanoligenens harbinense YUAN-3T (D) BxxR 
P= Firmicutes, C= Clostridia, F= Peptococcaceae 
Desulfitobacterium hafniense Y51 (F) BRCxR, CABR, CBR 
D. hafniense DCB-2 (F) BRC 
Desulfotomaculum reducens MI-1 (F) BR 
Pelotomaculum thermopropionicum (F) BR 
Thermincola sp. JR (F) BR 
P= Deferribacteres, C= Deferribacteres, F= Deferribacteraceae 
Deferribacter desulfuricans SSM1(F) BCR 
Denitrovibrio acetiphilus N2460 (F) CB 
P= Verrucomicrobia, C= Verrucomicrobea, F= Verrucomicrobiaceae 
Verrucomicrobium spinosum DSM4136 (D) CBxRxxxRx 
Verrucomicrobiae bacterium DG1235 (D) RBCAD 
P= Proteobacteria, C= Deltaproteobacteria, F= Desulfovibrionaceae 
Desulfovibrio sp. 3_1_syn3 (D) BR 
D. aespoeensis Aspo-2 (D) BR 
D. desulfuricans G20 (F) CCB 
D. magneticus RS-1 (F) BR 
D. salexigens DSM 2638 (F) BR 
Reference sequences (used for phylogenetic tree) 
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Species (Genome status) ars operon arrangement* 
P= Bacteroidetes, C= Bacteroidia, F= Bacteroidiaceae 
P. melaninogenica ATCC25845 (F) BCADxxxR 
P. bergensis DSM 17361 (D) BCAR 
P= Firmicutes, C= Clostridia, F= Clostridiaceae 
Clostridium kluyveri DSM 555 (F) CBR 
Cl. beijerinckii NCIMB 8052 (F) BCADR 
Cl. Phytofermentans ISDg (F) CDBAR 
P= Firmicutes, C= Bacilli, F= Staphylococcaceae 
Staphylococcus aureus RF122 (F) CBR 
P= Proteobacteria, C= Gammaproteobacteria, F= Enterobacteraceae 
Escherichia Coli FVEC 1412 (D) CBADR 
P= Proteobacteria, C= Gammaproteobacteria, F= Pseudomonadaceae 
Pseudomonas fluorescens PF-5 (F) HCBR 
P= Firmicutes, C= Bacilli, F= Bacillaceae 
Bacillus subtilis subtilis 168 (F) CBxR 
 
Table 3.7: Arrangement of ars operon in various bacterial species. For genome status F 
and D in parentheses indicates that the genome is completely sequenced (F) or in draft 
stage of sequencing (D). * The ars genes are written in the order they are found in the 
genome. ―x‖ represents genes encoding proteins of unknown function. 
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Within the ars operon, arsB and arsR genes were found in almost all the bacteria 
whereas arsA occurred in 40% of the bacteria. arsA was mainly distributed in 
Bacteroidetes phylum mostly in association with arsD. The majority of the Firmicutes 
had arsCBR or arsBR gene composition. Some of the species were found to have two ars 
operons. The arrangement of genes constituting the ars operon varied from species to 
species. Based on current estimates, ars operon is present in far more Bacteroidetes 
species than Firmicutes indicating that the expression of ars operon could be the reason 
behind selection for Bacteroidetes populations in As(III) exposed samples. In some of the 
species, the ars operon had genes for transposition and/or integration in its vicinity 
leading to speculation that ars gene might be transposed to other species.  
To determine the evolutionary relatedness of the ars operon in these microbes 
neighbor joining (NJ) phylogenetic trees were constructed separately for ArsA and ArsB 
protein sequences (Figure 3.12, Figure 3.13). In the NJ trees the ArsA and ArsB 
sequences formed three clusters. In both the trees Bacteroidetes were confined to a single 
cluster. All ArsA sequences from Firmicutes clustered together whereas some of the 
ArsB sequences formed clusters with Bacteroidia. Within Firmicutes, ArsB sequences 
from Lactobacillus species formed a separate sub cluster but were separated from other 
Bacilli. The ArsB sequences from Verrucomicrobiae, Delta proteobacteria and 
Deferribacteres grouped together. Desulfitobacterium hafniense consists of three ArsB 
sequences and each one of them was confined to separate sub cluster.  
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Figure 3.12: A Neighbor joining tree of ArsA protein sequences. Boot strap values 
obtained from 1000 replications are shown at the nodes. Scale bar represents evolutionary 
distance based on number of substitutions per site. The Genbank accession number for 
each sequence is given before the species name. 
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Figure 3.13: A Neighbor joining tree of ArsB protein sequences. Boot strap values 
obtained from 1000 replications are shown at the nodes. Scale bar represents evolutionary 
distance based on number of substitutions per site. The Genbank accession number for 
each sequence is given before the species name. 
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3.9 Effect of As(III) on microbial physiology of the host 
 
Selection of model organism  
In order to understand the in vivo effect of As(III) on gut microbiota physiology, 
ars and nrf operon genes were selected for comparing their expression at the mRNA level 
between control, 10 and 250 ppb As(III) exposed mice. Since enough variability exists 
between various species in the gene sequences from the two operons, a model organism 
was needed to accomplish the above aim. The selection of the model organism was based 
on the criteria that the selected organism should possess one or both of the operons (ars 
or nrf operon) being studied, should belong to the taxonomic group of significance in the 
gut and should be present in the mouse colon in detectable limits as determined by 
general PCR. Based on these criteria, seven microorganisms namely Bacteroides 
thetaiotamicron, Bacteroides intestinalis, Prevotella melaninogenica, Lactobacillus 
planatarum, Dorea formicigenerans, Clostridium phytofermentans and Oribacterium 
sinus were selected for further study. To screen for the presence of these species in the 
mouse colon microbial community, species specific primers were designed (Appendix 5). 
Table 3.8 shows the genes for which the species specific primers were designed and the 
results obtained with these primers after amplification by general PCR. The results 
indicated that B. thetaiotamicron was the microorganism that fulfilled all the above 
criteria. Thus, for the expression studies by real time qPCR, primers for reference gene 
(rpoB) and target genes (arsA, arsB, arsC and nrfA) were designed based on the sequence 
of these genes from B. thetaiotamicron. 
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Organism Phyla arsA rpoB nrfA 
Bacteroides thetaiotamicron Bacteroidetes + + + 
Bacteroides intestinalis Bacteroidetes − + − 
Prevotella melaninogenica Bacteroidetes − − Ab 
Oribacterium sinus Firmicutes − +/− Ab 
Lactobacillus planatarum Firmicutes − (6) NA NA 
Clostridium phytofermentans Firmicutes −(4) NA NA 
Dorea formicigenerans Firmicutes Ab +/− − 
 
Table 3.8: Genes used to determine the presence of specific microorganisms in the 
mouse colon microbiota. The symbols indicate amplification (+), no amplification (-), 
amplification in a few samples (+/−), gene sequence was not found in the genome (Ab) 
and no primers were designed (NA). The number in parentheses shown above indicates 
the number of primer pairs tested. For others only one primer pair was tested. 
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Specificity of the primers designed for expression studies  
Due to non-availability of the pure culture, genomic DNA from mouse colon was 
used to test the specificity of each of the primer pair designed for amplifying reference 
gene (rpoB) and target genes (arsA, arsB, arsC and nrfA). A total of 30 different primer 
pairs were tested in three different reaction conditions for amplifying the arsC gene from 
microbial community DNA of the mouse colon. However no amplification was achieved 
with any of the primer pairs tested.  These results indicate that either the arsC gene is 
present at a very low abundance in colon microbiota or the PCR conditions or the primers 
used were not suitable for the amplification of arsC gene from colon microbiota.  
Figure 3.14 shows representative agarose gels with 185, 121, 144 and 163 bp PCR 
products obtained from mouse colon microbial community DNA with rpoB, arsA, arsB 
and nrfA primer pairs respectively. The PCR products thus obtained were free of any 
secondary products, as indicated by the formation of a single band of desired length on a 
regular agarose gel. The absence of any visible band in the negative control (water) 
indicated that the primers do not form dimers under the PCR conditions tested. To further 
confirm the specificity of the primers used, the PCR product obtained from each primer 
pair was used for direct sequencing. The results from NCBI BLAST search confirmed 
that the amplified product corresponds to the rpoB, arsA, arsB and nrfA genes of B. 
thetaiotamicron.  
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Figure 3.14: Representative 1.8% agarose gels showing amplification of reference [(A) 
rpoB] and target genes [(B) nrfA (C) arsA and (D) arsB] from mouse colon microbial 
community DNA. L = 100 bp DNA ladder, -ve = negative control. 
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As mentioned in table 3.7, B. thetaiotamicron had 2 ars operons with gene 
configurations BCADxxxR and BADxxxR respectively. Table 3.9 shows the nucleotide 
identity of the genes that constitute the two ars operons from B. thetaiotamicron. 
Although arsA and arsB genes were not 100% identical at the primer binding sites, the 
primers designed specifically for amplifying part of arsA and arsB gene from operon 1 
(BCADxxxR ) of B. thetaiotamicron, amplified the arsA and arsB regions from operon 2 
(BADxxxR) as confirmed by direct sequencing of the PCR product. These results 
indicated that the operon 2 (without arsC gene) from B. thetaiotamicron or from a related 
strain was present in more copies in the mouse colon as compared to operon 1.  
 arsA arsB arsD arsR 
Nucleotide similarity 86% 84% 87% 88% 
 
Table 3.9: Nucleotide identity between the ars genes from the two ars operons of B. 
thetaiotamicron. 
Accuracy of primer pairs for real time PCR 
In order to obtain reliable results from comparative Ct method (∆∆Ct) the 
efficiency of reference gene and the target gene should be within 10% range. The 
efficiency of these genes was calculated by preparing a dilution series of the PCR product 
obtained from the general PCR performed on microbial community DNA extracted from 
mouse colon. Figure 3.15 shows the melt curve and the standard curve obtained for each 
of the primer pairs. The efficiency for rpoB, nrfA, arsA and arsB primer pairs was 99%, 
96%, 99% and 90% respectively. A single Tm peak was observed in the melt curve for 
each of the primer pair indicating that the primers were suitable for real time PCR. 
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A. rpoB 
 
B. nrfA 
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C. arsA 
 
D. arsB 
 
Figure 3.15: Melt curve and standard curve obtained for (A) rpoB (B) nrfA (C) arsA and 
(D) arsB gene. 
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Relative quantification of arsA and arsB expression in mouse colon 
The mRNA expression levels of arsA and arsB genes between control, 10 ppb and 
250 ppb mouse colon samples were compared by comparative Ct method (2
−∆∆Ct 
) of real 
time RT-qPCR. The arsA and arsB genes at 2 week time point yielded Ct values above 
35 indicating that the genes were expressed at very low levels and could not be compared 
by comparative Ct method. However for 5 and 10 week mouse colon samples, the Ct 
values for arsA gene were lower than 35, indicating that the gene copy number of arsA is 
higher in 5 and 10 week colon samples. Figure 3.16 shows the dose dependent response 
of arsA expression in the 5 and 10 week mouse colon samples after As(III) exposure. 
These results indicate that As(III) exposure at a concentration of 10 and 250 ppb does not 
affect the expression of arsA in gut microbes.  
With respect to the arsB gene, Ct values varied from sample to sample. For most 
of the 5 week samples at least one of the replicates of each sample yielded melt curve 
with desired Tm of 76
0
C and a single peak, whereas for the 10 week colon samples 
multiple Tm peaks were observed with most of the samples indicating that the arsB gene 
was not expressed at levels to be compared by real time qPCR. Figure 3.17 shows the 
dose dependent response of arsB expression in 5 week mouse colon samples after As(III) 
exposure. No evidence for changes in expression of the arsB gene was observed in the 5 
week samples in response to As(III) exposure. Together the results from expression 
studies of arsA and arsB genes indicated that As(III) exposure at a concentration of 10 
and 250 ppb via drinking water does not alter the expression of ars operon  in mouse gut 
microbes up to 10 weeks.  
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Figure 3.16: Relative expression levels of arsA gene in control, 10 ppb and 250 ppb 
mouse colons at (A) 5 week and (B) 10 week. Error bars indicate standard deviation. 
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Figure 3.17: Relative expression levels of arsB gene in control, 10 ppb and 250 ppb 
mouse colons at 5 week time point. Error bars indicate standard deviation. 
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As(III) induced dose dependent alterations in nrfA expression 
To determine the effect of As(III) exposure on physiology of the colon microbes, 
the mRNA expression levels of nrfA gene were compared between control, 10 ppb and 
250 ppb mouse colon samples by comparative Ct method (2
−∆∆Ct 
). Figure 3.18 shows the 
time and dose dependent response of nrfA expression in 5 and 10 week mouse colon 
samples after As(III) exposure. These results indicated that As(III) exposure at a 
concentration of 250 ppb induced significant increase in the expression of nrfA in gut 
microbes. For the 10 ppb As(III) exposure dose, significant increase in the expression of 
nrfA was observed only after 10 weeks of As(III) exposure. Altered expression of the 
nrfA gene in time and dose dependent manner in response to As(III) exposure 
demonstrated that As(III) exposure impacts the physiology of the microbes residing in the 
mouse colon. 
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Figure 3.18: Relative expression levels of nrfA gene in control, 10 ppb and 250 ppb 
mouse colons at (A) 5 week and (B) 10 week time point. Error bars indicate standard 
deviation. ** indicates p < 0.01 and *** indicates p < 0.001 after Tukey’s post-hoc test. 
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Chapter 4 : DISCUSSION 
 
4.1 Molecular techniques as a tool for studying colon microbiota 
 
In recent years, the use of culture independent techniques have grown at a fast 
pace and have extended our knowledge about the diversity and composition of the 
mammalian microbiota. This development has overcome the disadvantages associated 
with the traditional time consuming and labor intensive cultivation based approaches 
wherein the difficulty lies in differentiating related species/strains as well as in culturing 
anaerobic gut microbes under laboratory conditions (Duncan et al, 2007). Numerous 
studies have used 16S rRNA gene based sequencing (pyrosequencing, near full length 
16S rDNA sequencing) and fingerprinting techniques (DGGE, RFLP) to study the gut 
microbiota (Zoetendal et al, 2002; Nava et al, 2011; Eckburg et al, 2005; Osborn et al, 
2000). In addition some of the studies have used the variability in the spacer region 
between 16S and 23S rRNA gene (RISA, ARISA) of different bacterial species for 
comparative studies related to gut microbiota (Scanlan et al, 2008; Spencer et al, 2011). 
However the dynamic and complex nature of the mammalian microbiota along with the  
microbial variation between individuals pose a challenge in these studies as each of these 
technique comes with its own advantages and limitations (Sekirov et al, 2010). 16S 
rDNA clone libraries based results give high taxonomic resolution but is very time 
consuming and expensive approach. Pyrosequencing on the other hand is convenient and 
cost effective approach in case of multiple samples but provides shorter reads of <400 bp, 
thus giving only class or family level taxonomic resolution (Liu et al, 2008). DGGE and 
RFLP are rapid methods for comparing bacterial profiles from different groups but 
provide low taxonomic resolution due to smaller product size. With DGGE it is difficult 
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to achieve reproducible gels and the technique itself is associated with inherent biases 
since different bacterial species that have same GC content migrate to the same position 
in the gel (Muyzer & Smalla, 1998). Both RISA and ARISA are highly reproducible and 
less time consuming approaches. These provide low taxonomic resolution mainly 
because the intergenic region database is not extensively available, especially for gut 
microbes where majority of the bacteria have not been sequenced yet (Kovacs et al, 
2010). ARISA, although more expensive than RISA, is advantageous as the resolution of 
PCR products on the capillary is very high and it provides an accurate estimation of 
intergenic length. However in both cases, the technique is biased as a single species can 
have several intergenic regions with each one differing in length. Additionally a number 
of bacteria have been identified where 16S and 23S rRNA genes are not organized in 
operons but are separated from each other with > 3000 bp distance between them. This 
size between 16S and 23S rRNA genes is far greater than the normal size separated on a 
gel or a capillary (Kovacs et al, 2010). All of the fingerprinting techniques suffer from 
the limitation of being unable to detect species that are present at a very low abundance 
(<1%) in a mixed community. Fluorescent in situ hybridization (FISH) and RT-qPCR are 
two other 16S rRNA gene based techniques that are used to identify and compare 
bacterial communities in the gut (Kalliomäki et al, 2008; Penders et al, 2007). For both of 
these techniques either species specific or group specific probes/primers need to be 
designed, thus limiting the identification of novel species. Depending upon the conditions 
used for hybridization and PCR, these probes/primers can bind to other closely related 
species producing biased results (Sekirov et al, 2010). 
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The primary goal of this study was to compare the bacterial profile of control and 
As(III) exposed murine colon and to identify the taxonomic groups that are mainly 
affected by arsenic exposure. In order to achieve this goal and to overcome the 
constraints associated with cultivation independent techniques, 4 different molecular 
approaches (DGGE, RISA, ARISA, clone library) based on principles of inter species 
differences of GC content, variable length of 16S and 23S intergenic regions among 
different bacterial species and variability within the conserved 16S rRNA gene were used 
in this study to determine the effect of As(III) on colon microbiota.  
4.2 Biases associated with method of DNA extraction 
 
Besides individual limitations, all molecular techniques are prone to biases 
associated with methods of DNA extraction and PCR. The silica and guanidinium 
thiocynate method as well as QIAamp DNA stool mini kit from Qiagen Inc. were used in 
this study for extracting microbial community genomic DNA from mouse colon. Both the 
methods have been used previously in numerous studies to extract microbial DNA from 
the stool samples of various species (Larsen et al, 2010; Boom et al, 1990; Barnard et al, 
2011). Of these two methods, the silica method is inexpensive but time consuming 
procedure. The silica slurry used for isolating DNA requires a two day preparation time 
and requires preparation of buffers that are not regularly used in other procedures. 
Moreover when the same amount of DNA was used for PCR, some of the samples did 
not show any or minimal amplification indicating that PCR inhibitors were left in the 
final extracted genomic DNA (Figure A.1). QIAamp DNA stool mini kit protocol on the 
other hand gave more or less consistent yields of genomic DNA as well as PCR products 
for all the samples when equal amounts of starting materials were used. However in both 
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the methods, variations in the amount of DNA extracted due to incomplete 
homogenization of the sample cannot be ruled out. Also the 260:280 ratios for the 
extracted nucleic acid were better with QIAamp DNA stool mini kit protocol. Due to 
inconsistencies associated with silica protocol, only results obtained with QIAamp DNA 
stool mini kit from study 2 and part of study 1 are discussed below. 
4.3 Microbial composition of the murine colon 
 
Most of the studies related to the microbial communities in the colon of the host 
have used stool samples as their study source. However, within the gut the composition 
of microbial communities differs longitudinally between ascending and descending colon 
as well as radially between mucosal and luminal region (Frank et al, 2007; Zoetendal et 
al, 2002). To overcome these differences and to ensure that the bacterial community 
directly associated with the gut lining is accounted for, both the ascending and 
descending colon was used in this study to determine the in vivo impact of As(III) on 
colon microbiota.  
In the present study, comparison of RISA and ARISA profiles obtained from 
microbial community DNA of murine colon were used to track the effect of As(III) 
exposure on murine colon microbiota. The number of detectable bands obtained from 
RISA profiles of an individual mouse colon ranged from 16 – 30 and the similarity value 
between individuals of the same group ranged from 40 – 85%. The similarity index was 
relatively low considering that the mice were genetically identical and housed under same 
conditions. An attempt was made to sequence some of the dominant phylotypes obtained 
from RISA both by making a clone library and by excising specific bands from the gel. 
Reamplification of excised bands generally yielded multiple bands. This was attributed to 
  
117 
low resolution of RISA products on the polyacrylamide gel. Of the 21 sequences obtained 
from RISA clone libraries, 18 sequences showed similarity with Lactobacillus (Appendix 
6). The product length of the 18 sequences varied from 290 bps to 504 bps indicating that 
the spacer regions of Lactobacillus species and strains are distributed over a broad range. 
These results also showed bias towards preferential insertion of smaller products into the 
cloning vector. These results indicate that the inexpensive and rapid RISA approach is 
more suitable for comparative studies rather than the studies that require taxonomic 
identification of bacterial communities present in the host.  
ARISA profiles from individual colon samples yielded only 15 − 35 peaks 
whereas about 113 peaks were obtained collectively from all the samples. The number of 
bands and peaks obtained from RISA and ARISA profiles were far less than the number 
of species typically found in a host indicating that the techniques were not suitable for 
diversity estimations. The ordination plots obtained after statistical analysis of ARISA 
data differed between peak height, area and presence/absence and so does the peaks that 
contributed to the variation in these plots. Similar differences have been observed 
between the three types of ordination plots in other studies too, wherein it was 
recommended that ordination plots obtained from relative peak height are best suited for 
ordination based analysis of microbial community (Culman et al, 2008). 
Results from DGGE showed that the number of bands ranged from 20 − 40 in any 
individual mouse. Significant variation was observed between individuals of the same 
group with similarity index values ranging from 55 – 90% which was considerably low 
for the lower range. However other DGGE based studies on gut microbiota of mouse 
have showed comparable similarity index values (McCracken et al, 2001). Similar to 
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RISA and ARISA profiles, the number of bands obtained from DGGE fingerprints were 
far less than the number of species typically found in a host. These observations indicate 
that the DGGE based approach is more suitable for comparative studies that involve 
detecting shifts in microbial populations rather than diversity estimation studies. Excising 
specific bands from the DGGE gel and sequencing them or preparing a clone library from 
the same PCR products can give information about the type of bacteria present in the 
sample. However the PCR products resolved on DGGE gel in this study were ~177 bps in 
length and ≥50% of the obtained sequences were not classified to any phylum at 90% 
confidence threshold. When the classification was repeated at low confidence threshold 
of 50 – 60% most of the unclassified bacteria resolved into the phylum level of 
taxonomy. Moreover, the classification of these sequences to lower taxonomic levels was 
highly ambiguous. A similar pattern was observed with clone libraries obtained from the 
PCR products used for DGGE analysis (Figure A.5). These results showed that sequences 
obtained from DGGE are best classified at the phylum level of taxonomy or at the class 
level. Within each phylum the % GC ratio of species varies significantly. Thus sequences 
from Bacteroidetes and Firmicutes, the two predominant phyla found in mouse colon, 
were observed throughout the length of DGGE gel (Table A.1). Additionally no chimeric 
sequences were detected in a total of 418 sequences obtained from DGGE gel or DGGE-
PCR product clone library. This was in concordance to the fact that it is difficult to detect 
chimeras within smaller sequences (Haas et al, 2011). A typical near full length 16S 
clone library generally yields 5−30% sequences that are chimeric (Ashelford et al, 2005). 
Inability to detect chimeras in a DGGE sequence library indicates a potential bias 
associated with this approach. Despite these limitations, DGGE is a relatively 
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inexpensive method for detecting shifts in microbial populations under different 
conditions. 
The results from near full length 16S sequence analysis as well as the DGGE-
PCR product based library showed Bacteroidetes and Firmicutes as the predominant 
phyla in the murine colon accounting for >90% of the total sequenced population. This is 
in concordance with pyrosequencing based studies obtained from the colon and cecal 
samples of the same strain of mice (Nava et al, 2011; Ley et al, 2005; Hoffmann et al, 
2009). However those studies also found Actinobacteria, TM7, Acidobacteria, 
Tenericutes and Cyanobacteria in the murine colon and cecal regions comprising less 
than 1% of the total sequenced population. At the family level, 10 families were 
identified in this study with near full length 16S clone library based approach (Figure 
3.8). However sequences belonging to Prevotellaceae, Rikenellaceae, Clostridiaceae and 
other rare families that have been observed in murine colon by other research groups 
were found only in the clone libraries obtained from DGGE-PCR products (Figure A.6). 
These differences in the identification of rare phyla and assignment of sequences to lower 
taxonomic levels could reflect bias associated with inadequate sampling, criteria used for 
the classification of sequences, the length of 16S region amplified and most importantly 
the different primer sets used in the DGGE-PCR clone library, pyrosequencing and near 
full length 16S based sequencing approaches. At the genus level ~65% of the sequences 
were not assigned to any genus level, a trend found by other researchers too indicating 
that the lower GI tract of mammals is largely colonized by uncultivated and 
uncharacterized bacteria (Ley et al, 2005). These results emphasize the need to cultivate 
and study the microbes that colonize the gut environment.  
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4.4 Microbial community of the host changes with time 
 
An important observation found in this study was the gradual change in host 
microbiota with time (Figure 3.7). This observation was consistent with previous studies 
that have shown the microbial community of the host to be dynamic and changing with 
time (Tiihonen et al, 2010). However those time dependent studies estimated the 
microbial difference between infants, adult and elderly humans which is different from 
this study wherein differences in colon microbiota were observed within intervals of few 
weeks in adult mice. Other time dependent studies that had observed the effect of diet, 
antibiotic or any other factor on host microbiota have used only a 0 time point reference 
as the control (Dethlefsen et al, 2008; Ley et al, 2006). Only one study with four week 
old mice was found to reveal the differences in the microbial composition of the luminal 
and mucosal portions of caecum, proximal and distal colon within a five day interval 
(Hoffmann et al, 2009). No distinct pattern was observed regarding the relative 
proportions of Bacteroidetes and Fimicutes in the above study. However the data 
presented in the current study indicates a gradual increase in the ratio of Bacteroidetes 
and Firmicutes over time. The reason for this shift in microbial communities over such a 
short time span could be related to the developmental changes occurring in the mouse 
within this time frame. Thus the above observation underscores the importance of using 
separate control for each of the time points in microbiota related time course experiments.  
4.5 Effect of arsenic on microbial composition of the murine colon 
 
Exposure to arsenic via drinking water is a global health problem. The effect of 
acute and chronic exposures of arsenic on human health differs significantly. Acute 
exposure to arsenic at high doses generally leads to GI hemorrhage, multiple organ 
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damage and death (Armstrong et al, 1984). On the other hand, chronic exposures at 
environmentally relevant doses alter cell signaling pathways leading to cancers of various 
organs, cardiovascular disease and diabetes (WHO, 2001; Hughes, 2002). Therefore in 
this study the in vivo effect of As(III) on colon microbiota was determined after adding 
sodium arsenite to drinking water at concentrations that are commonly found in the 
environment. The results from this study reveal that As(III) in drinking water affects the 
microbial composition of the gut. The differences between the control and As(III) 
exposed  mouse colon microbiota were more significant than the differences that could 
have been due to variability within each group. Results from all the molecular approaches 
used in this study showed shifts in host microbial populations after two weeks of 250 ppb 
of As(III) exposure and ten weeks of 10 ppb of As(III) exposure. Banding patterns and 
dendrogram analysis of RISA and DGGE gels showed that the molecular similarity 
between the 2, 5 and 10 week 250 ppb exposed mice is greater than the similarity 
between any of the 250 ppb mice to any of the control group mice from the same time 
point. This type of intra group similarity was observed for 10 ppb As(III) exposed mice 
only after 10 weeks of As(III) exposure. PCA plots obtained from ARISA showed 
scattering of control and to a certain extent of the 10 ppb groups (except in 10 week 
samples) across the plot whereas the 250 ppb groups tended to form clusters. The results 
obtained from the 16S clone libraries were analyzed at various levels of taxonomical 
hierarchy to identify the taxa that differed significantly between control and As(III) 
exposed groups. An increase in Bacteroidetes and a proportionate decrease in Firmicutes 
were observed with increasing dose of arsenic exposure versus control groups. As 
expected the taxonomic composition of the 10 ppb group was intermediate to the control 
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and the 250 ppb group but like the 250 ppb group, the average Bacteroidetes population 
was also more in the 10 ppb group as compared to the control group. The stacked bar 
graph obtained for relative taxonomic distribution of near full length 16S as well as 
DGGE-PCR product based clone libraries showed that the 10 week 250 ppb exposed 
group is more similar to the 10 week control as opposed to the 2 and 5 week 250 ppb 
group, which differed significantly from their respective control groups. Also the level of 
significant differences between the control and 250 ppb group of 10 week changed when 
different confidence thresholds were used for classification. However, the significant 
difference remained the same at all confidence thresholds for all the other libraries used 
for comparison. The reason for such observation is unknown. The phylogenetic analysis 
showed that the changes observed between control and As(III) groups were attributed to 
class Bacteroidia and Clostridia and families Porphyromonadaceae, Lachnospiraceae and 
Ruminococcaceae. At the genus level over 19% of the increase in Bacteroidetes in As(III) 
exposed groups was associated with Barnesiella. In addition, an increase in Bacilli and 
Lactobacillus was found in the As(III) exposed group. Since many sequences remain 
unclassified at the order level it is not possible to conclude whether As(III) affects 
different genera and families within a phyla differently, causing one subgroup to increase 
while causing other to decrease. The results presented in this study reveal that, due to 
inter individual variations in microbial community structure, it is necessary to use a 
combination of molecular and statistical approaches to demonstrate the effect of any 
variable on the microbial community of the host.  
Human and mouse show considerable similarity in their distal gut microbiota at 
the higher levels of bacterial taxonomy (Ley et al, 2005). Several recent studies have used 
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murine models to reveal a relation between diseased and altered gut microbial 
communities (Bibiloni et al, 2005; Turnbaugh et al, 2006). Some of these studies as in the 
case of obesity showed similar results when repeated on human subjects (Ley et al, 2006; 
Turnbaugh et al, 2006). Thus it is plausible that the results from this work may be 
extended to humans.  
4.6 Effect of arsenic on microbial diversity 
 
The results from DGGE and RISA showed no significant difference in the total 
number of bands obtained from control and As(III) exposed groups. Similarly ARISA 
profiles and 16S clone libraries did not showed any difference in microbial richness 
between control and As(III) exposed groups. For DGGE-PCR product based clone 
libraries, the 250 ppb As(III) group was more diverse in the 5 week and less diverse in 
the 10 week libraries when compared to the control groups. However, the diversity index 
data from the near full length 16S based clone libraries showed low diversity in the 250 
ppb As(III) groups when compared to control for 2, 5 and 10 week time points at genetic 
distances of 0.05 and 0.1. These differences in the diversity estimations of 5 week 
samples between 16S and DGGE based clone libraries could be related to the differences 
in DNA extraction procedures used for obtaining the microbial community DNA. In the 
10 ppb group from 2, 5 and 10 week samples the diversity was always more than the 250 
ppb group but no particular trend was observed with respect to the control group from the 
same time point. Although no firm conclusion about the effect of As(III) on the  
microbial diversity of the mouse colon can be made from this study, nevertheless, the 
reduced diversity in the 250 ppb group that is predominated by Bacteroidetes might be 
related to the fact that Bacteroidetes is a far less diverse phylum when compared to the 
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Firmicutes. Reduced diversity in the colon may result in a decreased number of microbe 
associated metabolic pathways in the colon that might affect the physiological processes 
of the host.  
On the basis of diversity estimations and taxonomic classification, it can be 
concluded that in this study although the rare bacteria might not have been sampled 
efficiently, the effect of arsenic on predominant groups has been resolved. 
4.7 Selective effect of arsenite on host microbiota: a direct effect 
 
Bioinformatics analysis of distribution and occurrence of the ars operon in gut 
microbes showed that far more Bacteroidetes harbor this arsenic resistant mechanism as 
compared to the Firmicutes (Table 3.7). Grouping of ArsA and ArsB sequences from 
Bacteroidetes in the same cluster of the phylogenetic tree indicated common origin of 
these operons. However, the two proteins showed little similarity with any of the 
reference ArsA and ArsB sequences, which was surprising considering that most of the 
Bacteroidetes species had the E.coli type five gene ars operon configuration consisting of 
arsA, arsB, arsC, arsD and arsR genes. Most of the Firmicutes were devoid of arsA gene 
but their ArsB protein sequence clustered with B. subtilis indicating that these Firmicutes 
possess an Acr3 type As(III) transporter system. 
Primers designed specifically for amplifying part of arsA and arsB DNA and 
cDNA from operon 1 of B. thetaiotamicron, in return amplified the regions from operon 
2 as confirmed by sequencing. The reason for amplification of arsA and arsB cDNA from 
operon 2 could be related to the fact that in species that have more than one ars operon, 
the operon that lacks arsC gene is expressed at high levels in the presence of arsenite. 
However the amplification of 2
nd
 operon with genomic DNA indicates that the sequence 
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for 2
nd
 operon is present in more copies in the colon microbial community DNA. 
Presence of multiple copies of 2
nd
 operon in community DNA could relate to either intra 
or inter genomic mobilization of the ars operon under selective effect of As(III) exposure 
or gene duplication or binding of primers to ars operon of other closely related 
Bacteroides species. Bacteroidetes populations have been documented to possess well 
developed mechanisms for transposition of antibiotic resistant genes to other species 
(Salyers et al, 2004). Occurrence of the ars operon on plasmids and the presence of 
transposition related genes in the vicinity of the ars operon of certain species coupled 
with the results above indicate that the ars operon can undergo horizontal transfer under 
As(III) pressure and needs further investigation.  
No change in expression of arsA and arsB was observed in response to 10 and 
250 ppb of As(III) exposure under in vivo conditions of the colon. The reason could be 
that neither As(III) nor its metabolic forms are present in enough quantities in the colon 
so as to induce the expression of these genes. Studies with Shewanella sp strain ANA 3 
have demonstrated that the expression of ars operon requires ≤ 100 µM concentrations of 
As(III) in culture media and only 1.5 fold increase in expression was observed with 10 
fold increase in As(III) in the media (Saltikov et al, 2005a). These values for induction 
and fold increase in ars expression varies from species to species with a 14 - 39 fold 
change in the expression of ars operon genes observed in the presence of equal amounts 
of As(III) with different C. jejuni strains (Wang et al, 2009). However, the culture 
conditions used in those studies were very different from the current study where the fold 
change in arsA and arsB expression was determined under in vivo conditions with 10 and 
250 ppb of As(III) in drinking water.  Although levels of arsenic tested in this study did 
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not appear to induce any expression of ars genes in colon bacteria, the basal level of 
expression of these genes in colon bacteria might still provide selective advantage to the 
Bacteroidetes populations that harbor arsenic resistance genes as opposed to majority of 
the Firmicutes generally found in the colon that do not possess ars operon.  
Arsenic compounds have been used since ages as antimicrobial agents at high 
doses (Leonard, 1991). Arsenite levels in the range of 4 – 64 µg/ml of culture media have 
been found to be inhibitory to C. jejuni strains that possess ars operon ((Wang et al, 
2009). However the effect of ppb levels of As(III) on microbes that do not possess 
mechanism for arsenic resistance is not known. Another reason for the decrease in 
Firmicutes population in As(III) exposed murine colon could be to due antimicrobial 
action by other gut residents that bloomed in the colon in response to As(III) exposure. 
For example Lactobacillus converts sugars to lactic acid resulting in the acidification of 
the colon environment (Corr et al, 2009). An increase in Lactobacillus in response to 
As(III) exposure can suppress the growth of other gut microbes by reducing pH. However 
further work is needed to determine the role of microbe-microbe interaction in 
development of As(III) associated microbiota. 
This part of the study underscores the importance of measuring levels of arsenic 
and its metabolites in the colon as most of the ingested arsenic happens to be absorbed in 
the small intestine and any remaining amounts of arsenic or its metabolites may or may 
not have any direct effect on the viability of gut microbes per se. 
4.8 Effect of arsenic on the microbial physiology of the host 
 
Increased levels of nitrite, as an indicator used for estimating NO levels in the 
host, have been observed in mouse liver after As(III) exposure at low doses 
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(Barchowsky, unpublished data). Additionally, increased levels of nitrogen species such 
as peroxynitrite have been reported in mouse liver in response to the generation of 
superoxide anion from As(III) stimulated NADPH oxidase (Straub et al, 2008). Increased 
NO levels can affect the gut lining, cause inflammation and can have a bactericidal effect 
on gut bacteria (Endo et al, 2010; Kim et al, 2008; Sobko et al, 2006). An increase in NO 
levels in the host may result in selective increase of microbes that possess genes to 
combat high levels of NO. E.coli has been shown to combat NO toxicity by inducing the 
expression of nrfA (Poock et al, 2002). In this study, time and dose dependent increase in 
nrfA expression was observed in the mouse colon microbes after As(III) exposure under 
in vivo conditions. The increased expression of nrfA in colon microbes along with 
selective colonization of the colon by microbes that possess this gene may alter important 
metabolic pathways in the host that could result in development of pathogenic conditions 
in the host colon. The effect of As(III) on NO levels of the colon epithelia and microbial 
generation of NO is not known currently. However, based on the results above, increased 
NO level in the host in response to As(III) exposure seemed like a plausible explanation 
for the observed increase in the expression of nrfA in As(III) exposed mouse colon.  
4.9 Arsenic induced changes in the host: An indirect effect on gut microbiota 
 
Although evidence for angiogenesis and vascular remodeling in mouse liver 
indicated by defenestration of liver sinusoidal epithelial layer were seen by two weeks 
after exposure to 10 ppb of arsenite (Straub et al, 2008), the changes in the microbial 
flora of the murine colon started appearing at two weeks but these changes were not 
significant until ten weeks of arsenite exposure. These observations suggest that the 
effect of As(III) on gut community occurs in response to systemic changes of the host 
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and are not due to the direct exposure to arsenic itself. The interaction between colon 
epithelium and its microbiota is very complex with microbes present in the mucus layer 
of the epithelial lining playing a role in the regulation of epithelial cell regeneration and 
mucus layer production by goblet cells present in the epithelia. The outer mucus layer of 
the epithelia is the site where bacterial colonization occurs whereas the inner mucus layer 
acts as a shield and prevents microbial invasion into the host blood stream (Cherbuy et al, 
2010; Johansson et al, 2011). Like respiratory epithelia, colon epithelia may secrete 
innate immune protein like PLUNC that can regulate epithelial hydration as well as 
biofilm formation (Gakhar et al, 2010). Thus the colon epithelial environment influences 
the colonization of commensal bacteria by immune regulation and by providing access to 
complex carbohydrates in the mucus layer. In situ observations using transmission 
electron microscopy revealed that the small 0.25 μm coccoids (e.g. Ruminococcus) 
disappeared by the 5 week time point in mice treated with 250 ppb of As(III) (Stolz, 
unpublished data). This population also disappeared from the As(III) exposed 16S rRNA 
based clone libraries. Dietary factors such as Vitamin A deficiency affect the 
proliferation rate and differentiation of epithelial cells in the intestine (Uni et al, 2000). It 
has been well established that  arsenic at low levels alter signal transduction pathways 
involved in cell cycle regulation and differentiation and proteins involved in immune 
response and inflammation (Kozul et al, 2009b; Druwe & Vaillancourt, 2010). Although 
the effect of arsenic on gut epithelium is not known, the above evidence suggest that 
As(III) exposure can affect the colon epithelium differentiation, regeneration and 
function making it less favorable habitat for certain bacterial populations. In this way, 
As(III) associated changes in the gut microbiota can be more likely linked to arsenic 
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induced changes in the host and gut environment rather than the direct impact of toxic 
arsenic on gut community.  
4.10 Implications of Arsenic induced changes in colon microbiota on host health 
 
Gut microbes play a key role in various important processes in humans including 
nutrient processing, energy harvesting, immune system regulation and brain development 
(Hooper et al, 2002; Macpherson & Harris, 2004; Turnbaugh et al, 2006; Heijtz et al, 
2011). In this study an increase in Bacteroides and lesser proportions of Firmicutes were 
observed in colon of As(III) exposed mice. Similar trends involving an increased ratio of 
Bacteroidetes to Firmicutes have also been associated with type I and type II diabetes 
(Giongo et al, 2011; Larsen et al, 2010) and an opposite trend was observed in obesity 
(Ley et al, 2006). Higher levels of Bacilli and Lactobacillus observed in this study were 
also observed in type 2 diabetic human adults (Larsen et al, 2010). Bacteroidetes are 
gram negative bacteria with LPS in their outer membrane which is an important virulence 
factor and may cause inflammation (Allcock et al, 2001). Additionally Bacteroidetes 
produce small chain fatty acids as end products of their metabolic pathways that have 
important neurological effect on rat brain (MacFabe et al, 2007). Moreover arsenic 
exposure in the environmental settings has been associated with neurological defects, 
type II diabetes and reduced innate immunity ((Bardullas et al, 2009; Kozul et al, 2009a; 
Navas-Acien et al, 2008)). Together they suggest that arsenic induced changes in 
microbial community composition may induce further changes in mouse physiology such 
as nutrient uptake, fat distribution, weight loss, diabetes and innate immune responses.  
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Chapter 5 : SUMMARY AND FUTURE DIRECTIONS 
 
The overall hypothesis of this project was that the chronic exposure to 
environmentally relevant concentrations of As(III) will have direct impact on the 
composition and physiology of the gut microbiota. By using a combination of molecular 
approaches this study has shown that As(III) has time and dose dependent selective effect 
on the murine colon microbiota. These changes in the mouse colon microbiota started 
appearing at 2 weeks of 250 ppb of As(III) exposure and continued in 10 weeks. For 10 
ppb of As(III) exposure levels these changes became significant only after 10 weeks of 
As(III) exposure. Results from the 16S clone libraries showed an increase in 
Bacteroidetes and a proportionate decrease in Firmicutes in 10 and 250 ppb As(III) 
exposed groups versus control groups. Additionally, time and dose dependent changes in 
the physiology of gut microbes was observed in the form of increased expression of nrfA 
from Bacteroides in response to As(III) exposure. However no effect of As(III) exposure 
was observed on the same organism with respect to the expression of genes involved in 
arsenic resistance and detoxification (arsA and arsB). Since evidence for As(III) induced 
changes in mouse liver were seen by two weeks after exposure to 10 ppb of As(III) 
(Straub et al, 2008), it was concluded that the observed changes in the colon microbiota 
occurred more likely in response to As(III) induced changes in mouse physiology rather 
than the direct impact of As(III) on gut microbes.  
The data presented in this work is novel in the sense that it a first step towards 
understanding the in situ effect of chronic exposure to environmentally relevant 
concentrations of As(III) via drinking water on the colon microbiota. This study also 
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sheds light on the possible impact of arsenic on the physiology of microbes residing in 
the gut by using B. thetaiotamicron as the model organism and is the first study to show 
that arsenic resistant genes are expressed in colon microbes under normal conditions of 
the gut. However further work needs to be done to address specific questions such as the 
impact of As(III) associated altered microbiota on the host health and host-microbial 
interactions. The significance of this study is that it provides framework to study the 
effect of other environmental contaminants on the GI tract. In any case, further arsenic 
toxicological studies should include GI microbes as a possible affected organ or as an 
organ that may play a role in arsenic associated disease progression.  
Since enough similarity exists in the colon microbiota of mouse and humans, the 
findings of this study can be investigated on human subjects. The results presented in this 
study do not in any way prove that the microbiota of As(III) exposed mice is unhealthy, 
yet this type of changed microbiota can have health effects in addition to those directly 
related to arsenic exposure such as weight loss, diabetes, colon cancer and other GI tract 
related problems. Metabolomics or proteomics approaches might help in deciphering the 
effect of changed microbiota on host health and will be able to resolve the pathways by 
which As(III) associated changes in colon microbiota may or may not affect the health 
status of its host.   
Reversal studies involving removal of As(III) after few weeks of exposure and 
subsequent microbial studies will help in demonstrating whether As(III) associated 
changes in the microbial community of the host is reversible or not and to what extent. If 
the effect of As(III) is not reversible, then it should be analyzed whether introduction of 
prebiotics/probiotics aids in reestablishment of the normal microflora. Another question 
  
132 
worth investigating would be whether reestablishment of normal microflora reverts any 
of the host physiological conditions caused due to As(III) exposure. These studies will 
help to establish the link between As(III) associated microbiota and host physiology. 
Studies demonstrating the effect of chronic exposures of As(III) at low doses on the 
epithelial lining of the GI tract will help in understanding the mechanisms for selective 
effect of As(III) on gut microbiota. This study will help in enhancing the current view of 
the interactions that happen between the GI tract and its microbiota. 
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APPENDICES 
 
A.1 Materials and methods and results from Study 1 
 
Materials and methods: Similar to section 2.1 to 2.9 except for the following: 
 
Mice Exposure: Sodium arsenite at a concentration of 0 and 250 ppb in drinking water 
was fed to groups of six mice for a period of 2, 5 and 10 weeks. However, only three 
mice were exposed to As(III) for 10 week 0 ppb and 250 ppb group to obtain colon 
samples.   
DNA extraction: Microbial community DNA extraction from the colon of 2 and 5 week 
samples was done by silica and guanidinium thiocynate (GuSCN) method as described by 
Boom et al, 1990. Silica suspension was prepared by adding DI water to 6 g of SiO2 
(spectrum cat.no.S1388) to a total volume of 50 ml and was sedimented for 24 hrs at unit 
gravity. Forty three ml of the supernatant was removed from the silica gradient and the 
volume was again raised to 50 ml with DI water. The silica mix was again allowed to 
settle for 5 hrs at unit gravity. Forty four ml of the supernatant was removed from the 
silica gradient and 60 µl of 32% HCl was added and mixed by vortexing. The silica 
suspension thus obtained was aliquoted in 1.5ml eppendorf tubes and autoclaved. Nine 
hundred μl of lysis buffer L6 [24 g GuSCN, 20 ml of 0.1 M tris HCl (pH 6.4), 4.4 ml 0.2 
M EDTA (pH 8.0) and 0.5 ml Triton X] was added to 40 μl of silica suspension. 
Homogenized mouse colon sample was added to the above mix and vortexed for 5 
seconds. The tubes were incubated at room temperature for 10 minutes, vortexed and 
centrifuged at 12,000 x g for 15 seconds. The supernatant was removed and the pellet was 
washed twice with 1 ml of washing buffer L2 [24 g GuSCN in 20 ml of 0.1 M tris HCl 
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(pH 6.4)] followed by washing with 1 ml of 70% ethanol and 1 ml acetone. The pellet 
was dried after the washings and then resuspended in 50 μl of TE buffer (10 mM tris HCl 
and 1 mM EDTA pH 8.0) by incubating at 56
0
C for 10 minutes in a water bath. Any 
leftover debris was removed by centrifuging at 12,000 x g for 2 minutes and the 
supernatant containing the nucleic acid was transferred to a sterile eppendorf tube and 
quantified. DNA extraction from 10 week samples was done by QIAamp DNA stool mini 
kit as described in section 2.2. 
Reamplification of bands obtained from DGGE gels  
 
 Specific bands were excised from the DGGE gels by using a razor blade 
and were kept in 10 μl of sterile water at 4oC overnight and later transferred to −20oC 
until further use. The excised bands were reamplified using primers HDA1 (without GC 
clamp) and HDA2 (Table 2.1) (Walter et al, 2001). The reaction mixture consisted of 10 
μl of water eluted from DGGE bands, 4 μl of 5X buffer, 10 pmol each of forward and 
reverse primers, 0.4 μl dNTPs from a 200 μM stock, 0.5U of GoTaq DNA polymerase 
(Promega, Madison, WI, USA) and sterile water to a total volume of 20 μl. The reaction 
mixture was denatured at 94
o
C for 5 minutes, followed by 30 cycles of denaturation at 
94
o
C for 30 sec, annealing at 50
o
C for 30 sec, extension at 72
o
C for 30 sec and a final 
extension at 72
o
C for 5 min. After PCR, the amplification was confirmed by visualizing 
the products on a 1.8% agarose gel after EtBr staining. 
Cloning and sequencing of reamplified bands and DGGE-PCR products  
 
The reamplified PCR products and DGGE-PCR products were ligated into the 
pCR2.1®-TOPO vector following the manufacturer’s instructions (Invitrogen TOPO TA 
cloning kit, Invitrogen, Carlsbad, CA, USA). The ligation, transformation and plasmid 
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DNA extraction steps were done as mentioned in section 2.7. Sequencing was done using 
M13 forward and reverse primers provided with the Invitrogen TOPO TA cloning kit. 
The reaction mixture for sequencing consisted of 300 ng plasmid DNA, 3.2 pmol primer, 
4 µl BigDye solution, 2 µl 5X sequencing buffer and sterile water to a total volume of 20 
µl. The reaction conditions involved initial denaturation at 96
o
C for 1 min, 40 cycles of 
denaturation at 96
o
C for   30 sec, annealing at 50
o
C for 5 sec and extension at 60
o
C for 4 
min followed by a final hold at 4
o
C. The completed reaction was then purified using 
Centricep column refilled with 800 µl Sephadex G-50, dried in speed vac and 
resuspended in 10 µl  of deionized formamide and sequenced using a 3100-Avant 
Genetic Analyzer (Applied Biosystems, Foster City, CA, USA).  
Data deposition: The bacterial 16S rRNA gene sequences obtained from study 1 are 
deposited in Genbank database with accession numbers HQ681318-HQ681412 (10 week 
control), HQ681413 - HQ681511 (10 week 250 ppb), HQ681512 - HQ681605 (5 week 
250 ppb) and HQ681606 - HQ681697 (5 week Control). 
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Results: 
DNA extraction: Representative 0.8% agarose gels showing the quality of genomic DNA 
extracted from mouse colon using silica and guanidinium thiocynate method and 
QIAamp DNA stool mini kit are presented in Figure A.1. The 260:280 ratio for the 
extracted nucleic acids obtained with silica and guanidinium thiocynate method was 
generally ≤1.4 whereas with QIAamp DNA stool mini kit the 260:280 ratio varied 
between 1.6-1.8. 
A.           B. 
 
 
Figure A.1: Representative 0.8% agarose gels showing high MW genomic DNA 
obtained from mouse colons by using (A)  Silica and guanidinium thiocynate method and 
(B) QIAamp DNA stool mini kit. L= 100 bp DNA ladder, M= 1Kb DNA ladder.  
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RISA: The spacer region between the 16S and 23S rRNA gene was amplified from 2, 5 
and 10 week mouse colon community DNA. PCR products thus obtained were separated 
on a 5% polyacrylamide gel. Similar to study 2, the product size for the spacer region 
ranged from 300 bps to >1500 bps. Alterations in the RISA profiles of As(III) treated 
mice were observed when compared to the control mice in the form of absence/presence 
of bands and their intensity. These alterations between the control and 250 ppb As(III) 
exposed groups were more consistent and dramatic in 10 week samples than 2 and 5 
week samples (Figure A.2). Dendrogram analysis of the 10 week RISA gel showed 
separate clustering of the control and 250 ppb As(III) exposed groups. However, mixed 
clustering of the control and 250 ppb As(III) exposed groups was observed for 2 and 5 
week samples (Figure A.2). 
 
A. 2 week 
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B. 5 week 
 
C. 10 week 
 
Figure A.2: RISA gels and dendrogram analysis of negative image of RISA fingerprints 
generated from 16S-23S intergenic region of control (blue) and 250 ppb (red) arsenic 
exposed mice at A) 2 week, B) 5 week, and C) 10 week. L= 100 bp DNA ladder. 
Numbers on left side of the DNA ladder represent size of the marker band in base pairs. 
Scale bar on dendrograms represents similarity index values. 
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ARISA: ARISA was performed on 2, 5 and 10 samples using 5’end labeled 1406F and 
23Sr primers. The peaks obtained from ARISA electrophoregrams were analyzed in the 
same way as mentioned in section 3.2. The peak sizes obtained from ARISA profiles of 
this study ranged from 277 bps to 1155 bps representing intergenic spacer region of 27 
bps to 905 bps. The matrices obtained for presence/absence of peaks, relative peak height 
and area were used for Principle Component Analysis (PCA). PCA ordination plots 
obtained from all three matrices showed clear separation of control and 250 ppb As(III) 
exposed samples in case of 10 week samples but not for the 2 and 5 week samples 
(Figure A.3). An exception to this observation was separate clustering of the control 
samples from the 250 ppb As(III) exposed samples in the 2 week binary matrix. However 
similar clustering pattern was not found in the other two matrices (height and area) from 
the 2 week samples. 
2 week 
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5 week 
 
 
10 week 
 
Figure A.3: PCA plots generated from ARISA profiles of bacterial communities from 
control (black squares) and 250 ppb As(III) exposed colons (open squares) of (I) 2, (II) 5 
and (III) 10 week samples. The percentages shown along the axis represent the proportion 
of variation by that axis. PCA plots based on (A) presence/absence of peak (binary), (B) 
relative peak height and (C) relative peak area. Circles represent the groups that cluster 
together. 
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DGGE: A 177 bp long segment of the 16S rRNA gene was amplified from 2, 5 and 10 
week mice colon community DNA. PCR products thus obtained were separated on a 40-
60% DGGE gel and specific bands were excised and sequenced bidirectionally. 
Alterations in DGGE profiles of mice treated with 250 ppb of As(III) were observed 
when compared to the control mice. However, these changes were more consistent and 
dramatic in 10 week samples as compared to 2 and 5 week samples (Figure A.4). 
Dendrogram analysis of the DGGE gel showed clustering of control and 250 ppb As(III) 
exposed groups in two different clades in 10 week samples. Two and 5 week samples 
showed mixed clustering of the control and 250 ppb As(III) exposed groups (Figure A.4). 
Table A.1 shows the taxonomic classification of the sequences obtained from the DGGE 
gels of 2, 5 and 10 week colon samples. 
A. 2 week 
 
 
 
 
  
185 
B. 5 week 
 
C. 10 week 
 
Figure A.4: DGGE and dendrogram analysis of negative image of DGGE fingerprints 
generated from 16S rDNA PCR of  control (blue) and 250 ppb (red) As(III) exposed mice 
at A) 2 week, B) 5 week, and C) 10 week. Numbers on right side of each lane represent 
the sequenced band number. Scale bar on dendrograms represents similarity index values. 
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Taxonomic 
classification 
Time 
point 
Band name 
Unclassified bacteria 
5 week dgge14C1, dgge13C3, dgge5C3, dgge5C4 
10 week dgge19A9, dgge19B5 
Unclassified 
Firmicutes 
2 week 3C3 
10 week dgge19B4, dgge17B1, dgge17B8 
Unclassified 
Bacteroidetes 
2 week 11B1 
Unclassified 
Clostridia 
5 week dgge14A1 
Unclassified 
Clostridiales 
5 week dgge6A1 
Unclassified 
Lachnospiraceae 
2 week 
11A4, 11A5, 11B4, 11B2, 4B1, 3A3, 4A1, 3C2, 
3C5, 4B4 
5 week 
dgge13B1, dgge13A3, dgge14A2, dgge6B3, 
dgge6B2, dgge6B5, dgge6B4, dgge5B1 
10 week 
dgge19C2, dgge19C12, dgge19C5, dgge19B3, 
dgge19A8, dgge17A4, dgge17B6, dgge17C6, 
dgge17B7, dgge17B5, dgge17A1 
Unclassified 
Porphyromonadaceae 
2 week 12C3, 11C1, 11C2, 3A2, 3C1, 4B3, 4B6 
10 week 
dgge17C11, dgge17B10, dgge17A2, dgge17C12, 
dgge17C13, dgge17B2, dgge17C5, dgge17A3 
Unclassified 
Prevotellaceae 
10 week dgge17C4 
Unclassified 
Rikenellaceae 
2 week 12A2 
Unclassified 
Ruminococcaceae 
10 week dgge19A5, dgge19B7, dgge19C4 
Lachnospiraceae 
2 week 4B2, 12A2.1 
5 week 
dgge5C1, dgge6A3, dgge6B1, dgge6A2, dgge6A5, 
dgge5C5, dgge13A1 
10 week dgge17C8, dgge17B4, dgge19C13, dgge19C1 
Porphyromonadaceae 
2 week 12C1, 12B1, 11A1 
10 week 
dgge17C14, dgge17C7, dgge17A7, dgge19A2, 
dgge19C6, dgge19C1 
 
Prevotellaceae 
2 week 3A1 
10 week dgge17B9, dgge17C10, dgge17A5, dgge17A8 
Rikenellaceae 
2 week 
11A3, 12C2, 12B2, 11B3, 4A2, 4A4, 4A3, 4A5, 
4B5 
10 week dgge19C3 
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Taxonomic 
classification 
Time 
point 
Band name 
Ruminococcaceae 
5 week dgge13A2 
10 week dgge19B6, dgge17B3, dgge17A6, dgge19B2 
Anaeroplasmataceae 5 week dgge14C3 
Bacteroidaceae 
2 week 11A2, 3C4 
5 week dgge5C2, dgge14C2, dgge14A3 
10 week 
dgge19C7, dgge17C2, dgge19A1,dgge17C9, 
dgge19C10,dgge17C3, dgge19C8, dgge19C9 
dgge19A3, dgge19A4, dgge19A6, dgge19A7  
 
Deferribacteraceae 
5 week dgge6A4, dgge13B2 
10 week dgge17C1, dgge19B1 
Lactobacillaceae 
2 week 12A 
5 week dgge13C2, dgge13C1, dgge6B6 
 
Table A.1: Taxonomic classification of the bands sequenced from 2, 5 and 10 week 
DGGE gels. Each sequenced band is assigned to the lowest taxonomic level achieved at 
50% confidence threshold. The time point refers to the DGGE gel from which the bands 
were sequenced. Nomenclature of the bands is such that it can be associated with the 
band numbers on the DGGE gels shown in figure A.3. For example, dgge13C2 from 5 
week time point in the last row of the above table refers to band labeled as 2 from 13C 
lane of 5 week DGGE gel. 
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Clone library: A total of 194 clones from 10 week colon samples were analyzed, 32 from 
DGGE bands of control mice, 29 from DGGE bands of As(III) treated mice, 62 from 
control and 70 from 250 ppb of As(III) treated DGGE-PCR product clone library. In case 
of 5 week colon samples, 186 clones were analyzed, 17 from DGGE bands of control mice, 
14 from DGGE bands of As(III) treated mice, 75 from 16S rDNA control clone library and 
80 from 250 ppb of As(III) DGGE-PCR product clone library. The majority of the cloned 
sequences were assigned to the phylum Bacteroidetes and Firmicutes. Very few 
sequences belonging to the phylum Deferribacteres, Verrucomicrobia, Proteobacteria and 
Tenericutes were obtained. Most of the sequences classified under Firmicutes phylum 
were members of the class Clostridia and family Lachnospiraceae. Ruminococcaceae, 
Lactobacillaceae, Clostridiaceae and Erysipelotricheaceae were other families observed 
under the phylum Firmicutes. Within phylum Bacteroidetes, Bacteroidia was the 
predominant class constituted by families Bacteroidaceae, Prevotellaceae, Rikenellaceae 
and Porphyromonadaceae. Only one sequence was observed from the class 
Sphingobacteria, a Bacteroidetes. Furthermore, a number of clones were identified as 
uncultured bacterial clone when the sequences were classified at 90% confidence 
threshold. However the number of unclassified bacteria dropped immensely when 
classification was performed at 50% confidence threshold (Figure A.5). 
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Figure A.5: Class level taxonomic classification of sequences obtained from DGGE-
PCR product clone library. Left side classification was obtained at confidence threshold 
of 50% while right side taxonomic classification was obtained at a confidence threshold 
of 90%. * indicates significantly different from the control group for the same class 
(p<0.01). 
Comparison of the control and 250 ppb libraries at 50% confidence threshold by 
using RDP II library compare tool showed that the two libraries differ with respect to the 
number of sequences that belong to phylum Bacteroidetes at both 5 and 10 weeks. At the 
same time, the control and 250 ppb libraries were different for Firmicutes only at the 5 
week time point. Significant increase in Bacteroidaceae was observed after 250 ppb of 
As(III) exposure at 5 and 10 week intervals.  In the 10 weeks samples, presence of 
  
190 
Prevotellaceae in the control clone library along with significant increase in 
Bacteroidaceae and decrease in Porphyromonadaceae after arsenic treatment kept the 
Bacteroidetes population constant in both control and 250 ppb of As(III) exposed 
libraries. Additionally sequences belonging to the Rikenellaceae family were observed 
only in the 5 and 10 week 250 ppb As(III) exposed clone libraries. The number of 
sequences belonging to class Clostridia and family Lachnospiraceae decreased 
significantly in 5 week samples after 250 ppb of As(III) exposure but did not had any 
effect at 10 weeks. Since most of the sequences that belong to family Lachnospiraceae 
could not be classified any further it was difficult to detect whether arsenic treatment was 
affecting a single or more than one genus from this family.  
Paired comparison of 5 and 10 week control and As(III) treated libraries using 
Libshuff yielded a p-value <0.001, indicating that the two libraries are significantly 
different from each other. Regardless of the As(III) exposure it was found that the 
microbial community of mouse changed over time. The ratio of Firmicutes to 
Bacteroidetes decreased with time from 5 to 10 week in DGGE-PCR products clone 
libraries (Figure A.5, A.6). 
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Figure A.6: Family level taxonomic classification of sequences obtained from DGGE-
PCR product clone library at confidence threshold of 50%. * indicates significant 
difference between the control and 250 ppb As(III) exposed group for the same family 
(p<0.01). 
Microbial diversity: Based on distance matrix, sequences obtained from the 5 and 10 
week DGGE gels and DGGE PCR product based clone library were grouped into the 
same phylotype when they were 97%, 95% or 90% identical. For the combined dataset, 
the number of OTUs with only one sequence at a distance of 0.03, 0.05 and 0.1 were 71, 
45 and 23 respectively. Regardless of As(III) exposure, a total of 121 unique phylotypes 
were identified including 72 and 71 phylotypes from  5 and 10 week clone libraries 
respectively at the distance level of 0.03. The number of unique phylotypes observed in 
the DGGE based clone libraries decreased with an increase in distance. However no 
significant difference in the number of observed OTUs was found in response to the 
As(III) exposure or time. Figure A.7 shows the number of OTUs shared between the 
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control and 250 ppb As(III) exposed clone libraries obtained from the 5 and 10 week 
mouse colon samples at a distance of 0.05. 
 
 
Figure A.7: Venn diagram showing the number of OTUs shared between control and 250 
ppb As(III) treated DGGE-PCR product based clone libraries obtained from 5 and 10 
week colon samples at a distance of 0.05. 250 ppb As(III) exposed groups are indicated 
by experimental in the figure. 
The values obtained from Good’s coverage indicate that sequencing additional 
clones will add only a few OTUs at the family and genus level. For each individual 
library, >80% coverage was observed at distances of 0.05 and 0.10. Table A.2 shows the 
number of OTUs, estimated richness, Good’s coverage and diversity indices obtained 
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from each library and from the combined data set. Overall the Good’s coverage was 88% 
and 94% for the combined libraries at a distance of 0.05 and 0.1 respectively.  
Rarefaction curves obtained for the combined dataset at 0.03 and 0.05 distance 
levels did not reach saturation towards the end of the sampling. However for the 0.05 
distance level, the curve rise was less steep towards the end of the sampling. At 0.1 
distance level the curve almost reached plateau towards the end of sampling (Figure A.8). 
Both rarefaction curves and Good’s coverage estimates indicated that the majority of 
bacteria at the family level of taxonomy have been captured in the current sequencing 
efforts. Similarly, estimation of species richness by Chao’s estimator predicted that 
sequencing more clones could reveal more unique sequences in all the clone libraries 
(Table A.2). The percentage of observed/estimated OTUs was almost similar for both the 
family and genus level and ranged between 43−73%. 
Within the individual library data sets, bacterial diversity at the family and genus 
level as measured by Shannon and Simpson index was highest for the 10 week control 
and lowest for the 5 week control group. These results differ slightly from the microbial 
richness wherein observed number of OTUs as determined by rarefaction curve was 
lowest in the 10 week 250 ppb As(III) exposed group. Overall, no effect of As(III) 
exposure was observed on the microbial diversity of mouse colon at any time point with 
any of the diversity estimations used in this study (Table A.2). 
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Observed 
OTUs 
Chao Estimator 
of species 
richness 
Good’s 
Coverage 
(C)  
Shannon 
Diversity 
Index (H) 
Simpson 
Diversity 
Index (D) 
Distance 0.05 
5wk 
control 
30 60.6 80% 2.733323 0.105829 
5wk 
250 ppb 
33 57.42857 80% 2.971714 0.067948 
5wk all 53 111.6667 82% 3.063833 0.098925 
10wk 
control 
38 63.5 81% 3.392611 0.030459 
10wk 
250 ppb 
29 40 88% 3.009824 0.053597 
10wkall 53 120.6667 85% 3.215441 0.051493 
All 84 154.7143 88% 3.584084 0.049188 
Distance 0.01 
5wk 
control 
18 29.25 89% 1.766123 0.325609 
5wk 
250 ppb 
23 53.33333 85% 2.231012 0.180508 
5wk all 31 69.25 90% 2.153226 0.229468 
10wk 
control 
26 48.75 85% 2.687578 0.096305 
10wk 
250 ppb 
18 27.33333 92% 2.112844 0.184086 
10wk 36 83.5 90% 2.655157 0.128946 
All 52 77.3 94% 2.619702 0.169657 
 
Table A.2: Indices of richness, diversity and library coverage obtained for DGGE-PCR 
product based clonal libraries at distances of 0.05 and 0.10.  
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Figure A.8: Rarefaction curves obtained from all the sequences obtained from the 
DGGE-PCR product based clone library at a distance of 0.03, 0.05 and 0.10. 
Phylogenetic tree: A neighbor joining tree of the representative OTU sequences obtained 
at a distance of 0.05 from the control and 250 ppb DGGE-PCR product based clone 
libraries of 5 and 10 week mouse colon samples was constructed (Figure A.9). A total of 
130 OTUs were represented on the neighbor-joining tree. The phylogenetic tree indicated 
that most of the OTUs identified in the DGGE-PCR product based clone libraries are 
present in the control as well as 250 ppb As(III) exposed groups. The Lachospiraceae 
family formed the largest clade in the phylogenetic tree followed by Bacteroideaceae and 
Porphyromonadaceae. The number of sequences within certain OTUs was drastically 
different between the control and As(III) exposed libraries. For e.g. OTUs represented by 
Rikenellaceae were exclusively obtained from 5 and 10 week 250 ppb of As(III) exposed 
mouse colons. 
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Figure A.9: Neighbor joining tree showing the positions of 16S rDNA phylotypes 
obtained from the mouse colon. Clones obtained from control samples are shown as blue 
circles and those obtained from 250 ppb As(III) exposed samples are shown as red 
triangles. Boot strap values obtained from 1000 replications and above 50% are shown at 
the nodes. Scale bar represents genetic distance based on 10 substitutions per 100 
nucleotides. The number between ―│ │‖ indicates the number of sequences that were 
found under the same representative OTU. 
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A.2 Protocol for 5% polyacrylamide gel 
 
5X TBE buffer 
 
54 g Tris base 
27.5 g Boric acid 
20 ml 0.5M EDTA pH (8.0) 
Make up the volume to 1000 ml with nanopure water  
 
40% Acrylamide/Bis 
 
38.93 g acrylamide 
1.07 g bis-acrylamide 
Dissolve in 100 ml nanopure water 
Filter and store in dark at 4
o
C 
 
10% APS 
 
Dissolve 1g APS in 10 ml nanopure water. 
 
5% polyacrylamide gel 
 
3 ml 5X TBE buffer 
1.87 ml 40% Acrylamide/Bis 
150 µl 10% APS  
15 µl TEMED 
Make up the volume to 15 ml with nanopure water  
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A.3 Protocol for DGGE  
 
50X TAE buffer 
 
242 g Tris base 
57.1 ml glacial acetic acid 
100 ml 0.5M EDTA pH (8.0) 
Make up the volume to 1000 ml with nanopure water  
 
40% Acrylamide/Bis 
 
38.93 g acrylamide 
1.07 g bis-acrylamide 
Dissolve in 100 ml nanopure water 
Filter and store in dark at 4
o
C 
 
10% APS 
 
Dissolve 1g APS in 10 ml nanopure water. 
 
0% Urea-formamide(UF) stock solution for 10% arylamide gels 
 
12.5 ml 40% acrylamide 
1 ml 50X TAE 
Make up the volume to 50 ml with nanopure water  
 
80% Urea-formamide stock solution for 10% arylamide gels 
 
12.5 ml 40% acrylamide 
1 ml 50X TAE 
16 ml ultrapure formamide 
16.8 g Urea 
Make up the volume to 50 ml using pure water. 
 
Working urea-formamide gradient solutions 
40% UF: Mix 5 ml 0% UF stock solution and 5 ml 80% UF stock solution 
60% UF: Mix 2.5 ml 0% UF stock solution and 7.5 ml 80% UF stock solution 
 
Add 100 µl 10% APS and 10 µl TEMED to working gradient solutions immediately 
before pouring the gel.  
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A.4 LB media preparation 
 
LB liquid broth (pH 7) 
 
10 g tryptone  
5 g yeast extract  
10 g NaCl  
Make up the volume to 1 L with nanopure water and autoclave. 
 
LB Agarose plates 
 
10 g tryptone  
5 g yeast extract  
10 g NaCl  
15 g agar 
Make up the volume to 1 L with nanopure water and autoclave. 
  
Ampicillin selective media 
 
Prepare stock solution (100 mg/ml) by dissolving 100 mg ampicillin in 1 ml of 50% 
ethanol. Add 1000 µl of ampicillin stock solution to 1 L of LB media. 
 
X- Gal 
 
Add 40 mg of X-gal to 1ml of dimethylformamide. Use 40 µl of X-gal for each LB plate. 
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A.5 Primers used in section 3.9 
 
Organism 
Gene 
IMG Gene 
Object 
Identifier 
Primer Sequence (5’ to 3’ end) 
Bacteroides 
intestinalis 
rpoB 642809876 
F2168-GGCGTCGTACAAACCAGAAT 
R2368-CCACACGTTCGTTCAATACG 
arsA 642811825 
F59-AGGGCGGTGTAGGAAAAACT 
R253-CTTGTTCCGGGTCGAGATTA 
nrfA 642811669 
F1023-CAATGTGTACGAACGCCAAC 
R1221-ATGGAAAGAACCACCGTGAG 
Prevotella 
melaninogenica 
rpoB 645585915 
F2269- AACGGTGAGTTGGCATTAGG 
R2579-TCGCTTTCACCCTTAGGAGA 
arsA 645586155 
F121-GGCTTGGCAGATAATGGAAA 
R298-TAACGCCTTCCCTGTATTCG 
Oribacterium 
sinus 
rpoB 644432171 
F627-TGTCTTTATTCGTGCGCTTG 
R867-GTATCGTCCCACCTTGGCTA 
arsA 644434364 
F89-GTGCAACAGCAGTGGCTTTA 
R371-AAGGCAGCAATCTCCACTGT 
Lactobacillus 
planatarum 
arsA 
 
637590361 
F274-AGTGTTGTTGGCCCTTATCG 
R734-GGTGTTTTAAGCGTGCCATT 
F715-AATGGCACGCTTAAAACACC 
R1164-CAATACCTGCTGCTCGTCAA 
F1063-ACCGTTCATCTAGCCACCAC 
R1594- GTGTAGCCAGCATGCTTTGA 
F274-AGTGTTGTTGGCCCTTATCG 
R831- CGGCACTTCATACTGAGCAA 
F274-AGTGTTGTTGGCCCTTATCG 
R1164-CAATACCTGCTGCTCGTCAA 
F715-AATGGCACGCTTAAAACACC 
R1594- GTGTAGCCAGCATGCTTTGA 
Clostridium 
phytofermentans 
arsA 
 
641293247 
F254-AGGCTGCTGCTGAATATCGT 
R1017-TTTTCCAACACCACCCTTTC 
F254-AGGCTGCTGCTGAATATCGT 
R1158-ATGCTCATCAATGTGGCTCA 
F998-GAAAGGGTGGTGTTGGAAAA 
R1320-GTTATCTGCACGCTCCACAA 
F254-AGGCTGCTGCTGAATATCGT 
R1320-GTTATCTGCACGCTCCACAA 
Dorea 
formicigenerans 
rpoB 641806964 
F2765-AGATGTCACCGGGAGTGAAC 
R3051-CGCACCATCAAATACAGGTG 
nirB 641808481 
F1026-AGATAACCGCCTGACTGGTG 
R1210-CCGGTGTAAATCTGCAAGGT 
 
Table- 0.3: The sequences for the above genes were retrieved from DOE Joint Genome 
Institute portal (http://img.jgi.doe.gov/) and the primers were designed using primer 3 
program. 
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A.6 Sequences obtained from RISA clone library and their top BLAST result 
 
>12A3 (472 bp) 
GCCAGGCATCCACCATGCGCCCTTAATAACTTAACCTATATTATCTTATGATA
ATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGC
GGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATACTATCTAGTTTT
CAAAGAACAAGTTTGATAACTAATGTTATCAATGGAGCTTAACGGGATCGAA
CCGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAGCCC
CGTATAATGGGCCTAAGGTGGACTCGAACCACCGACCTCACGCTTATCAGGC
GTGCGCTCTAACCAGCTGAGCTATAGGCCCATTTAGCTCTGAGAGTAGACCTC
TCAAAACTAAACAAAGTTTACGATAAAAGTGCAGGTTTCCGAAATTATCCTT
AGAAAGGAGGTGATCCAGCCGCAGGTTCTCCTACGGCTACCTTGTTACGACA 
 
gb|AY526616.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer, tRNA-Ile and tRNA-Ala genes, complete 
sequence; and 23S ribosomal RNA gene, partial sequence Length=762 
 Score =  819 bits (443),  Expect = 0.0, Identities = 463/472 (98%), Gaps = 4/472 (1%) 
 
>12A4 (486 bp) 
GCCAGGCATCCACCATGCGCCCTTAATAACTTAACCTATATTATCTTACGATA
ATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGC
GGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTT
CAAAGAACAAGTTTGATAACTAACGTTATCAATGGAGCTTAACGGGATCGAA
CCGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAGCCC
CAAAATATTTATTTAATGGGCCTAAGTGGACTCGAACCACCGACCTCACGCTT
ATCAGGCGTGCGCTCTAACCAGCTGAGCTATAGGCCCAAAATAAGCAACCTT
GAGAAAAGTAAATCTCTCAAAACTAAACAAAGTTTACGATAAAAGTGCAGGT
TTCCAAATTATCCTTAGAAGGGGGGGATCCAGCCGCAGGTTCTCCTACGGCT
ACCTGGTTACGACA 
 
gb|AY526614.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer, tRNA-Ile and tRNA-Ala genes, complete 
sequence; and 23S ribosomal RNA gene, partial sequence Length=776 
 Score =  822 bits (445),  Expect = 0.0, Identities = 475/488 (97%), Gaps = 8/488 (2%) 
 
>12A6 (395 bp) 
GCCAAGGGCATCCACCATGGCGCCCTTAATAACTTAACCTATATTATCTTACG
ATAATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAA
CGCGGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGT
TTTCAAAGAACAAGTTTGATAACTATTGTTATCAATGGGAGCTTAACGGGATC
GAACCGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAG
CCCCATGTTTTAAGAGTAAACCTCTCAAAACTAAACAAAGTTTACGATAAAA
AGTGCAGGTTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCCAGCCGCAGG
TTCTCCTACGGCTACCTTGTTACGACA 
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gb|AY526613.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer and tRNA-Ala gene, complete sequence; and 
23S ribosomal RNA gene, partial sequence Length=682 
 Score =  669 bits (362),  Expect = 0.0, Identities = 386/396 (97%), Gaps = 8/396 (2%) 
 
>12A7 (542 bp) 
GTCGTACAGGGTAGCCGTACCGGAAGGTGCGGCTGGAACACCTCCTTTCTGG
GAGCGCANAGTTCGTTATCAAGTTGACTCAGAGGTATTAGTTAACTTGTACTA
CGGTTGAATATGTATAAAATATAGATCTACCGGCAATAAAGTGTCGGCAAGA
GAGAAAAATGATGCTGAGGGAAACCAAGGCAAAGTTGACAGTCCTATAGCT
CAGTTGGTTAGAGCGCTACACTGATAATGTAGAGGTCGGCAGTTCANCTCTG
CCTGGGACTACAGAATCTCTGAGAGAGAATTTTGGGGGATTAGCTCAGCTGG
CTAGAGCATCTGCCTTGCACGCAGAGGGTCAACGGTTCGAATCCGTTATTCTC
CACAAAAAAGTTACCGAGACATCAGAAACGTAAAGTAACGACAAGATCTTTG
ACNTGATGGACAACGTAAATAAAGTAACCAGGAGCAAGCTGAANATTTATCA
ATCCGATTTACCCCTGTGGGTANCCGGAAATAAAAAAGTAAGCCAGGGGCAG
ACGGGTGGATGCCNTTGGNCA 
 
gb|EU136697.1|  Parabacteroides goldsteinii strain JCM13446 16S ribosomal RNA 
gene, partial sequence Length=2002 
 Score =  889 bits (481),  Expect = 0.0, Identities = 521/541 (96%), Gaps = 9/541 (2%) 
 
>4A23 (291 bp) 
GCCAGGCATCCACCATGGCGCCCTTAATAACTTAACCTATATTATCTTACGAT
AAATGGTTATGAGTTTAGCGATCANACATTAAATGTTTTAACTCTTTAAAACG
CGGTGTTCTCGGTTATTTTAATTAACANAGAAATAAAAGATATTATCTAGTTT
TCAAAGAACAAGTTTGAGAGTAGACCTCTCAAAACTAAACAAAGTTTACGAT
AAAAGTGCNGGTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCAG
GTTCTCCTACGGCTACCTTGTTACGACA 
 
gb|AY526615.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA 
gene, partial sequence Length=581 
Score =  473 bits (256),  Expect = 2e-130, Identities = 280/292 (96%), Gaps = 6/292 
(2%) 
 
>4A7 (292 bp) 
GCCAGGCATCCACCATGCGCCCTTAATAACTTAACCTATATTATCTTACGATA
ATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGC
GGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTT
CAAAGAACAAGTTTGAGAGTAGACCTCTCAAAACTAAACAAAGTTTACGATA
AAAGTGCAGGTTTCCGAAATTATCCTTAGAANGGAGGTGATCCAGCCGCAGG
TTCTCCTACGGGCTACCTTGTTACGACNA 
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gb|AY526615.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA 
gene, partial sequence Length=581 
Score =  492 bits (266),  Expect = 6e-136, Identities = 283/291 (97%), Gaps = 4/291 
(1%) 
 
>4A17 (293 bp) 
GCCAGGGCATCCACCATGGCGCCCTTAATAACTTAACCTATATTATCTTACGA
TAATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAAC
GCGGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTT
TTCAAAGAACANGTTTGAGAGTAGACCTCTCAAAACTAAACAAAGTTTACGA
TAAAAGTGCAGGTTTCCGAAATCATCCTTAGAAAGGAGGTGATCCAGCCGCA
GGTTCTCCTACGGCTACCTTGTTACGACNA 
 
gb|AY526615.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA 
gene, partial sequence Length=581 
 Score =  486 bits (263),  Expect = 3e-134, Identities = 282/291 (97%), Gaps = 3/291 
(1%) 
 
>4A18 (389 bp) 
GCCAGGCATCCACCATGCGCCCTTAATANCTTAACCTATATTATCTTACGATA
ATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGC
GGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTT
CAAAGAACAAGTTTGATAACTATTGTTATCAATGGAGCTTAACGGGATCGAA
CCGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAGCCC
CATGTTTTAAGAGTAAACCTCTCAAAACTAAACCAAAGTTTACGATAAAAAG
NGCNGGTTTCCGNAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCGGTTCT
CCTACGGCTACCTTGTTACGAC 
 
gb|AY526613.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer and tRNA-Ala gene, complete sequence; and 
23S ribosomal RNA gene, partial sequence Length=682 
Score =  658 bits (356),  Expect = 0.0, Identities = 381/393 (97%), Gaps = 7/393 (2%) 
 
>4A3 (392 bp) 
GCCAGGCATCCACCATGGCGCCCTTAATAACTTAACCTATATTATCTTACGAT
AATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACG
CGGTGTTCTCGGTTATTTTAATTANCAAAGAAATAAAAGATATTATCTAGTTT
TCAAAGAACAAGTTTGATAACTATTGTTATCAATGGAGCTTAACGGGATCGA
ACCGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAGCC
CCATGTTTTAAGAGTAAACCTCTCAAAACTAAACAAAGTTTACGATAAAAAG
TGCNGGTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCAGGTTTCT
CCTANCGGCTACCTNGGTTACGAC 
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gb|AY526613.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer and tRNA-Ala gene, complete sequence; and 
23S ribosomal RNA gene, partial sequence Length=682 
Score =  656 bits (355),  Expect = 0.0, Identities = 382/395 (97%), Gaps = 8/395 (2%) 
 
>4A19 (291 bp) 
GCCAGGCATCCACCATGCGCCCTTAATAACTTAACCTATATTATCTTACGATA
ATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGC
GGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTT
CAAAGAACAAGTTTGAGAGTAGATCTCTCAAAACTAAACAAAGTTTACGATA
AANGTGCAGGGTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCAG
GTCCTCCTACGGCTACCTTGTTACGACA 
 
gb|AY526615.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA 
gene, partial sequence Length=581 
Score =  484 bits (262),  Expect = 1e-133, Identities = 282/291 (97%), Gaps = 4/291 
(1%) 
 
>4A4 (~470 bp) 
GCCAAGGCATCCACCATGCGCCCTTATAACTTAACCTATATTATCTTATGATA
TGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAACTCTTTAAAACGCGG
TGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATACTATCTAGTTTTCA
AAGAACAAGTTTGATAACTAATGTTATCAATGGAGCTTAACGGGATCGAACC
GTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAGCCCCG
TATANTGGGCCTAAGTGNACTCCNAACCACCGACCTCACGCTTATCAGGCGT
GCGCTCTAACCAGCTGAGCTATAGGCCCATTTACTCCTGAGNGTAANCCNCN
CCAAACTAACCAANGTTANNATAANGGNGCGGGTTTCCGAAATTATCCTTAA
AAAGGNGGGTGANCCCCCCCCCGGTTNCCCTACGGGTACCTTGGTACNACA 
 
gb|AY526616.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer, tRNA-Ile and tRNA-Ala genes, complete 
sequence; and 23S ribosomal RNA gene, partial sequence Length=762 
Score =  649 bits (351),  Expect = 0.0, Identities = 431/473 (91%), Gaps = 14/473 (3% 
 
>4A12 (389 bp) 
GCCAGGCATCCACCATGGCGCCCTTAATAACTTAACCTATATTATCTTACGAT
NATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACG
CGGTGTTCTCGGTTATTTTAATTAACAAAGAATAAAAGATATTATCTAGTTTT
CAAAGAACAAGTTTGATAACTATTGTTATCAATGGAGCTTAACGGGATCGAA
CCGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAGCCCC
ATGTTTTAAGAGTAACCCTCTCAAAACTAAACAAAGTTTACGATAAAAGGTG
CAGGTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCAGGGTTCTC
CTACGGCTACCTTGTTACGACA 
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gb|AY526613.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer and tRNA-Ala gene, complete sequence; and 
23S ribosomal RNA gene, partial sequence Length=682 
Score =  649 bits (351),  Expect = 0.0, Identities = 380/393 (97%), Gaps = 8/393 (2%) 
 
>4A20 (290 bp) 
GCCAGGCATCCACCATGCGCCCTTAATAACTTAACCTATATTATCTTACGATA
ATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGC
GGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTT
CAAAGAACAAGTTTGAGAGTAGACCTCTCAAAACTAAACAAAGTTTACGATA
AAAGTGCGGGTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCAGG
TTCTCCTACGGCTACCTTGTTACGACA 
 
gb|AY526615.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA 
gene, partial sequence Length=581 
Score =  494 bits (267),  Expect = 2e-136, Identities = 283/290 (98%), Gaps = 3/290 
(1%) 
 
>4A6 (289 bp) 
GCCAGGCATCCACCATGCGCCCTTAATAACTTAACCTATATTATCTTACGATA
ATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAACTCTTTAAAACGCG
GTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTTC
AAAGAACAAGTTTGAGAGTAGACCTCTCAAAACTAAACAAAGTTTACGATAA
AAGNGCNGGTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCAGGT
TCTCCTACGGCTACCTTGTTACGACA 
 
gb|AY526615.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA 
gene, partial sequence Length=581 
Score =  486 bits (263),  Expect = 3e-134, Identities = 281/290 (97%), Gaps = 4/290 
(1%) 
 
>4A15 (292 bp) 
GCCAGGCATCCACCATGGCGCCCTTNAATAACTTAACCTATATTATCTTACGA
TAATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAAC
GCGGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTT
TTCAAAGAACAAGTTTGAGAGTAGACCTCTCAAAACTAAACAAAGTTTACGA
TAAAAGTGCAGGTTTCCGAAATTATCCTTAGAAAGGAGGTGATCCAGCCGCA
GGGTTCTCCTACGGCTACCTTGTTACGAC 
 
gb|AY526615.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA 
gene, partial sequence Length=581 
Score =  486 bits (263),  Expect = 3e-134, Identities = 284/293 (97%), Gaps = 6/293 
(2%) 
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>4A5 (388 bp) 
GCCAGGCATCCACCATGCGCCCTTATANCTTAACCTATATTATCTTACGATAA
TGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGCG
GTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTTC
AAAGAACAAGTTTGATAACTATTGTTATCAATGGAGCTTAACGGGATCGAAC
CGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAGCCCC
ATGTTTTAAGAGTAAACCTCTCAAAACTAAACANAGTTTACGATAANAAGTG
CAGGTTTCCGAAATTATCCTTAGAAAGGNGGTGATCCNGCCGCNGGTTCTCCT
ACGGCTACCTTNGTTACAAC 
 
gb|AY526613.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer and tRNA-Ala gene, complete sequence; and 
23S ribosomal RNA gene, partial sequence Length=682 
Score =  647 bits (350),  Expect = 0.0, Identities = 375/389 (96%), Gaps = 6/389 (2%) 
 
>4A21 (~482 bp) 
GCCAGGCATCCACCATGGCGCCCTTAATAACTTAACCTATATTATCTTAACGA
TAATGGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAAC
GCGGTGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTT
TTCAAAGAACAAGTTTGATAACTAACGTTATCAATGGAGCTTAACGGGATCG
AACCGTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAAAGC
CCCGTATANTGGGCCTAAGTGGACTCGAACCNCCGACCTCACGCTTATCNGG
CGTGCGCTCTAACCAGCTGAGCTATAGGNCCNTTTAGCTCTGAAGAGTAGAC
CTCTCAAAACTAAACANAGGTTTACGATAANNGTGGCNGGTTTCCCNAAATT
ATCCTTAGAAAGGGAGGNGATCCNNNCCCGNNGGTTCNCCCACGGGCTACNT
TGGTTCNAACG 
 
gb|AY526616.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer, tRNA-Ile and tRNA-Ala genes, complete 
sequence; and 23S ribosomal RNA gene, partial sequence Length=762 
Score =  693 bits (375),  Expect = 0.0, Identities = 419/443 (95%), Gaps = 10/443 (2%) 
 
>4A1 (~486 bp) 
GCCAGGCATCCACCATGCGCCCTTATACTTAACCTATATTATCTTACGATAAT
GGTTATGAGTTTAGCGATCAAACATTAAATGTTTTAAACTCTTTAAAACGCGG
TGTTCTCGGTTATTTTAATTAACAAAGAAATAAAAGATATTATCTAGTTTTCA
AAGAACAAGCTTGATAACTAACGTTATCAATGGAGCTTAACGGGATCGAACC
GTTGACCTCCTGCGTGCAAAGCAGGCGCTCTCCCAGCTGAGCTAANGCCCCA
AAATATTTATTTAANGGGGCCTAGGNGGACTCGAACCCCCGACCTCACGCTT
ATCNGGCGTGCGCTCTAACCAGNTGAGCTATNNGCCCAAATAAGCAACCTTN
GAANAAAAGTANANCTCTCAAACTAACAAAGTTTACGANNANGGTGCNGGN
TCCNAAATTACCCTTNGAANGAGGGGNTCCCNCCCCCNGGTNCNCNTACNGG
CTACCTTGGTANNAAC 
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gb|AY526614.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer, tRNA-Ile and tRNA-Ala genes, complete 
sequence; and 23S ribosomal RNA gene, partial sequence Length=776 
Score =  651 bits (352),  Expect = 0.0, Identities = 436/485 (90%), Gaps = 16/485 (3%) 
 
>4A2 (~290 bp) 
GCCAAGGCATCCACCATGCGCCCTTAATACTTAACCTATATTATCTTACGATA
ATGGNNATGGAGTTTAGCGATCAAACNTTAAATGTTTTTAAACTCTTTGNNNC
GCGGTGTTCTCGGTTATTTTAATTAACAANGAATAAAAGATTTTATCTAGTTT
TTCAAGAACAAGTTTGAGAGTAGGCCTCTCAAACCTANGCAAAGTTTNCATG
AGGGGGNNGGGNTCCNAAATTATCCTTAAAAGGTAGGGGACCCANCCCCNA
GTTCCCCTNCGGNNACNTTNNAACNANA 
 
gb|AY526615.1|  Lactobacillus animalis strain LA51 16S ribosomal RNA gene, partial 
sequence; 16S/23S rRNA intergenic spacer, complete sequence; and 23S ribosomal RNA 
gene, partial sequence Length=581 
Score =  292 bits (158),  Expect = 6e-76, Identities = 237/280 (85%), Gaps = 13/280 
(5%) 
 
>4A22 (Incomplete sequence) 
GTCGTACAGGTAGCCGTATCGGAAGGTGCGGCTGGATCACCTCCTTTCTAGG
GAAAAAGTAGGGGTTGGATTACTGTCTAGTTGTCAAGGAGTCCGTGCGGCGG
AAGACATATAGGAACAGCTGCTGTGCTTGCACAGGCAGATGTGGATATATGG
ATTCCGGCATAAGGCNAATGACCGAGCGCGAGGTATTGCAAANCATTACCCG
AGAGTGCGGGGATTCGAGNCACGGGGCNGAGTAAATAAAANACNACNCAAN
NANANGNNTTCNCGNTGGCCAATGCCCCTTATGGGNACACCCCCCGTTTCNC
NTCCCAAACACGNNGGTTAANCCCGTANGCGGGCCGAA 
 
gb|GU208684.1|  Alicyclobacillus tolerans strain DSM 16297 16S-23S ribosomal RNA 
intergenic spacer and 23S ribosomal RNA gene, partial sequence Length=366 
Score = 99.0 bits (53),  Expect = 2e-17 Identities = 65/70 (93%), Gaps = 4/70 (6%) 
 
>4A13 (Incomplete sequence) 
GGTCGTAACAAGGGTAGCCGTATCGGNAAGGTGCGGCTGGATCACCTCCTTT
CTAGGGAAGAAGAAGTAGGGTTGTATTGCTGTTTAAAAGTGAAGGATTCCGG
TGGTGATGCNCTTAGGGGANACACACGTACCCTTCCCGAACACGATCGTTAA
GACTTAAGCGGCCGATGGTACTATACTGGAGACGGTATGGGAGAGCAGGTGT
NGTGCCGGAACNTAAAAAACATTTAGAATTGCTGGTTTTACCNGGGATCAGA
GACNGGGACANAGATTCTTTGNATCTGATGGCTGATAAAGCCTNCACCCATG
GCATGTGAAAACTTGTCCGNANCCCAAAGAGGNCCCCCCGTACCTTTAAAAA
CCAAATATTGNANANTTCTTTTTTACCNGNTTTGCCANCGAAGATNCC 
 
gb|CP001107.1|  Eubacterium rectale ATCC 33656, Features in this part of subject 
sequence: rRNA-16S ribosomal RNA rRNA-5S ribosomal RNA, complete genome 
Length=3449685 
Score =  163 bits (88),  Expect = 8e-37 Identities = 183/227 (81%), Gaps = 19/227 (8%) 
  
209 
A.7 Clustal alignment of ars genes from the two operons of B. thetaiotamicron  
 
arsA 
 
operon2            ATGAAAGCATTCAATTTATCCGATATAGAACTGACTAAATACCTGTTTTTTACAGGTAAA 60 
operon1            ATGAAAGCATTTAATTTATCCGATATAGAACTAACAAAATACTTATTCTTCACAGGAAAA 60 
                   *********** ******************** ** ****** * ** ** ***** *** 
 
operon2            GGTGGAGTAGGAAAGACTTCTATTGCTTGTGCCACAGCAGTTGGTTTGGCTGATAAGGGA 120 
operon1            GGTGGAGTAGGAAAAACCTCTATTGCTTGCGCTACGGCAGTGGGATTAGCTGATAAAGGG 120 
                   ************** ** *********** ** ** ***** ** ** ******** **  
 
operon2            AAGAAAATACTTCTTATCAGTACAGATCCGGCTTCTAACTTACAAGATGTTTTCGATCAA 180 
operon1            GAGAAAATTCTTCTTATCAGTACAGACCCGGCTTCTAACCTGCAAGATGTTTTCAATCAA 180 
                    ******* ***************** ************ * ************ ***** 
 
operon2            TCCTTAAACGGACACGGTACAGCTATTTCAGAAGTGCCGGGACTGACTGTTGTAAACCTT 240 
operon1            ACCCTAAACGGACATGGTACAGCTATTTCAGAAGTACCGGGGCTGACGGTCGTAAACCTT 240 
                    ** ********** ******************** ***** ***** ** ********* 
 
operon2            GATCCTGAGCAGGCAGCAGCAGAATACAGAGAAAGTGTTATTGCACCTTTCAGGGGAAAA 300 
operon1            GACCCTGAACAGGCAGCAGCAGAGTACAGGGAAAGTGTGATTGCACCTTTTAGAGGACAA 300 
                   ** ***** ************** ***** ******** *********** ** *** ** 
 
operon2            TTACCCGAAAGCGTTATTCAGAATATGGAAGAACAGCTTTCAGGTTCCTGCACAGTAGAA 360 
operon1            TTACCTGAAAGCGTTATTCAAAATATGGAAGAACAACTTTCAGGCTCTTGTACGGTAGAA 360 
                   ***** ************** ************** ******** ** ** ** ****** 
 
operon2            ATCGCAGCTTTTAATGAGTTCTCGGACTTTATTACCGATGCTGATAAAGCAAAGGAGTAT 420 
operon1            ATCGCTGCCTTTAATGAGTTTTCAGACTTTATCACCGATGCTGATAAAGCGAAGGAATAC 420 
                   ***** ** *********** ** ******** ***************** ***** **  
 
operon2            GACCATATAATTTTTGATACAGCACCTACCGGACATACATTGCGAATGTTGCAGCTTCCA 480 
operon1            GACCACATTATTTTTGATACAGCACCTACCGGACACACATTGCGAATGTTGCAGCTTCCA 480 
                   ***** ** ************************** ************************ 
 
operon2            TCTGCATGGAGTACATTTATTAGTGAAAGTACACATGGTGCATCCTGTTTAGGGCAGTTA 540 
operon1            TCGGCATGGAGTACATTTATTAGTGAAAGTACACATGGCGCATCTTGTTTAGGACAATTA 540 
                   ** *********************************** ***** ******** ** *** 
 
operon2            TCAGGCTTGGAGGAACGGAAAGGAATTTATAAACAGGCGGTAGAAACCCTATCTAATACA 600 
operon1            TCAGGCTTGGAAGAAAGGAAAGGTATCTATAAACAGGCGGTTGATACATTGTCTGATACA 600 
                   *********** *** ******* ** ************** ** **  * *** ***** 
 
operon2            AGCGCAACTCGGTTAGTACTGGTCAGTCGTCCTGAAATTTCTCCATTGAAAGAAGCTGCC 660 
operon1            AGCGCAACCCGGTTAGTATTGGTAAGCCGTCCTGAAATAGCACCGTTGAAAGAAGCTGCC 660 
                   ******** ********* **** ** ***********  * ** *************** 
 
operon2            CGCTCTTCATCTGAATTACAGCTATTGGGAATTAAAAATCAGTTGTTGGTGATAAATGGT 720 
operon1            CGTTCTTCGCATGAATTACAACTATTGGGAATTAAAAATCAGCTATTGGTGATAAATGGT 720 
                   ** *****   ********* ********************* * *************** 
 
operon2            ATTTTACAGCAACTGAATGAAGCGGATGATGTGTCACGACAACTGCATAACAGGCAGCAA 780 
operon1            GTTTTACAGCAATTAGATGAAGCAGACAATGTTTCACAACAACTGTATAACAGGCAGCAA 780 
                   *********** *  ******* **  **** **** ******* ************** 
 
operon2            AAGGCATTACAGGGTATGCCTGCTGAACTATCTGAATATCCTATGTACAGCGTTCCTCTA 840 
operon1            AAGGCGTTACAAAGTATGCCTATTGCATTATCTGAATATCCCATGTATAGCGTTCCTCTG 840 
                   ***** *****  ********  ** * ************* ***** ***********  
 
operon2            CGTTCTTATAATTTATCTGATATAGCTAATATACGCCGTATGTTATACAGCGACAGCCTT 900 
operon1            CGTTCTTACAATTTATCCAATATTGCCAATATCCGCCGTATGCTATACAGTGATAGTATT 900 
                   ******** ********  **** ** ***** ********* ******* ** **  ** 
 
operon2            GCGGATGATATTTGTTATCAGCCTGTAAGTGGTGCTAAAAGTATAGACGACTTGGTTAAT 960 
operon1            ACGAATGAAATTCGTTATCAGCCGATAACTGATAGCAAAAGTATAGATGAATTGGTAAAT 960 
                   ** **** *** **********  *** ** *   *********** ** ***** *** 
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operon2            GACCTCTATACTTCCGGTAAGCGGGTAGTGTTCACAATGGGAAAAGGCGGTGTAGGTAAA 1020 
operon1            GACCTCTATACTTCCGGTAAACGAGTAGTGTTCACAATGGGAAAAGGTGGCGTAGGAAAA 1020 
                   ******************** ** *********************** ** ***** *** 
 
 
operon2            ACTACCTTAGCAACAGAAATAGCTCTGAAATTAACAAAACTCGGTGCAAAGGTACATCTT 1080 
operon1            ACGACCTTAGCCACAGAAATAGCCTTGAAATTAACAAAGCTCGGTGCAAAGGTTCATCTT 1080 
                   ** ******** ***********  ************* ************** ****** 
 
operon2            ACCACCACTGATCCGGCAAACCATCTGAACTATGATCTCGCTATAAAGTCGGGTATTACA 1140 
operon1            ACCACTACTGACCCGGCAAATCACCTGAACTATGATTTTGCCATCAAATCAGGTATTACG 1140 
                   ***** ***** ******** ** ************ * ** ** ** ** ********  
 
operon2            GTAAGTCATATTGATGAAGCGGAAGTATTGGAAAACTACAAGAATGAAGTTCGTAGCAAA 1200 
operon1            GTAAGCCATATAGACGAAGCGGAAGTGCTGGAAAAATACAAGAATGAAGTTCGTAGCAAA 1200 
                   ***** ***** ** ***********  ******* ************************ 
 
operon2            GCGGCAGAAACCATGACTGCCGAAGATATGGAATATATTGAAGAAGATTTACGTTCGCCA 1260 
operon1            GCTGCCGAAACCATGACTGCCGAAGATATGGAATATATAGAGGAAGATTTACGTTCACCA 1260 
                   ** ** ******************************** ** ************** *** 
 
operon2            TGCACACAAGAAATCGCAGTTTTCAAGGCATTTGCCGAAATTGTAGATAAAGCGGACAAT 1320 
operon1            TGTACGCAAGAAATCGCCGTATTTAAGGCTTTTGCTGAAATTGTAGATAAAGCGGAGAAT 1320 
                   ** ** *********** ** ** ***** ***** ******************** *** 
 
operon2            GAAATTGTGGTGATTGATACTGCACCGACAGGTCATACATTGTTGCTTTTGGATGCTACC 1380 
operon1            GAAATCGTAGTGATTGATACTGCACCAACAGGACATACTTTGTTGCTTTTGGATGCTACC 1380 
                   ***** ** ***************** ***** ***** ********************* 
 
operon2            CAAAGCTACCATAAAGAAGTAGAACGTACCCAAGGAGCAGTTACGGGAGCGGTAGCCAAT 1440 
operon1            CAAAGCTATCACAAAGAAGTAGAACGTACACAGGGAGAAGTAACCGGAGCAGTAGCCAAT 1440 
                   ******** ** ***************** ** **** *** ** ***** ********* 
 
operon2            TTATTGCCCCGTTTGCGTAATCCAAAGGAAACGGAAGTCGTAATTGTTACCTTGCCTGAA 1500 
operon1            TTATTACCCCGTTTACGCAATCCACAGGAAACGGAAGTAGTAATAGTCACTTTACCCGAA 1500 
                   ***** ******** ** ****** ************* ***** ** ** ** ** *** 
 
operon2            GCGACACCTGTATTTGAAGCTGAACGCCTGCAAATGGATTTGCAACGCGCCGGAATTAAT 1560 
operon1            GCAACACCTGTTTTTGAAGCAGAACGCCTACAAATGGATTTGCAGCGTGCCGGGATTAAC 1560 
                   ** ******** ******** ******** ************** ** ***** *****  
 
operon2            AACAAATGGTGGGTAGTAAATGCCTGCCTGTCAATGACAAATACGGAAAATTCATTTTTG 1620 
operon1            AACAAATGGTGGGTAGTAAATGCCTGTTTGTCATTGACAAATACAGCAAATTCATTTTTG 1620 
                   **************************  ***** ********** * ************* 
 
operon2            CAGGCGAAAGCACAAAATGAAGTAAATTGGATTAAGAAAGTAGAACAATTGTCAAAGGGT 1680 
operon1            CAAGCAAAAGCGCAAAGTGAATTGACTTGGATTAAGAAAGTAGAAGAATTGTCAAAGGGC 1680 
                   ** ** ***** **** **** * * ******************* *************  
 
operon2            AATGCTGCCTTGATTGGATGGAAAAATATATAG 1713 
operon1            AATACTGCCCTGATTGAATGGAAAAACTTATAA 1713 
                   *** ***** ****** *********  ****  
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operon2            ATGGAAAAATATATAGGAATTGGATTTTTTGAAAGATACCTGACTGTTTGGGTAACTTTG 60 
operon1            ATGGAAAAGAAACAAGGAATTGGATTTTTTGAAAGATACCTGACTATTTGGGTAGCCTTG 60 
                   ********  *   ******************************* ******** * *** 
 
operon2            TGCATTGTTGCTGGTATTGCTATCGGACAATGGTTTCCGGCAATATCGCAAACATTGAGT 120 
operon1            TGTATCGTTATCGGGATAGCCATCGGACAATATCTTCCGGCAATACCGCAAACATTGAGC 120 
                   ** ** ***   ** ** ** **********   *********** *************  
 
operon2            AAATTAGAATACGCCAATGTGTCTATACCTGTGGCTATCCTGATTTGGTTAATGATTTAC 180 
operon1            AAATTTGAATATGCCAACGTGTCTATACCTGTGGCTATCCTGATTTGGTTAATGATATAT 180 
                   ***** ***** ***** ************************************** **  
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operon2            CCCATGATGCTGAAAGTAGATTTTCAGAGTATTAAAAACGTTGGTAAGCGTCCGAAAGGA 240 
operon1            CCCATGATGCTGAAAGTAGATTTTCAGAGCATCAAGAACGTAGGCAAACGTCCGAAAGGG 240 
                   ***************************** ** ** ***** ** ** ***********  
 
operon2            ATTATCATCACTTGTATTACAAATTGGCTTATAAAGCCTTTTACAATGTTTGGAATAGCT 300 
operon1            ATTGTCATTACTTGTGTGACGAACTGGGTAATAAAGCCATTCACCATGTTTGGAATAGCT 300 
                   *** **** ****** * ** ** *** * ******** ** ** *************** 
 
operon2            TATCTATTCTTCTACGTTGTTTTCAAGTCTCTAATATCTGCCGAATTGGCCGAAGAATAT 360 
operon1            TATCTATTCTTCTACGTTATTTTCAAGTCATTAATCCCTGCCGGATTAGCCGAAGAATAT 360 
                   ****************** **********  ****  ****** *** ************ 
 
operon2            TTAGCAGGGGCAGTCTTATTGGGTGCTGCACCTTGTACGGCAATGGTATTTGTATGGAGT 420 
operon1            TTAGCTGGGGCAGTTCTGTTAGGTGCTGCACCCTGTACGGCGATGGTGTTTGTATGGAGT 420 
                   ***** ********  * ** *********** ******** ***** ************ 
 
operon2            TATCTGACCAAAGGGGATGCTGCCTATACATTGGTGCAGGTTGCAGTGAATGATTTAATC 480 
operon1            CATTTAACCAAAGGGGATGCAGCTTACACATTGGTGCAAGTGGCAGTCAATGATTTAATA 480 
                    ** * ************** ** ** *********** ** ***** ***********  
 
operon2            ATATTGGTTGCTTTCGCTCCTATTGTTGCTTTTTTATTGGGCGTAGGTGGCGTTACGATT 540 
operon1            ATATTGGTTGCTTTCGCTCCTATCGTTGCGTTTTTGTTGGGTGTCGGTGGCGTTTCTATC 540 
                   *********************** ***** ***** ***** ** ********* * **  
 
operon2            CCGTGGGATACATTATTGCTTTCAGTTGTATTGTTTGTTGTCATTCCTCTTTCTGCCGGA 600 
operon1            CCGTGGGACACGCTTATACTCTCGGTCGTACTGTTTGTTGTCATTCCACTTTCTGCCGGA 600 
                   ******** **  *  * ** ** ** *** **************** ************ 
 
operon2            ATAATAACCCGCATACTGGTTATCCGGCGAAAAGGGATAGAATATTTTAATACTGTATTT 660 
operon1            ATAGTAACCCGTGTAACGGTTATCCGGCGAAAAGGAATAGACTATTTCAATACCGTCTTT 660 
                   *** *******  **  ****************** ***** ***** ***** ** *** 
 
operon2            ATCCGTAAGTTTGATAATTATACGACTGGCGGGTTACTATTAACGCTTATCATTCTGTTT 720 
operon1            GTCCGCAAGTTCGATAACTATACGGTTGGCGGATTGCTATTAACGCTTATCATCCTGTTT 720 
                    **** ***** ***** ******  ****** ** ***************** ****** 
 
operon2            TCATTTCAAGGAGAAACCATATTGAACAATCCGTTGCACATCGTATTGATTGCCGTTCCG 780 
operon1            TCGTTTCAGGGGGAAACGATACTGAACAATCCGTTACATATTGTCTTGATTGCCGTCCCG 780 
                   ** ***** ** ***** *** ************* ** ** ** *********** *** 
 
operon2            CTTGTGTTGCAAACAGTTCTGATATTCTTTGTAGCCTATGGTTGGGCGAAATGGTGGAAA 840 
operon1            CTTGTCCTGCAAACGGTTCTGATATTCTTTGTTGCCTACGGTTGGGCAAAGTGGTGGAAG 840 
                   *****  ******* ***************** ***** ******** ** ********  
 
operon2            TTACCTCACAATATAGCTGCACCTGCCGGAATGATTGGTGCAAGCAATTTTTTTGAATTA 900 
operon1            TTACCCCACAATGTCGCCGCACCTGCCGGAATGATTGGTGCGAGTAACTTCTTTGAGTTG 900 
                   ***** ****** * ** *********************** ** ** ** ***** **  
 
operon2            TCGGTGGCTGTGGCTATATCGCTTTTCGGTTTGCAATCCGGTGCTGCATTGGCTACAGTG 960 
operon1            GCGGTGGCGGTGGCTATTTCTCTTTTCGGCTTACAGTCCGGTGCTGCACTGGCTACCGTA 960 
                    ******* ******** ** ******** ** ** ************ ******* **  
 
operon2            GTAGGGGTGTTGGTTGAAGTTCCGGTTATGCTGATGTTAGTGAGAGTTGCAAATAATACA 1020 
operon1            GTAGGCGTATTGGTTGAAGTTCCAGTAATGCTTATGTTAGTAAAAATAGCCAATAATACA 1020 
                   ***** ** ************** ** ***** ******** * * * ** ********* 
 
operon2            TACAGGTGGTTTACAATAAAATCAAGTATGAGTAAATAG 1059 
operon1            AGAAGTTGGTTTCC--TAAAGTAAAATAA---------- 1047 
                      ** ****** *  **** * ** **            
 
arsR 
 
Operon1       ATGGGTCACCCGGCACGAATGGCAATTCTTAGTTTCTTAGCTAAACAAGAAAGTTGTTTC 
Operon2       ATGGGACACCCGGCACGAATGGCTATTCTTAGTTTCTTGGCTAAACAGGAAAGTTGTTTC 
              ***** ***************** ************** ******** ************ 
 
Operon1       TTCGGAGATATTCACGAAGTACTACCCATTGCTAAAGCAACCGTTTCGCAGCATTTAAAA 
Operon2       TTCGGAGATATTCACGAAGAATTGCCTATTGCCAAAGCAACCGTTTCACAGCACTTGAAA 
              ******************* * * ** ***** ************** ***** ** *** 
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Operon1       GAACTGAAAGATGCAGGGTTAATTCAGGGGGAAATAGAAACACCAAAAGTTCGGTATTGT 
Operon2       GAGCTGAAAGATGCAGGATTAATTCAGGGAGAAATAGAAACGCCCAAGGTGCGATATTGT 
              ** ************** *********** *********** ** ** ** ** ****** 
 
Operon1       ATCAACCGAGAGAATTGGGAACTTGCCCGTAAATTATTTGCTGCATTTTTGGGTGATTGT 
Operon2       ATTAATAAGGAAAATTGGGAACTTGCCCGCAAATTATTTGCTGCATTTTTGGGAGATTGT 
              ** **    ** ***************** *********************** ****** 
 
Operon1       AAATGTACGGGTACATCGTGCTGTGGATAA 
Operon2       AAATGTACAGGAACATCGTGCTGTGGATAA 
              ******** ** ****************** 
arsD 
Operon1       ATGAAAACAATAGAAATTTTTGACCCGGCAATGTGTTGCCCTACGGGTTTGTGTGGAACT 
Operon2       ATGAAAAAGATAGAAATTTTTGATCCGGCAATGTGTTGCCCTACGGGTTTGTGTGGAACA 
              *******  ************** ***********************************  
 
Operon1       AATATTAATCCTGAATTAATGAGGATAGCCGTTGTTATCGAAACATTGAAAAGACAGGGT 
Operon2       AATATCAATCCTGAATTGATGAGGGTTGCAGTTGTTGTCGAAACATTGAAAAGACAGGGT 
              ***** *********** ****** * ** ****** *********************** 
 
Operon1       GTTGTTGTTACCCGTCATAATTTGCGGGACGAACCGCAAGTTTATGTAAGTAACAAGACT 
Operon2       GTTATTGTTACCCGTCACAATTTACGGGATGAACCACAGGTGTATGTGAGCAATAAAACA 
              *** ************* ***** ***** ***** ** ** ***** ** ** ** **  
 
Operon1       GTAAACCAATATCTTCAAAAGAATGGTGCAGAAGCACTGCCTATTACTTTGGTGGATGGT 
Operon2       GTAAATGAATATCTTCAAAAGAATGGTGCAGAAGCTTTACCTATTACTTTAGTAGATGGT 
              *****  ****************************  * *********** ** ****** 
 
Operon1       GAAATTGCAGTTTCTAAAGATTATCCCACAACTAAACAAATGAGTGAATGGACAGGAATT 
Operon2       GAAATTGCAGTTTCTAAAGTTTATCCTACCACTAAACAAATGAGTGAATGGACGGGAGTG 
              ******************* ****** ** *********************** *** *  
 
Operon1       AATTTAGACTTGATGCCCGTTAAATAA 
Operon2       AATTTAGATTTAATGCCCGCTAAATAA 
                                  ******** ** ******* ******* 
 
 
